id	sid	tid	token	lemma	pos
dpc-4071	1	1	dermatology	dermatology	NOUN
dpc-4071	1	2	:	:	PUNCT
dpc-4071	1	3	practical	practical	ADJ
dpc-4071	1	4	and	and	CCONJ
dpc-4071	1	5	conceptual	conceptual	ADJ
dpc-4071	1	6	original	original	ADJ
dpc-4071	1	7	article	article	NOUN
dpc-4071	1	8	|	|	ADV
dpc-4071	1	9	dermatol	dermatol	ADJ
dpc-4071	1	10	pract	pract	NOUN
dpc-4071	1	11	concept	concept	NOUN
dpc-4071	1	12	.	.	PUNCT
dpc-4071	2	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	2	2	1	1	NUM
dpc-4071	2	3	frequency	frequency	NOUN
dpc-4071	2	4	and	and	CCONJ
dpc-4071	2	5	correlation	correlation	NOUN
dpc-4071	2	6	of	of	ADP
dpc-4071	2	7	peripheral	peripheral	ADJ
dpc-4071	2	8	and	and	CCONJ
dpc-4071	2	9	tissue	tissue	NOUN
dpc-4071	2	10	eosinophilia	eosinophilia	NOUN
dpc-4071	2	11	with	with	ADP
dpc-4071	2	12	clinical	clinical	ADJ
dpc-4071	2	13	manifestations	manifestation	NOUN
dpc-4071	2	14	in	in	ADP
dpc-4071	2	15	 	 	SPACE
dpc-4071	2	16	patients	patient	NOUN
dpc-4071	2	17	with	with	ADP
dpc-4071	2	18	bullous	bullous	ADJ
dpc-4071	2	19	pemphigoid	pemphigoid	ADJ
dpc-4071	2	20	bahareh	bahareh	NOUN
dpc-4071	2	21	abtahi	abtahi	NOUN
dpc-4071	2	22	-	-	PUNCT
dpc-4071	2	23	naeini1,2	naeini1,2	PROPN
dpc-4071	2	24	,	,	PUNCT
dpc-4071	2	25	farhad	farhad	VERB
dpc-4071	2	26	zare	zare	PROPN
dpc-4071	2	27	-	-	PUNCT
dpc-4071	2	28	mehrjerdi3	mehrjerdi3	PROPN
dpc-4071	2	29	,	,	PUNCT
dpc-4071	2	30	zabihollah	zabihollah	PROPN
dpc-4071	2	31	shahmoradi1	shahmoradi1	PROPN
dpc-4071	2	32	,	,	PUNCT
dpc-4071	2	33	fereshte	fereshte	NOUN
dpc-4071	2	34	rastegarnasab3	rastegarnasab3	PROPN
dpc-4071	2	35	,	,	PUNCT
dpc-4071	2	36	mojtaba	mojtaba	PROPN
dpc-4071	2	37	akbari4	akbari4	PROPN
dpc-4071	2	38	,	,	PUNCT
dpc-4071	2	39	azadeh	azadeh	PROPN
dpc-4071	2	40	zolfaghari1	zolfaghari1	PROPN
dpc-4071	2	41	,	,	PUNCT
dpc-4071	2	42	asiyeh	asiyeh	NOUN
dpc-4071	2	43	heidari1	heidari1	PROPN
dpc-4071	2	44	,	,	PUNCT
dpc-4071	2	45	fateme	fateme	NOUN
dpc-4071	2	46	mohaghegh1	mohaghegh1	PROPN
dpc-4071	2	47	1	1	NUM
dpc-4071	2	48	skin	skin	NOUN
dpc-4071	2	49	diseases	disease	NOUN
dpc-4071	2	50	and	and	CCONJ
dpc-4071	2	51	leishmaniasis	leishmaniasis	NOUN
dpc-4071	2	52	research	research	NOUN
dpc-4071	2	53	center	center	NOUN
dpc-4071	2	54	,	,	PUNCT
dpc-4071	2	55	isfahan	isfahan	PROPN
dpc-4071	2	56	university	university	PROPN
dpc-4071	2	57	of	of	ADP
dpc-4071	2	58	medical	medical	ADJ
dpc-4071	2	59	sciences	sciences	PROPN
dpc-4071	2	60	,	,	PUNCT
dpc-4071	2	61	isfahan	isfahan	NOUN
dpc-4071	2	62	,	,	PUNCT
dpc-4071	2	63	iran	iran	PROPN
dpc-4071	2	64	2	2	NUM
dpc-4071	2	65	pediatric	pediatric	ADJ
dpc-4071	2	66	dermatology	dermatology	NOUN
dpc-4071	2	67	division	division	NOUN
dpc-4071	2	68	of	of	ADP
dpc-4071	2	69	department	department	NOUN
dpc-4071	2	70	of	of	ADP
dpc-4071	2	71	pediatrics	pediatric	NOUN
dpc-4071	2	72	,	,	PUNCT
dpc-4071	2	73	imam	imam	PROPN
dpc-4071	2	74	hossein	hossein	PROPN
dpc-4071	2	75	children	children	PROPN
dpc-4071	2	76	’s	’s	PART
dpc-4071	2	77	hospital	hospital	NOUN
dpc-4071	2	78	,	,	PUNCT
dpc-4071	2	79	isfahan	isfahan	PROPN
dpc-4071	2	80	university	university	PROPN
dpc-4071	2	81	of	of	ADP
dpc-4071	2	82	medical	medical	ADJ
dpc-4071	2	83	sciences	sciences	PROPN
dpc-4071	2	84	,	,	PUNCT
dpc-4071	2	85	isfahan	isfahan	NOUN
dpc-4071	2	86	,	,	PUNCT
dpc-4071	2	87	iran	iran	PROPN
dpc-4071	2	88	3	3	NUM
dpc-4071	2	89	student	student	NOUN
dpc-4071	2	90	research	research	NOUN
dpc-4071	2	91	committee	committee	NOUN
dpc-4071	2	92	,	,	PUNCT
dpc-4071	2	93	isfahan	isfahan	PROPN
dpc-4071	2	94	university	university	PROPN
dpc-4071	2	95	of	of	ADP
dpc-4071	2	96	medical	medical	ADJ
dpc-4071	2	97	sciences	sciences	PROPN
dpc-4071	2	98	,	,	PUNCT
dpc-4071	2	99	isfahan	isfahan	NOUN
dpc-4071	2	100	,	,	PUNCT
dpc-4071	2	101	iran	iran	PROPN
dpc-4071	2	102	4	4	NUM
dpc-4071	2	103	department	department	NOUN
dpc-4071	2	104	of	of	ADP
dpc-4071	2	105	epidemiology	epidemiology	NOUN
dpc-4071	2	106	,	,	PUNCT
dpc-4071	2	107	school	school	NOUN
dpc-4071	2	108	of	of	ADP
dpc-4071	2	109	health	health	NOUN
dpc-4071	2	110	,	,	PUNCT
dpc-4071	2	111	isfahan	isfahan	PROPN
dpc-4071	2	112	university	university	PROPN
dpc-4071	2	113	of	of	ADP
dpc-4071	2	114	medical	medical	ADJ
dpc-4071	2	115	sciences	sciences	PROPN
dpc-4071	2	116	,	,	PUNCT
dpc-4071	2	117	iran	iran	PROPN
dpc-4071	2	118	key	key	ADJ
dpc-4071	2	119	words	word	NOUN
dpc-4071	2	120	:	:	PUNCT
dpc-4071	2	121	bullous	bullous	ADJ
dpc-4071	2	122	pemphigoid	pemphigoid	NOUN
dpc-4071	2	123	,	,	PUNCT
dpc-4071	2	124	eosinophilia	eosinophilia	PROPN
dpc-4071	2	125	,	,	PUNCT
dpc-4071	2	126	eosinophils	eosinophil	NOUN
dpc-4071	2	127	,	,	PUNCT
dpc-4071	2	128	bpdai	bpdai	NOUN
dpc-4071	2	129	citation	citation	NOUN
dpc-4071	2	130	:	:	PUNCT
dpc-4071	2	131	abtahi	abtahi	NOUN
dpc-4071	2	132	-	-	PUNCT
dpc-4071	2	133	naeini	naeini	PROPN
dpc-4071	2	134	b	b	PROPN
dpc-4071	2	135	,	,	PUNCT
dpc-4071	2	136	zare	zare	PROPN
dpc-4071	2	137	-	-	PUNCT
dpc-4071	2	138	mehrjerdi	mehrjerdi	PROPN
dpc-4071	2	139	f	f	PROPN
dpc-4071	2	140	,	,	PUNCT
dpc-4071	2	141	shahmoradi	shahmoradi	PROPN
dpc-4071	2	142	z	z	PROPN
dpc-4071	2	143	,	,	PUNCT
dpc-4071	2	144	et	et	PROPN
dpc-4071	2	145	al	al	PROPN
dpc-4071	2	146	.	.	PROPN
dpc-4071	2	147	frequency	frequency	NOUN
dpc-4071	2	148	and	and	CCONJ
dpc-4071	2	149	correlation	correlation	NOUN
dpc-4071	2	150	of	of	ADP
dpc-4071	2	151	peripheral	peripheral	ADJ
dpc-4071	2	152	and	and	CCONJ
dpc-4071	2	153	tissue	tissue	NOUN
dpc-4071	2	154	eosinophilia	eosinophilia	NOUN
dpc-4071	2	155	with	with	ADP
dpc-4071	2	156	clinical	clinical	ADJ
dpc-4071	2	157	manifestations	manifestation	NOUN
dpc-4071	2	158	in	in	ADP
dpc-4071	2	159	patients	patient	NOUN
dpc-4071	2	160	with	with	ADP
dpc-4071	2	161	bullous	bullous	ADJ
dpc-4071	2	162	pemphigoid	pemphigoid	NOUN
dpc-4071	2	163	.	.	PUNCT
dpc-4071	3	1	dermatol	dermatol	NOUN
dpc-4071	3	2	pract	pract	PROPN
dpc-4071	3	3	concept	concept	NOUN
dpc-4071	3	4	.	.	PUNCT
dpc-4071	4	1	2024;14(3):e2024169	2024;14(3):e2024169	X
dpc-4071	4	2	.	.	PUNCT
dpc-4071	4	3	doi	doi	NOUN
dpc-4071	4	4	:	:	PUNCT
dpc-4071	5	1	https://doi	https://doi	PROPN
dpc-4071	5	2	.	.	PUNCT
dpc-4071	5	3	org/10.5826	org/10.5826	NUM
dpc-4071	5	4	/	/	SYM
dpc-4071	5	5	dpc.1403a169	dpc.1403a169	PRON
dpc-4071	5	6	accepted	accept	VERB
dpc-4071	5	7	:	:	PUNCT
dpc-4071	5	8	april	april	PROPN
dpc-4071	5	9	6	6	NUM
dpc-4071	5	10	,	,	PUNCT
dpc-4071	5	11	2024	2024	NUM
dpc-4071	5	12	;	;	PUNCT
dpc-4071	5	13	published	publish	VERB
dpc-4071	5	14	:	:	PUNCT
dpc-4071	6	1	july	july	PROPN
dpc-4071	6	2	2024	2024	NUM
dpc-4071	6	3	copyright	copyright	NOUN
dpc-4071	6	4	:	:	PUNCT
dpc-4071	6	5	©	©	PROPN
dpc-4071	6	6	2024	2024	NUM
dpc-4071	6	7	abtahi	abtahi	PROPN
dpc-4071	6	8	-	-	PUNCT
dpc-4071	6	9	naeini	naeini	NOUN
dpc-4071	6	10	et	et	PROPN
dpc-4071	6	11	al	al	PROPN
dpc-4071	6	12	.	.	PUNCT
dpc-4071	7	1	this	this	PRON
dpc-4071	7	2	is	be	AUX
dpc-4071	7	3	an	an	DET
dpc-4071	7	4	open	open	ADJ
dpc-4071	7	5	-	-	PUNCT
dpc-4071	7	6	access	access	NOUN
dpc-4071	7	7	article	article	NOUN
dpc-4071	7	8	distributed	distribute	VERB
dpc-4071	7	9	under	under	ADP
dpc-4071	7	10	the	the	DET
dpc-4071	7	11	terms	term	NOUN
dpc-4071	7	12	of	of	ADP
dpc-4071	7	13	the	the	DET
dpc-4071	7	14	creative	creative	ADJ
dpc-4071	7	15	commons	common	NOUN
dpc-4071	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4071	7	17	license	license	NOUN
dpc-4071	7	18	(	(	PUNCT
dpc-4071	7	19	by	by	ADP
dpc-4071	7	20	-	-	PUNCT
dpc-4071	7	21	nc-4.0	nc-4.0	NOUN
dpc-4071	7	22	)	)	PUNCT
dpc-4071	7	23	,	,	PUNCT
dpc-4071	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4071	7	25	,	,	PUNCT
dpc-4071	7	26	which	which	PRON
dpc-4071	7	27	permits	permit	VERB
dpc-4071	7	28	unrestricted	unrestricted	ADJ
dpc-4071	7	29	noncommercial	noncommercial	ADJ
dpc-4071	7	30	use	use	NOUN
dpc-4071	7	31	,	,	PUNCT
dpc-4071	7	32	distribution	distribution	NOUN
dpc-4071	7	33	,	,	PUNCT
dpc-4071	7	34	and	and	CCONJ
dpc-4071	7	35	reproduction	reproduction	NOUN
dpc-4071	7	36	in	in	ADP
dpc-4071	7	37	any	any	DET
dpc-4071	7	38	medium	medium	NOUN
dpc-4071	7	39	,	,	PUNCT
dpc-4071	7	40	provided	provide	VERB
dpc-4071	7	41	the	the	DET
dpc-4071	7	42	original	original	ADJ
dpc-4071	7	43	authors	author	NOUN
dpc-4071	7	44	and	and	CCONJ
dpc-4071	7	45	source	source	NOUN
dpc-4071	7	46	are	be	AUX
dpc-4071	7	47	credited	credit	VERB
dpc-4071	7	48	.	.	PUNCT
dpc-4071	8	1	funding	funding	NOUN
dpc-4071	8	2	:	:	PUNCT
dpc-4071	8	3	none	none	NOUN
dpc-4071	8	4	.	.	PUNCT
dpc-4071	9	1	competing	compete	VERB
dpc-4071	9	2	interests	interest	NOUN
dpc-4071	9	3	:	:	PUNCT
dpc-4071	9	4	none	none	NOUN
dpc-4071	9	5	.	.	PUNCT
dpc-4071	10	1	authorship	authorship	NOUN
dpc-4071	10	2	:	:	PUNCT
dpc-4071	10	3	all	all	DET
dpc-4071	10	4	authors	author	NOUN
dpc-4071	10	5	have	have	AUX
dpc-4071	10	6	contributed	contribute	VERB
dpc-4071	10	7	significantly	significantly	ADV
dpc-4071	10	8	to	to	ADP
dpc-4071	10	9	this	this	DET
dpc-4071	10	10	publication	publication	NOUN
dpc-4071	10	11	.	.	PUNCT
dpc-4071	11	1	corresponding	correspond	VERB
dpc-4071	11	2	author	author	NOUN
dpc-4071	11	3	:	:	PUNCT
dpc-4071	11	4	fateme	fateme	PROPN
dpc-4071	11	5	mohaghegh	mohaghegh	PROPN
dpc-4071	11	6	,	,	PUNCT
dpc-4071	11	7	skin	skin	NOUN
dpc-4071	11	8	diseases	disease	NOUN
dpc-4071	11	9	and	and	CCONJ
dpc-4071	11	10	leishmaniasis	leishmaniasis	NOUN
dpc-4071	11	11	research	research	NOUN
dpc-4071	11	12	center	center	NOUN
dpc-4071	11	13	,	,	PUNCT
dpc-4071	11	14	isfahan	isfahan	PROPN
dpc-4071	11	15	university	university	PROPN
dpc-4071	11	16	of	of	ADP
dpc-4071	11	17	medical	medical	ADJ
dpc-4071	11	18	sciences	sciences	PROPN
dpc-4071	11	19	,	,	PUNCT
dpc-4071	11	20	isfahan	isfahan	NOUN
dpc-4071	11	21	,	,	PUNCT
dpc-4071	11	22	iran	iran	PROPN
dpc-4071	11	23	.	.	PUNCT
dpc-4071	12	1	email	email	NOUN
dpc-4071	12	2	:	:	PUNCT
dpc-4071	12	3	f.mohaghegh199@gmail.com	f.mohaghegh199@gmail.com	X
dpc-4071	12	4	introduction	introduction	NOUN
dpc-4071	12	5	:	:	PUNCT
dpc-4071	12	6	bullous	bullous	ADJ
dpc-4071	12	7	pemphigoid	pemphigoid	NOUN
dpc-4071	12	8	(	(	PUNCT
dpc-4071	12	9	bp	bp	PROPN
dpc-4071	12	10	)	)	PUNCT
dpc-4071	12	11	is	be	AUX
dpc-4071	12	12	an	an	DET
dpc-4071	12	13	autoimmune	autoimmune	ADJ
dpc-4071	12	14	disease	disease	NOUN
dpc-4071	12	15	involving	involve	VERB
dpc-4071	12	16	the	the	DET
dpc-4071	12	17	sub	sub	ADJ
dpc-4071	12	18	-	-	ADJ
dpc-4071	12	19	epidermal	epidermal	ADJ
dpc-4071	12	20	layer	layer	NOUN
dpc-4071	12	21	.	.	PUNCT
dpc-4071	13	1	eosinophilia	eosinophilia	PROPN
dpc-4071	13	2	may	may	AUX
dpc-4071	13	3	play	play	VERB
dpc-4071	13	4	a	a	DET
dpc-4071	13	5	role	role	NOUN
dpc-4071	13	6	in	in	ADP
dpc-4071	13	7	the	the	DET
dpc-4071	13	8	pathogenesis	pathogenesis	NOUN
dpc-4071	13	9	of	of	ADP
dpc-4071	13	10	bp	bp	PROPN
dpc-4071	13	11	.	.	PUNCT
dpc-4071	14	1	objectives	objective	NOUN
dpc-4071	14	2	:	:	PUNCT
dpc-4071	14	3	we	we	PRON
dpc-4071	14	4	aimed	aim	VERB
dpc-4071	14	5	to	to	PART
dpc-4071	14	6	investigate	investigate	VERB
dpc-4071	14	7	the	the	DET
dpc-4071	14	8	correlation	correlation	NOUN
dpc-4071	14	9	between	between	ADP
dpc-4071	14	10	dermal	dermal	NOUN
dpc-4071	14	11	or	or	CCONJ
dpc-4071	14	12	peripheral	peripheral	ADJ
dpc-4071	14	13	eosinophilia	eosinophilia	NOUN
dpc-4071	14	14	with	with	ADP
dpc-4071	14	15	clinical	clinical	ADJ
dpc-4071	14	16	presentations	presentation	NOUN
dpc-4071	14	17	in	in	ADP
dpc-4071	14	18	patients	patient	NOUN
dpc-4071	14	19	with	with	ADP
dpc-4071	14	20	bp	bp	PROPN
dpc-4071	14	21	.	.	PUNCT
dpc-4071	15	1	methods	method	NOUN
dpc-4071	15	2	:	:	PUNCT
dpc-4071	15	3	this	this	DET
dpc-4071	15	4	cross	cross	ADJ
dpc-4071	15	5	-	-	ADJ
dpc-4071	15	6	sectional	sectional	ADJ
dpc-4071	15	7	study	study	NOUN
dpc-4071	15	8	was	be	AUX
dpc-4071	15	9	conducted	conduct	VERB
dpc-4071	15	10	on	on	ADP
dpc-4071	15	11	108	108	NUM
dpc-4071	15	12	bp	bp	PROPN
dpc-4071	15	13	patients	patient	NOUN
dpc-4071	15	14	from	from	ADP
dpc-4071	15	15	january	january	PROPN
dpc-4071	15	16	2010	2010	NUM
dpc-4071	15	17	to	to	ADP
dpc-4071	15	18	september	september	PROPN
dpc-4071	15	19	2019	2019	NUM
dpc-4071	15	20	.	.	PUNCT
dpc-4071	16	1	clinical	clinical	ADJ
dpc-4071	16	2	data	datum	NOUN
dpc-4071	16	3	were	be	AUX
dpc-4071	16	4	recovered	recover	VERB
dpc-4071	16	5	.	.	PUNCT
dpc-4071	17	1	skin	skin	NOUN
dpc-4071	17	2	biopsies	biopsy	NOUN
dpc-4071	17	3	were	be	AUX
dpc-4071	17	4	re	re	VERB
dpc-4071	17	5	-	-	VERB
dpc-4071	17	6	evaluated	evaluated	ADJ
dpc-4071	17	7	,	,	PUNCT
dpc-4071	17	8	and	and	CCONJ
dpc-4071	17	9	the	the	DET
dpc-4071	17	10	bullous	bullous	ADJ
dpc-4071	17	11	pemphigoid	pemphigoid	PROPN
dpc-4071	17	12	disease	disease	PROPN
dpc-4071	17	13	area	area	NOUN
dpc-4071	17	14	index	index	NOUN
dpc-4071	17	15	(	(	PUNCT
dpc-4071	17	16	bpdai	bpdai	NOUN
dpc-4071	17	17	)	)	PUNCT
dpc-4071	17	18	severity	severity	NOUN
dpc-4071	17	19	score	score	NOUN
dpc-4071	17	20	was	be	AUX
dpc-4071	17	21	calculated	calculate	VERB
dpc-4071	17	22	.	.	PUNCT
dpc-4071	18	1	finally	finally	ADV
dpc-4071	18	2	,	,	PUNCT
dpc-4071	18	3	the	the	DET
dpc-4071	18	4	relationship	relationship	NOUN
dpc-4071	18	5	between	between	ADP
dpc-4071	18	6	clinical	clinical	ADJ
dpc-4071	18	7	features	feature	NOUN
dpc-4071	18	8	of	of	ADP
dpc-4071	18	9	bp	bp	PROPN
dpc-4071	18	10	and	and	CCONJ
dpc-4071	18	11	dermal	dermal	ADJ
dpc-4071	18	12	or	or	CCONJ
dpc-4071	18	13	peripheral	peripheral	ADJ
dpc-4071	18	14	eosinophilia	eosinophilia	PROPN
dpc-4071	18	15	was	be	AUX
dpc-4071	18	16	analyzed	analyze	VERB
dpc-4071	18	17	.	.	PUNCT
dpc-4071	19	1	results	result	NOUN
dpc-4071	19	2	:	:	PUNCT
dpc-4071	19	3	a	a	DET
dpc-4071	19	4	total	total	ADJ
dpc-4071	19	5	number	number	NOUN
dpc-4071	19	6	of	of	ADP
dpc-4071	19	7	108	108	NUM
dpc-4071	19	8	patients	patient	NOUN
dpc-4071	19	9	were	be	AUX
dpc-4071	19	10	included	include	VERB
dpc-4071	19	11	in	in	ADP
dpc-4071	19	12	this	this	DET
dpc-4071	19	13	study	study	NOUN
dpc-4071	19	14	.	.	PUNCT
dpc-4071	20	1	thirty	thirty	NUM
dpc-4071	20	2	-	-	PUNCT
dpc-4071	20	3	five	five	NUM
dpc-4071	20	4	were	be	AUX
dpc-4071	20	5	excluded	exclude	VERB
dpc-4071	20	6	due	due	ADP
dpc-4071	20	7	to	to	ADP
dpc-4071	20	8	our	our	PRON
dpc-4071	20	9	exclusion	exclusion	NOUN
dpc-4071	20	10	criteria	criterion	NOUN
dpc-4071	20	11	.	.	PUNCT
dpc-4071	21	1	finally	finally	ADV
dpc-4071	21	2	,	,	PUNCT
dpc-4071	21	3	data	datum	NOUN
dpc-4071	21	4	from	from	ADP
dpc-4071	21	5	73	73	NUM
dpc-4071	21	6	patients	patient	NOUN
dpc-4071	21	7	were	be	AUX
dpc-4071	21	8	analyzed	analyze	VERB
dpc-4071	21	9	.	.	PUNCT
dpc-4071	22	1	fifty	fifty	NUM
dpc-4071	22	2	-	-	PUNCT
dpc-4071	22	3	seven	seven	NUM
dpc-4071	22	4	point	point	NOUN
dpc-4071	22	5	five	five	NUM
dpc-4071	22	6	percent	percent	NOUN
dpc-4071	22	7	of	of	ADP
dpc-4071	22	8	the	the	DET
dpc-4071	22	9	population	population	NOUN
dpc-4071	22	10	was	be	AUX
dpc-4071	22	11	female	female	ADJ
dpc-4071	22	12	.	.	PUNCT
dpc-4071	23	1	there	there	PRON
dpc-4071	23	2	was	be	VERB
dpc-4071	23	3	a	a	DET
dpc-4071	23	4	significant	significant	ADJ
dpc-4071	23	5	direct	direct	ADJ
dpc-4071	23	6	correlation	correlation	NOUN
dpc-4071	23	7	(	(	PUNCT
dpc-4071	23	8	r	r	NOUN
dpc-4071	23	9	=	=	SYM
dpc-4071	23	10	0.33	0.33	NUM
dpc-4071	23	11	)	)	PUNCT
dpc-4071	23	12	between	between	ADP
dpc-4071	23	13	bpdai	bpdai	NOUN
dpc-4071	23	14	severity	severity	NOUN
dpc-4071	23	15	score	score	NOUN
dpc-4071	23	16	and	and	CCONJ
dpc-4071	23	17	tissue	tissue	NOUN
dpc-4071	23	18	eosinophilia	eosinophilia	NOUN
dpc-4071	23	19	(	(	PUNCT
dpc-4071	23	20	p	p	X
dpc-4071	23	21	=	=	NOUN
dpc-4071	23	22	0.03	0.03	NUM
dpc-4071	23	23	)	)	PUNCT
dpc-4071	23	24	.	.	PUNCT
dpc-4071	24	1	no	no	DET
dpc-4071	24	2	significant	significant	ADJ
dpc-4071	24	3	relationship	relationship	NOUN
dpc-4071	24	4	was	be	AUX
dpc-4071	24	5	found	find	VERB
dpc-4071	24	6	between	between	ADP
dpc-4071	24	7	bpdai	bpdai	NOUN
dpc-4071	24	8	severity	severity	NOUN
dpc-4071	24	9	score	score	NOUN
dpc-4071	24	10	and	and	CCONJ
dpc-4071	24	11	peripheral	peripheral	ADJ
dpc-4071	24	12	eosinophilia	eosinophilia	NOUN
dpc-4071	24	13	(	(	PUNCT
dpc-4071	24	14	p	p	X
dpc-4071	24	15	=	=	NOUN
dpc-4071	24	16	0.52	0.52	NUM
dpc-4071	24	17	)	)	PUNCT
dpc-4071	24	18	.	.	PUNCT
dpc-4071	25	1	there	there	PRON
dpc-4071	25	2	were	be	VERB
dpc-4071	25	3	significant	significant	ADJ
dpc-4071	25	4	positive	positive	ADJ
dpc-4071	25	5	correlations	correlation	NOUN
dpc-4071	25	6	between	between	ADP
dpc-4071	25	7	tissue	tissue	NOUN
dpc-4071	25	8	eosinophilia	eosinophilia	NOUN
dpc-4071	25	9	with	with	ADP
dpc-4071	25	10	absolute	absolute	ADJ
dpc-4071	25	11	serum	serum	NOUN
dpc-4071	25	12	eosinophil	eosinophil	ADJ
dpc-4071	25	13	count	count	NOUN
dpc-4071	25	14	(	(	PUNCT
dpc-4071	25	15	p	p	X
dpc-4071	25	16	=	=	NOUN
dpc-4071	25	17	0.002	0.002	NUM
dpc-4071	25	18	;	;	PUNCT
dpc-4071	25	19	r	r	NOUN
dpc-4071	25	20	=	=	NOUN
dpc-4071	25	21	0.49	0.49	NUM
dpc-4071	25	22	)	)	PUNCT
dpc-4071	25	23	and	and	CCONJ
dpc-4071	25	24	percentage	percentage	NOUN
dpc-4071	25	25	(	(	PUNCT
dpc-4071	25	26	p	p	X
dpc-4071	25	27	<	<	X
dpc-4071	25	28	0.0001	0.0001	NUM
dpc-4071	25	29	;	;	PUNCT
dpc-4071	25	30	r	r	NOUN
dpc-4071	25	31	=	=	NOUN
dpc-4071	25	32	0.89	0.89	NUM
dpc-4071	25	33	)	)	PUNCT
dpc-4071	25	34	.	.	PUNCT
dpc-4071	26	1	abstract	abstract	ADJ
dpc-4071	26	2	2	2	NUM
dpc-4071	26	3	original	original	ADJ
dpc-4071	26	4	article	article	NOUN
dpc-4071	26	5	|	|	ADV
dpc-4071	26	6	dermatol	dermatol	ADJ
dpc-4071	26	7	pract	pract	NOUN
dpc-4071	26	8	concept	concept	NOUN
dpc-4071	26	9	.	.	PUNCT
dpc-4071	27	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	27	2	introduction	introduction	NOUN
dpc-4071	27	3	bullous	bullous	ADJ
dpc-4071	27	4	pemphigoid	pemphigoid	NOUN
dpc-4071	27	5	(	(	PUNCT
dpc-4071	27	6	bp	bp	PROPN
dpc-4071	27	7	)	)	PUNCT
dpc-4071	27	8	is	be	AUX
dpc-4071	27	9	an	an	DET
dpc-4071	27	10	autoimmune	autoimmune	ADJ
dpc-4071	27	11	bullous	bullous	ADJ
dpc-4071	27	12	disease	disease	NOUN
dpc-4071	27	13	[	[	X
dpc-4071	27	14	1	1	X
dpc-4071	27	15	]	]	X
dpc-4071	27	16	more	more	ADV
dpc-4071	27	17	prevalent	prevalent	ADJ
dpc-4071	27	18	in	in	ADP
dpc-4071	27	19	the	the	DET
dpc-4071	27	20	elderly	elderly	ADJ
dpc-4071	27	21	with	with	ADP
dpc-4071	27	22	higher	high	ADJ
dpc-4071	27	23	morbidity	morbidity	NOUN
dpc-4071	27	24	and	and	CCONJ
dpc-4071	27	25	mortality	mortality	NOUN
dpc-4071	27	26	[	[	X
dpc-4071	27	27	2	2	NUM
dpc-4071	27	28	]	]	PUNCT
dpc-4071	27	29	.	.	PUNCT
dpc-4071	28	1	bp	bp	PROPN
dpc-4071	28	2	occurs	occur	VERB
dpc-4071	28	3	due	due	ADJ
dpc-4071	28	4	to	to	ADP
dpc-4071	28	5	immunological	immunological	ADJ
dpc-4071	28	6	responses	response	NOUN
dpc-4071	28	7	against	against	ADP
dpc-4071	28	8	hemi	hemi	NOUN
dpc-4071	28	9	-	-	PUNCT
dpc-4071	28	10	desmosomal	desmosomal	ADJ
dpc-4071	28	11	proteins	protein	NOUN
dpc-4071	28	12	responsible	responsible	ADJ
dpc-4071	28	13	for	for	ADP
dpc-4071	28	14	dermo	dermo	NOUN
dpc-4071	28	15	-	-	PUNCT
dpc-4071	28	16	epidermal	epidermal	ADJ
dpc-4071	28	17	cohesion	cohesion	NOUN
dpc-4071	28	18	[	[	X
dpc-4071	28	19	3	3	NUM
dpc-4071	28	20	]	]	PUNCT
dpc-4071	28	21	.	.	PUNCT
dpc-4071	29	1	lesions	lesion	NOUN
dpc-4071	29	2	mostly	mostly	ADV
dpc-4071	29	3	present	present	ADJ
dpc-4071	29	4	on	on	ADP
dpc-4071	29	5	the	the	DET
dpc-4071	29	6	lower	low	ADJ
dpc-4071	29	7	abdomen	abdomen	NOUN
dpc-4071	29	8	,	,	PUNCT
dpc-4071	29	9	inner	inner	ADJ
dpc-4071	29	10	surface	surface	NOUN
dpc-4071	29	11	and	and	CCONJ
dpc-4071	29	12	flexors	flexor	NOUN
dpc-4071	29	13	of	of	ADP
dpc-4071	29	14	the	the	DET
dpc-4071	29	15	thighs	thigh	NOUN
dpc-4071	29	16	,	,	PUNCT
dpc-4071	29	17	and	and	CCONJ
dpc-4071	29	18	forearms	forearm	NOUN
dpc-4071	29	19	,	,	PUNCT
dpc-4071	29	20	localized	localized	ADJ
dpc-4071	29	21	or	or	CCONJ
dpc-4071	29	22	generalized	generalize	VERB
dpc-4071	29	23	.	.	PUNCT
dpc-4071	30	1	mucosal	mucosal	ADJ
dpc-4071	30	2	involvement	involvement	NOUN
dpc-4071	30	3	is	be	AUX
dpc-4071	30	4	rarely	rarely	ADV
dpc-4071	30	5	seen	see	VERB
dpc-4071	30	6	[	[	PUNCT
dpc-4071	30	7	4	4	NUM
dpc-4071	30	8	]	]	PUNCT
dpc-4071	30	9	.	.	PUNCT
dpc-4071	31	1	the	the	DET
dpc-4071	31	2	metacognitive	metacognitive	ADJ
dpc-4071	31	3	characteristics	characteristic	NOUN
dpc-4071	31	4	and	and	CCONJ
dpc-4071	31	5	biological	biological	ADJ
dpc-4071	31	6	properties	property	NOUN
dpc-4071	31	7	of	of	ADP
dpc-4071	31	8	eosinophils	eosinophil	NOUN
dpc-4071	31	9	suggest	suggest	VERB
dpc-4071	31	10	a	a	DET
dpc-4071	31	11	potential	potential	ADJ
dpc-4071	31	12	role	role	NOUN
dpc-4071	31	13	in	in	ADP
dpc-4071	31	14	the	the	DET
dpc-4071	31	15	onset	onset	NOUN
dpc-4071	31	16	or	or	CCONJ
dpc-4071	31	17	progression	progression	NOUN
dpc-4071	31	18	of	of	ADP
dpc-4071	31	19	bp	bp	PROPN
dpc-4071	32	1	[	[	X
dpc-4071	32	2	5	5	NUM
dpc-4071	32	3	]	]	PUNCT
dpc-4071	32	4	.	.	PUNCT
dpc-4071	33	1	eosinophilic	eosinophilic	ADJ
dpc-4071	33	2	infiltration	infiltration	NOUN
dpc-4071	33	3	of	of	ADP
dpc-4071	33	4	the	the	DET
dpc-4071	33	5	dermis	dermis	NOUN
dpc-4071	33	6	is	be	AUX
dpc-4071	33	7	one	one	NUM
dpc-4071	33	8	of	of	ADP
dpc-4071	33	9	the	the	DET
dpc-4071	33	10	crucial	crucial	ADJ
dpc-4071	33	11	early	early	ADJ
dpc-4071	33	12	events	event	NOUN
dpc-4071	33	13	in	in	ADP
dpc-4071	33	14	the	the	DET
dpc-4071	33	15	development	development	NOUN
dpc-4071	33	16	of	of	ADP
dpc-4071	33	17	bullous	bullous	ADJ
dpc-4071	33	18	lesions	lesion	NOUN
dpc-4071	33	19	in	in	ADP
dpc-4071	33	20	bp	bp	PROPN
dpc-4071	34	1	[	[	X
dpc-4071	34	2	6	6	NUM
dpc-4071	34	3	]	]	PUNCT
dpc-4071	34	4	.	.	PUNCT
dpc-4071	35	1	previous	previous	ADJ
dpc-4071	35	2	studies	study	NOUN
dpc-4071	35	3	on	on	ADP
dpc-4071	35	4	the	the	DET
dpc-4071	35	5	histopathological	histopathological	ADJ
dpc-4071	35	6	features	feature	NOUN
dpc-4071	35	7	of	of	ADP
dpc-4071	35	8	the	the	DET
dpc-4071	35	9	lesions	lesion	NOUN
dpc-4071	35	10	revealed	reveal	VERB
dpc-4071	35	11	the	the	DET
dpc-4071	35	12	presence	presence	NOUN
dpc-4071	35	13	of	of	ADP
dpc-4071	35	14	extracellular	extracellular	ADJ
dpc-4071	35	15	eosinophil	eosinophil	ADJ
dpc-4071	35	16	granules	granule	NOUN
dpc-4071	35	17	,	,	PUNCT
dpc-4071	35	18	degranulated	degranulate	VERB
dpc-4071	35	19	eosinophils	eosinophil	NOUN
dpc-4071	35	20	,	,	PUNCT
dpc-4071	35	21	and	and	CCONJ
dpc-4071	35	22	free	free	ADJ
dpc-4071	35	23	granule	granule	NOUN
dpc-4071	35	24	proteins	protein	NOUN
dpc-4071	35	25	throughout	throughout	ADP
dpc-4071	35	26	the	the	DET
dpc-4071	35	27	upper	upper	ADJ
dpc-4071	35	28	dermis	dermis	NOUN
dpc-4071	35	29	or	or	CCONJ
dpc-4071	35	30	at	at	ADP
dpc-4071	35	31	the	the	DET
dpc-4071	35	32	dermo	dermo	NOUN
dpc-4071	35	33	-	-	PUNCT
dpc-4071	35	34	epidermal	epidermal	ADJ
dpc-4071	35	35	junction	junction	NOUN
dpc-4071	35	36	[	[	X
dpc-4071	35	37	7,8	7,8	NUM
dpc-4071	35	38	]	]	PUNCT
dpc-4071	35	39	.	.	PUNCT
dpc-4071	36	1	peripheral	peripheral	ADJ
dpc-4071	36	2	eosinophilia	eosinophilia	PROPN
dpc-4071	36	3	has	have	AUX
dpc-4071	36	4	been	be	AUX
dpc-4071	36	5	reported	report	VERB
dpc-4071	36	6	in	in	ADP
dpc-4071	36	7	50	50	NUM
dpc-4071	36	8	-	-	SYM
dpc-4071	36	9	60	60	NUM
dpc-4071	36	10	%	%	NOUN
dpc-4071	36	11	of	of	ADP
dpc-4071	36	12	patients	patient	NOUN
dpc-4071	36	13	with	with	ADP
dpc-4071	36	14	bp	bp	PROPN
dpc-4071	36	15	and	and	CCONJ
dpc-4071	36	16	is	be	AUX
dpc-4071	36	17	associated	associate	VERB
dpc-4071	36	18	with	with	ADP
dpc-4071	36	19	disease	disease	NOUN
dpc-4071	36	20	severity	severity	NOUN
dpc-4071	37	1	[	[	X
dpc-4071	37	2	9	9	NUM
dpc-4071	37	3	]	]	PUNCT
dpc-4071	37	4	.	.	PUNCT
dpc-4071	38	1	however	however	ADV
dpc-4071	38	2	,	,	PUNCT
dpc-4071	38	3	the	the	DET
dpc-4071	38	4	relationship	relationship	NOUN
dpc-4071	38	5	between	between	ADP
dpc-4071	38	6	peripheral	peripheral	ADJ
dpc-4071	38	7	eosinophilia	eosinophilia	NOUN
dpc-4071	38	8	and	and	CCONJ
dpc-4071	38	9	clinical	clinical	ADJ
dpc-4071	38	10	presentations	presentation	NOUN
dpc-4071	38	11	,	,	PUNCT
dpc-4071	38	12	and	and	CCONJ
dpc-4071	38	13	also	also	ADV
dpc-4071	38	14	the	the	DET
dpc-4071	38	15	presence	presence	NOUN
dpc-4071	38	16	of	of	ADP
dpc-4071	38	17	tissue	tissue	NOUN
dpc-4071	38	18	eosinophilia	eosinophilia	NOUN
dpc-4071	38	19	has	have	AUX
dpc-4071	38	20	not	not	PART
dpc-4071	38	21	been	be	AUX
dpc-4071	38	22	studied	study	VERB
dpc-4071	38	23	in	in	ADP
dpc-4071	38	24	bp	bp	PROPN
dpc-4071	38	25	patients	patient	NOUN
dpc-4071	38	26	.	.	PUNCT
dpc-4071	39	1	objectives	objective	VERB
dpc-4071	39	2	this	this	DET
dpc-4071	39	3	study	study	NOUN
dpc-4071	39	4	aimed	aim	VERB
dpc-4071	39	5	to	to	PART
dpc-4071	39	6	investigate	investigate	VERB
dpc-4071	39	7	the	the	DET
dpc-4071	39	8	possible	possible	ADJ
dpc-4071	39	9	relationship	relationship	NOUN
dpc-4071	39	10	between	between	ADP
dpc-4071	39	11	peripheral	peripheral	ADJ
dpc-4071	39	12	and	and	CCONJ
dpc-4071	39	13	tissue	tissue	NOUN
dpc-4071	39	14	eosinophilia	eosinophilia	NOUN
dpc-4071	39	15	and	and	CCONJ
dpc-4071	39	16	clinical	clinical	ADJ
dpc-4071	39	17	manifestations	manifestation	NOUN
dpc-4071	39	18	in	in	ADP
dpc-4071	39	19	patients	patient	NOUN
dpc-4071	39	20	with	with	ADP
dpc-4071	39	21	bp	bp	PROPN
dpc-4071	39	22	to	to	PART
dpc-4071	39	23	provide	provide	VERB
dpc-4071	39	24	more	more	ADJ
dpc-4071	39	25	insight	insight	NOUN
dpc-4071	39	26	into	into	ADP
dpc-4071	39	27	the	the	DET
dpc-4071	39	28	disease	disease	NOUN
dpc-4071	39	29	mechanism	mechanism	NOUN
dpc-4071	39	30	.	.	PUNCT
dpc-4071	40	1	methods	method	NOUN
dpc-4071	40	2	study	study	NOUN
dpc-4071	40	3	design	design	VERB
dpc-4071	40	4	this	this	DET
dpc-4071	40	5	cross	cross	ADJ
dpc-4071	40	6	-	-	ADJ
dpc-4071	40	7	sectional	sectional	ADJ
dpc-4071	40	8	study	study	NOUN
dpc-4071	40	9	was	be	AUX
dpc-4071	40	10	conducted	conduct	VERB
dpc-4071	40	11	among	among	ADP
dpc-4071	40	12	bp	bp	PROPN
dpc-4071	40	13	patients	patient	NOUN
dpc-4071	40	14	hospitalized	hospitalize	VERB
dpc-4071	40	15	in	in	ADP
dpc-4071	40	16	al	al	PROPN
dpc-4071	40	17	-	-	PUNCT
dpc-4071	40	18	zahra	zahra	PROPN
dpc-4071	40	19	hospital	hospital	PROPN
dpc-4071	40	20	,	,	PUNCT
dpc-4071	40	21	a	a	DET
dpc-4071	40	22	referral	referral	ADJ
dpc-4071	40	23	center	center	NOUN
dpc-4071	40	24	for	for	ADP
dpc-4071	40	25	dermatological	dermatological	ADJ
dpc-4071	40	26	disease	disease	NOUN
dpc-4071	40	27	in	in	ADP
dpc-4071	40	28	isfahan	isfahan	NOUN
dpc-4071	40	29	,	,	PUNCT
dpc-4071	40	30	iran	iran	PROPN
dpc-4071	40	31	,	,	PUNCT
dpc-4071	40	32	from	from	ADP
dpc-4071	40	33	january	january	PROPN
dpc-4071	40	34	2010	2010	NUM
dpc-4071	40	35	to	to	ADP
dpc-4071	40	36	september	september	PROPN
dpc-4071	40	37	2019	2019	NUM
dpc-4071	40	38	.	.	PUNCT
dpc-4071	41	1	the	the	DET
dpc-4071	41	2	study	study	NOUN
dpc-4071	41	3	was	be	AUX
dpc-4071	41	4	approved	approve	VERB
dpc-4071	41	5	by	by	ADP
dpc-4071	41	6	the	the	DET
dpc-4071	41	7	ethical	ethical	PROPN
dpc-4071	41	8	committee	committee	NOUN
dpc-4071	41	9	of	of	ADP
dpc-4071	41	10	isfahan	isfahan	PROPN
dpc-4071	41	11	university	university	PROPN
dpc-4071	41	12	of	of	ADP
dpc-4071	41	13	medical	medical	PROPN
dpc-4071	41	14	sciences	sciences	PROPN
dpc-4071	41	15	(	(	PUNCT
dpc-4071	41	16	ethical	ethical	PROPN
dpc-4071	41	17	code	code	NOUN
dpc-4071	41	18	:	:	PUNCT
dpc-4071	41	19	ir.mui.med.rec.1399.250	ir.mui.med.rec.1399.250	NOUN
dpc-4071	41	20	)	)	PUNCT
dpc-4071	41	21	.	.	PUNCT
dpc-4071	42	1	inclusion	inclusion	NOUN
dpc-4071	42	2	criteria	criterion	NOUN
dpc-4071	42	3	all	all	DET
dpc-4071	42	4	patients	patient	NOUN
dpc-4071	42	5	with	with	ADP
dpc-4071	42	6	a	a	DET
dpc-4071	42	7	definite	definite	ADJ
dpc-4071	42	8	diagnosis	diagnosis	NOUN
dpc-4071	42	9	of	of	ADP
dpc-4071	42	10	bp	bp	PROPN
dpc-4071	42	11	by	by	ADP
dpc-4071	42	12	an	an	DET
dpc-4071	42	13	expert	expert	NOUN
dpc-4071	42	14	dermatologist	dermatologist	NOUN
dpc-4071	42	15	were	be	AUX
dpc-4071	42	16	included	include	VERB
dpc-4071	42	17	in	in	ADP
dpc-4071	42	18	the	the	DET
dpc-4071	42	19	study	study	NOUN
dpc-4071	42	20	.	.	PUNCT
dpc-4071	43	1	the	the	DET
dpc-4071	43	2	diagnosis	diagnosis	NOUN
dpc-4071	43	3	of	of	ADP
dpc-4071	43	4	bp	bp	PROPN
dpc-4071	43	5	was	be	AUX
dpc-4071	43	6	based	base	VERB
dpc-4071	43	7	on	on	ADP
dpc-4071	43	8	suggestive	suggestive	ADJ
dpc-4071	43	9	clinical	clinical	ADJ
dpc-4071	43	10	features	feature	NOUN
dpc-4071	43	11	,	,	PUNCT
dpc-4071	43	12	subepidermal	subepidermal	NOUN
dpc-4071	43	13	blister	blister	NOUN
dpc-4071	43	14	formation	formation	NOUN
dpc-4071	43	15	with	with	ADP
dpc-4071	43	16	dermal	dermal	ADJ
dpc-4071	43	17	eosinophilic	eosinophilic	ADJ
dpc-4071	43	18	infiltration	infiltration	NOUN
dpc-4071	43	19	on	on	ADP
dpc-4071	43	20	histopathological	histopathological	ADJ
dpc-4071	43	21	evaluations	evaluation	NOUN
dpc-4071	43	22	,	,	PUNCT
dpc-4071	43	23	and	and	CCONJ
dpc-4071	43	24	linear	linear	PROPN
dpc-4071	43	25	igg	igg	PROPN
dpc-4071	43	26	and/or	and/or	CCONJ
dpc-4071	43	27	c3	c3	VERB
dpc-4071	43	28	deposits	deposit	NOUN
dpc-4071	43	29	along	along	ADP
dpc-4071	43	30	the	the	DET
dpc-4071	43	31	dermo	dermo	NOUN
dpc-4071	43	32	-	-	PUNCT
dpc-4071	43	33	epidermal	epidermal	ADJ
dpc-4071	43	34	junction	junction	NOUN
dpc-4071	43	35	by	by	ADP
dpc-4071	43	36	direct	direct	ADJ
dpc-4071	43	37	immunofluorescence	immunofluorescence	NOUN
dpc-4071	44	1	[	[	X
dpc-4071	44	2	10	10	NUM
dpc-4071	44	3	]	]	PUNCT
dpc-4071	44	4	.	.	PUNCT
dpc-4071	45	1	exclusion	exclusion	NOUN
dpc-4071	45	2	criteria	criterion	NOUN
dpc-4071	45	3	patients	patient	NOUN
dpc-4071	45	4	with	with	ADP
dpc-4071	45	5	(	(	PUNCT
dpc-4071	45	6	i	i	NOUN
dpc-4071	45	7	)	)	PUNCT
dpc-4071	45	8	incomplete	incomplete	ADJ
dpc-4071	45	9	documents	document	NOUN
dpc-4071	45	10	,	,	PUNCT
dpc-4071	45	11	(	(	PUNCT
dpc-4071	45	12	ii	ii	NOUN
dpc-4071	45	13	)	)	PUNCT
dpc-4071	45	14	hospitalization	hospitalization	NOUN
dpc-4071	45	15	for	for	ADP
dpc-4071	45	16	less	less	ADJ
dpc-4071	45	17	than	than	ADP
dpc-4071	45	18	24	24	NUM
dpc-4071	45	19	hours	hour	NOUN
dpc-4071	45	20	,	,	PUNCT
dpc-4071	45	21	and	and	CCONJ
dpc-4071	45	22	(	(	PUNCT
dpc-4071	45	23	iii	iii	NOUN
dpc-4071	45	24	)	)	PUNCT
dpc-4071	45	25	peripheral	peripheral	ADJ
dpc-4071	45	26	eosinophilia	eosinophilia	NOUN
dpc-4071	45	27	related	relate	VERB
dpc-4071	45	28	to	to	ADP
dpc-4071	45	29	other	other	ADJ
dpc-4071	45	30	medical	medical	ADJ
dpc-4071	45	31	conditions	condition	NOUN
dpc-4071	45	32	(	(	PUNCT
dpc-4071	45	33	i.e.	i.e.	X
dpc-4071	45	34	atopic	atopic	NOUN
dpc-4071	45	35	dermatitis	dermatitis	NOUN
dpc-4071	45	36	,	,	PUNCT
dpc-4071	45	37	asthma	asthma	NOUN
dpc-4071	45	38	,	,	PUNCT
dpc-4071	45	39	other	other	ADJ
dpc-4071	45	40	allergic	allergic	ADJ
dpc-4071	45	41	conditions	condition	NOUN
dpc-4071	45	42	,	,	PUNCT
dpc-4071	45	43	parasitic	parasitic	ADJ
dpc-4071	45	44	diseases	disease	NOUN
dpc-4071	45	45	,	,	PUNCT
dpc-4071	45	46	and	and	CCONJ
dpc-4071	45	47	hyper	hyper	ADJ
dpc-4071	45	48	-	-	ADJ
dpc-4071	45	49	eosinophilic	eosinophilic	ADJ
dpc-4071	45	50	syndrome	syndrome	NOUN
dpc-4071	45	51	)	)	PUNCT
dpc-4071	45	52	were	be	AUX
dpc-4071	45	53	excluded	exclude	VERB
dpc-4071	45	54	from	from	ADP
dpc-4071	45	55	the	the	DET
dpc-4071	45	56	study	study	NOUN
dpc-4071	45	57	.	.	PUNCT
dpc-4071	46	1	studied	study	VERB
dpc-4071	46	2	variables	variable	NOUN
dpc-4071	46	3	the	the	DET
dpc-4071	46	4	files	file	NOUN
dpc-4071	46	5	of	of	ADP
dpc-4071	46	6	hospitalized	hospitalize	VERB
dpc-4071	46	7	patients	patient	NOUN
dpc-4071	46	8	were	be	AUX
dpc-4071	46	9	reviewed	review	VERB
dpc-4071	46	10	.	.	PUNCT
dpc-4071	47	1	age	age	NOUN
dpc-4071	47	2	,	,	PUNCT
dpc-4071	47	3	sex	sex	NOUN
dpc-4071	47	4	,	,	PUNCT
dpc-4071	47	5	pregnancy	pregnancy	NOUN
dpc-4071	47	6	,	,	PUNCT
dpc-4071	47	7	site	site	NOUN
dpc-4071	47	8	of	of	ADP
dpc-4071	47	9	involvement	involvement	NOUN
dpc-4071	47	10	,	,	PUNCT
dpc-4071	47	11	hospitalization	hospitalization	NOUN
dpc-4071	47	12	duration	duration	NOUN
dpc-4071	47	13	,	,	PUNCT
dpc-4071	47	14	concomitant	concomitant	ADJ
dpc-4071	47	15	diseases	disease	NOUN
dpc-4071	47	16	,	,	PUNCT
dpc-4071	47	17	past	past	ADJ
dpc-4071	47	18	drug	drug	NOUN
dpc-4071	47	19	history	history	NOUN
dpc-4071	47	20	,	,	PUNCT
dpc-4071	47	21	treatment	treatment	NOUN
dpc-4071	47	22	protocol	protocol	NOUN
dpc-4071	47	23	,	,	PUNCT
dpc-4071	47	24	and	and	CCONJ
dpc-4071	47	25	the	the	DET
dpc-4071	47	26	serum	serum	NOUN
dpc-4071	47	27	eosinophil	eosinophil	ADJ
dpc-4071	47	28	count	count	NOUN
dpc-4071	47	29	were	be	AUX
dpc-4071	47	30	recruited	recruit	VERB
dpc-4071	47	31	from	from	ADP
dpc-4071	47	32	the	the	DET
dpc-4071	47	33	medical	medical	ADJ
dpc-4071	47	34	records	record	NOUN
dpc-4071	47	35	.	.	PUNCT
dpc-4071	48	1	the	the	DET
dpc-4071	48	2	bullous	bullous	ADJ
dpc-4071	48	3	pemphigoid	pemphigoid	PROPN
dpc-4071	48	4	disease	disease	PROPN
dpc-4071	48	5	area	area	NOUN
dpc-4071	48	6	index	index	NOUN
dpc-4071	48	7	(	(	PUNCT
dpc-4071	48	8	bpdai	bpdai	NOUN
dpc-4071	48	9	)	)	PUNCT
dpc-4071	48	10	severity	severity	NOUN
dpc-4071	48	11	score	score	NOUN
dpc-4071	48	12	was	be	AUX
dpc-4071	48	13	calculated	calculate	VERB
dpc-4071	48	14	for	for	ADP
dpc-4071	48	15	each	each	DET
dpc-4071	48	16	patient	patient	NOUN
dpc-4071	48	17	.	.	PUNCT
dpc-4071	49	1	bpdai	bpdai	NOUN
dpc-4071	49	2	is	be	AUX
dpc-4071	49	3	an	an	DET
dpc-4071	49	4	index	index	NOUN
dpc-4071	49	5	assessing	assess	VERB
dpc-4071	49	6	cutaneous	cutaneous	ADJ
dpc-4071	49	7	and	and	CCONJ
dpc-4071	49	8	mucosal	mucosal	ADJ
dpc-4071	49	9	involvement	involvement	NOUN
dpc-4071	49	10	with	with	ADP
dpc-4071	49	11	a	a	DET
dpc-4071	49	12	total	total	ADJ
dpc-4071	49	13	score	score	NOUN
dpc-4071	49	14	[	[	X
dpc-4071	49	15	11	11	NUM
dpc-4071	49	16	]	]	PUNCT
dpc-4071	49	17	.	.	PUNCT
dpc-4071	50	1	this	this	DET
dpc-4071	50	2	index	index	NOUN
dpc-4071	50	3	quantifies	quantify	VERB
dpc-4071	50	4	the	the	DET
dpc-4071	50	5	size	size	NOUN
dpc-4071	50	6	and	and	CCONJ
dpc-4071	50	7	number	number	NOUN
dpc-4071	50	8	of	of	ADP
dpc-4071	50	9	the	the	DET
dpc-4071	50	10	lesions	lesion	NOUN
dpc-4071	50	11	altogether	altogether	ADV
dpc-4071	50	12	.	.	PUNCT
dpc-4071	51	1	in	in	ADP
dpc-4071	51	2	addition	addition	NOUN
dpc-4071	51	3	,	,	PUNCT
dpc-4071	51	4	the	the	DET
dpc-4071	51	5	affected	affected	ADJ
dpc-4071	51	6	areas	area	NOUN
dpc-4071	51	7	of	of	ADP
dpc-4071	51	8	the	the	DET
dpc-4071	51	9	skin	skin	NOUN
dpc-4071	51	10	are	be	AUX
dpc-4071	51	11	weighted	weight	VERB
dpc-4071	51	12	based	base	VERB
dpc-4071	51	13	on	on	ADP
dpc-4071	51	14	bpdai	bpdai	NOUN
dpc-4071	51	15	with	with	ADP
dpc-4071	51	16	more	more	ADJ
dpc-4071	51	17	emphasis	emphasis	NOUN
dpc-4071	51	18	on	on	ADP
dpc-4071	51	19	limbs	limb	NOUN
dpc-4071	51	20	and	and	CCONJ
dpc-4071	51	21	less	less	ADJ
dpc-4071	51	22	on	on	ADP
dpc-4071	51	23	the	the	DET
dpc-4071	51	24	face	face	NOUN
dpc-4071	51	25	or	or	CCONJ
dpc-4071	51	26	scalp	scalp	NOUN
dpc-4071	51	27	.	.	PUNCT
dpc-4071	52	1	the	the	DET
dpc-4071	52	2	higher	high	ADJ
dpc-4071	52	3	scores	score	NOUN
dpc-4071	52	4	are	be	AUX
dpc-4071	52	5	attributed	attribute	VERB
dpc-4071	52	6	to	to	ADP
dpc-4071	52	7	worse	bad	ADJ
dpc-4071	52	8	conditions	condition	NOUN
dpc-4071	52	9	.	.	PUNCT
dpc-4071	53	1	the	the	DET
dpc-4071	53	2	slides	slide	NOUN
dpc-4071	53	3	of	of	ADP
dpc-4071	53	4	skin	skin	NOUN
dpc-4071	53	5	biopsies	biopsy	NOUN
dpc-4071	53	6	were	be	AUX
dpc-4071	53	7	also	also	ADV
dpc-4071	53	8	re	re	VERB
dpc-4071	53	9	-	-	VERB
dpc-4071	53	10	evaluated	evaluate	VERB
dpc-4071	53	11	by	by	ADP
dpc-4071	53	12	a	a	DET
dpc-4071	53	13	blinded	blind	VERB
dpc-4071	53	14	skilled	skilled	ADJ
dpc-4071	53	15	dermatopathologist	dermatopathologist	NOUN
dpc-4071	53	16	for	for	ADP
dpc-4071	53	17	histopathological	histopathological	ADJ
dpc-4071	53	18	findings	finding	NOUN
dpc-4071	53	19	including	include	VERB
dpc-4071	53	20	subepidermal	subepidermal	NOUN
dpc-4071	53	21	blister	blister	NOUN
dpc-4071	53	22	,	,	PUNCT
dpc-4071	53	23	c3	c3	PROPN
dpc-4071	53	24	,	,	PUNCT
dpc-4071	53	25	igg	igg	PROPN
dpc-4071	53	26	,	,	PUNCT
dpc-4071	53	27	tissue	tissue	NOUN
dpc-4071	53	28	inflammation	inflammation	NOUN
dpc-4071	53	29	,	,	PUNCT
dpc-4071	53	30	peripheral	peripheral	ADJ
dpc-4071	53	31	eosinophilia	eosinophilia	NOUN
dpc-4071	53	32	,	,	PUNCT
dpc-4071	53	33	and	and	CCONJ
dpc-4071	53	34	dermal	dermal	ADJ
dpc-4071	53	35	eosinophilia	eosinophilia	NOUN
dpc-4071	53	36	.	.	PUNCT
dpc-4071	54	1	the	the	DET
dpc-4071	54	2	presence	presence	NOUN
dpc-4071	54	3	or	or	CCONJ
dpc-4071	54	4	absence	absence	NOUN
dpc-4071	54	5	of	of	ADP
dpc-4071	54	6	a	a	DET
dpc-4071	54	7	cleft	cleft	NOUN
dpc-4071	54	8	was	be	AUX
dpc-4071	54	9	registered	register	VERB
dpc-4071	54	10	.	.	PUNCT
dpc-4071	55	1	tissue	tissue	NOUN
dpc-4071	55	2	inflammation	inflammation	NOUN
dpc-4071	55	3	was	be	AUX
dpc-4071	55	4	assessed	assess	VERB
dpc-4071	55	5	at	at	ADP
dpc-4071	55	6	grade	grade	NOUN
dpc-4071	55	7	0	0	NUM
dpc-4071	55	8	=	=	SYM
dpc-4071	55	9	0	0	NUM
dpc-4071	55	10	%	%	NOUN
dpc-4071	55	11	,	,	PUNCT
dpc-4071	55	12	grade	grade	NOUN
dpc-4071	55	13	1	1	NUM
dpc-4071	55	14	<	<	X
dpc-4071	55	15	25	25	NUM
dpc-4071	55	16	%	%	NOUN
dpc-4071	55	17	,	,	PUNCT
dpc-4071	55	18	grade	grade	NOUN
dpc-4071	55	19	2	2	NUM
dpc-4071	55	20	=	=	SYM
dpc-4071	55	21	25	25	NUM
dpc-4071	55	22	%	%	NOUN
dpc-4071	55	23	to	to	PART
dpc-4071	55	24	50	50	NUM
dpc-4071	55	25	%	%	NOUN
dpc-4071	55	26	,	,	PUNCT
dpc-4071	55	27	grade	grade	NOUN
dpc-4071	55	28	3	3	NUM
dpc-4071	55	29	=	=	SYM
dpc-4071	55	30	50	50	NUM
dpc-4071	55	31	%	%	NOUN
dpc-4071	55	32	to	to	PART
dpc-4071	55	33	75	75	NUM
dpc-4071	55	34	%	%	NOUN
dpc-4071	55	35	,	,	PUNCT
dpc-4071	55	36	and	and	CCONJ
dpc-4071	55	37	grade	grade	NOUN
dpc-4071	55	38	4	4	NUM
dpc-4071	55	39	>	>	SYM
dpc-4071	55	40	75	75	NUM
dpc-4071	55	41	%	%	NOUN
dpc-4071	55	42	,	,	PUNCT
dpc-4071	55	43	based	base	VERB
dpc-4071	55	44	on	on	ADP
dpc-4071	55	45	the	the	DET
dpc-4071	55	46	proportion	proportion	NOUN
dpc-4071	55	47	of	of	ADP
dpc-4071	55	48	light	light	ADJ
dpc-4071	55	49	microscopic	microscopic	ADJ
dpc-4071	55	50	fields	field	NOUN
dpc-4071	55	51	containing	contain	VERB
dpc-4071	55	52	inflammatory	inflammatory	ADJ
dpc-4071	55	53	cells	cell	NOUN
dpc-4071	55	54	.	.	PUNCT
dpc-4071	56	1	four	four	NUM
dpc-4071	56	2	fields	field	NOUN
dpc-4071	56	3	of	of	ADP
dpc-4071	56	4	×40	×40	PROPN
dpc-4071	56	5	power	power	NOUN
dpc-4071	56	6	of	of	ADP
dpc-4071	56	7	each	each	DET
dpc-4071	56	8	slide	slide	NOUN
dpc-4071	56	9	were	be	AUX
dpc-4071	56	10	evaluated	evaluate	VERB
dpc-4071	56	11	,	,	PUNCT
dpc-4071	56	12	each	each	DET
dpc-4071	56	13	field	field	NOUN
dpc-4071	56	14	was	be	AUX
dpc-4071	56	15	divided	divide	VERB
dpc-4071	56	16	into	into	ADP
dpc-4071	56	17	four	four	NUM
dpc-4071	56	18	quadrants	quadrant	NOUN
dpc-4071	56	19	(	(	PUNCT
dpc-4071	56	20	each	each	DET
dpc-4071	56	21	25	25	NUM
dpc-4071	56	22	%	%	NOUN
dpc-4071	56	23	)	)	PUNCT
dpc-4071	56	24	,	,	PUNCT
dpc-4071	56	25	and	and	CCONJ
dpc-4071	56	26	the	the	DET
dpc-4071	56	27	tissue	tissue	NOUN
dpc-4071	56	28	inflammation	inflammation	NOUN
dpc-4071	56	29	was	be	AUX
dpc-4071	56	30	scored	score	VERB
dpc-4071	56	31	based	base	VERB
dpc-4071	56	32	on	on	ADP
dpc-4071	56	33	the	the	DET
dpc-4071	56	34	presence	presence	NOUN
dpc-4071	56	35	of	of	ADP
dpc-4071	56	36	inflammatory	inflammatory	ADJ
dpc-4071	56	37	cells	cell	NOUN
dpc-4071	56	38	in	in	ADP
dpc-4071	56	39	each	each	DET
dpc-4071	56	40	quadrant	quadrant	NOUN
dpc-4071	57	1	[	[	X
dpc-4071	57	2	12	12	NUM
dpc-4071	57	3	]	]	PUNCT
dpc-4071	57	4	.	.	PUNCT
dpc-4071	58	1	finally	finally	ADV
dpc-4071	58	2	,	,	PUNCT
dpc-4071	58	3	the	the	DET
dpc-4071	58	4	average	average	ADJ
dpc-4071	58	5	percentage	percentage	NOUN
dpc-4071	58	6	in	in	ADP
dpc-4071	58	7	the	the	DET
dpc-4071	58	8	four	four	NUM
dpc-4071	58	9	fields	field	NOUN
dpc-4071	58	10	was	be	AUX
dpc-4071	58	11	considered	consider	VERB
dpc-4071	58	12	as	as	ADP
dpc-4071	58	13	the	the	DET
dpc-4071	58	14	final	final	ADJ
dpc-4071	58	15	tissue	tissue	NOUN
dpc-4071	58	16	inflammation	inflammation	NOUN
dpc-4071	58	17	score	score	NOUN
dpc-4071	58	18	.	.	PUNCT
dpc-4071	59	1	dermal	dermal	ADJ
dpc-4071	59	2	eosinophilia	eosinophilia	PROPN
dpc-4071	59	3	was	be	AUX
dpc-4071	59	4	also	also	ADV
dpc-4071	59	5	scored	score	VERB
dpc-4071	59	6	as	as	ADP
dpc-4071	59	7	grade	grade	NOUN
dpc-4071	59	8	0	0	NUM
dpc-4071	59	9	=	=	SYM
dpc-4071	59	10	0	0	NUM
dpc-4071	59	11	%	%	NOUN
dpc-4071	59	12	,	,	PUNCT
dpc-4071	59	13	grade	grade	NOUN
dpc-4071	59	14	1	1	NUM
dpc-4071	59	15	<	<	X
dpc-4071	59	16	25	25	NUM
dpc-4071	59	17	%	%	NOUN
dpc-4071	59	18	,	,	PUNCT
dpc-4071	59	19	grade	grade	NOUN
dpc-4071	59	20	2	2	NUM
dpc-4071	59	21	=	=	SYM
dpc-4071	59	22	25	25	NUM
dpc-4071	59	23	%	%	NOUN
dpc-4071	59	24	to	to	PART
dpc-4071	59	25	50	50	NUM
dpc-4071	59	26	%	%	NOUN
dpc-4071	59	27	,	,	PUNCT
dpc-4071	59	28	grade	grade	NOUN
dpc-4071	59	29	3	3	NUM
dpc-4071	59	30	=	=	SYM
dpc-4071	59	31	50	50	NUM
dpc-4071	59	32	%	%	NOUN
dpc-4071	59	33	to	to	PART
dpc-4071	59	34	75	75	NUM
dpc-4071	59	35	%	%	NOUN
dpc-4071	59	36	,	,	PUNCT
dpc-4071	59	37	conclusions	conclusion	NOUN
dpc-4071	59	38	:	:	PUNCT
dpc-4071	59	39	this	this	DET
dpc-4071	59	40	study	study	NOUN
dpc-4071	59	41	revealed	reveal	VERB
dpc-4071	59	42	significant	significant	ADJ
dpc-4071	59	43	relationships	relationship	NOUN
dpc-4071	59	44	between	between	ADP
dpc-4071	59	45	tissue	tissue	NOUN
dpc-4071	59	46	eosinophilia	eosinophilia	NOUN
dpc-4071	59	47	and	and	CCONJ
dpc-4071	59	48	bp	bp	PROPN
dpc-4071	59	49	severity	severity	NOUN
dpc-4071	59	50	.	.	PUNCT
dpc-4071	60	1	these	these	DET
dpc-4071	60	2	findings	finding	NOUN
dpc-4071	60	3	could	could	AUX
dpc-4071	60	4	be	be	AUX
dpc-4071	60	5	useful	useful	ADJ
dpc-4071	60	6	in	in	ADP
dpc-4071	60	7	clinical	clinical	ADJ
dpc-4071	60	8	practice	practice	NOUN
dpc-4071	60	9	.	.	PUNCT
dpc-4071	61	1	the	the	DET
dpc-4071	61	2	possible	possible	ADJ
dpc-4071	61	3	role	role	NOUN
dpc-4071	61	4	of	of	ADP
dpc-4071	61	5	eosinophils	eosinophil	NOUN
dpc-4071	61	6	in	in	ADP
dpc-4071	61	7	bp	bp	PROPN
dpc-4071	61	8	clinical	clinical	ADJ
dpc-4071	61	9	features	feature	NOUN
dpc-4071	61	10	should	should	AUX
dpc-4071	61	11	be	be	AUX
dpc-4071	61	12	considered	consider	VERB
dpc-4071	61	13	as	as	ADP
dpc-4071	61	14	a	a	DET
dpc-4071	61	15	promising	promising	ADJ
dpc-4071	61	16	help	help	NOUN
dpc-4071	61	17	for	for	ADP
dpc-4071	61	18	better	well	ADJ
dpc-4071	61	19	diagnosis	diagnosis	NOUN
dpc-4071	61	20	and	and	CCONJ
dpc-4071	61	21	treatment	treatment	NOUN
dpc-4071	61	22	.	.	PUNCT
dpc-4071	62	1	original	original	ADJ
dpc-4071	62	2	article	article	NOUN
dpc-4071	62	3	|	|	ADV
dpc-4071	62	4	dermatol	dermatol	ADJ
dpc-4071	62	5	pract	pract	NOUN
dpc-4071	62	6	concept	concept	NOUN
dpc-4071	62	7	.	.	PUNCT
dpc-4071	63	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	63	2	3	3	NUM
dpc-4071	63	3	and	and	CCONJ
dpc-4071	63	4	grade	grade	NOUN
dpc-4071	63	5	4	4	NUM
dpc-4071	63	6	>	>	SYM
dpc-4071	63	7	75	75	NUM
dpc-4071	63	8	%	%	NOUN
dpc-4071	64	1	[	[	X
dpc-4071	64	2	13	13	NUM
dpc-4071	64	3	]	]	PUNCT
dpc-4071	64	4	.	.	PUNCT
dpc-4071	65	1	eosinophils	eosinophil	NOUN
dpc-4071	65	2	were	be	AUX
dpc-4071	65	3	counted	count	VERB
dpc-4071	65	4	among	among	ADP
dpc-4071	65	5	the	the	DET
dpc-4071	65	6	inflammatory	inflammatory	ADJ
dpc-4071	65	7	cells	cell	NOUN
dpc-4071	65	8	and	and	CCONJ
dpc-4071	65	9	then	then	ADV
dpc-4071	65	10	the	the	DET
dpc-4071	65	11	percentage	percentage	NOUN
dpc-4071	65	12	was	be	AUX
dpc-4071	65	13	calculated	calculate	VERB
dpc-4071	65	14	in	in	ADP
dpc-4071	65	15	the	the	DET
dpc-4071	65	16	same	same	ADJ
dpc-4071	65	17	four	four	NUM
dpc-4071	65	18	fields	field	NOUN
dpc-4071	65	19	of	of	ADP
dpc-4071	65	20	×40	×40	PROPN
dpc-4071	65	21	power	power	NOUN
dpc-4071	65	22	.	.	PUNCT
dpc-4071	66	1	the	the	DET
dpc-4071	66	2	average	average	ADJ
dpc-4071	66	3	percentage	percentage	NOUN
dpc-4071	66	4	in	in	ADP
dpc-4071	66	5	the	the	DET
dpc-4071	66	6	four	four	NUM
dpc-4071	66	7	fields	field	NOUN
dpc-4071	66	8	was	be	AUX
dpc-4071	66	9	considered	consider	VERB
dpc-4071	66	10	the	the	DET
dpc-4071	66	11	final	final	ADJ
dpc-4071	66	12	dermal	dermal	ADJ
dpc-4071	66	13	eosinophilia	eosinophilia	NOUN
dpc-4071	66	14	score	score	NOUN
dpc-4071	66	15	.	.	PUNCT
dpc-4071	67	1	peripheral	peripheral	ADJ
dpc-4071	67	2	eosinophilia	eosinophilia	PROPN
dpc-4071	67	3	is	be	AUX
dpc-4071	67	4	defined	define	VERB
dpc-4071	67	5	as	as	SCONJ
dpc-4071	67	6	the	the	DET
dpc-4071	67	7	serum	serum	NOUN
dpc-4071	67	8	eosinophil	eosinophil	ADJ
dpc-4071	67	9	count	count	VERB
dpc-4071	67	10	higher	high	ADJ
dpc-4071	67	11	than	than	ADP
dpc-4071	67	12	500	500	NUM
dpc-4071	67	13	eosinophils	eosinophil	NOUN
dpc-4071	67	14	per	per	ADP
dpc-4071	67	15	microliter	microliter	NOUN
dpc-4071	67	16	.	.	PUNCT
dpc-4071	68	1	peripheral	peripheral	ADJ
dpc-4071	68	2	eosinophilia	eosinophilia	PROPN
dpc-4071	68	3	(	(	PUNCT
dpc-4071	68	4	serum	serum	PROPN
dpc-4071	68	5	eosinophilia	eosinophilia	PROPN
dpc-4071	68	6	)	)	PUNCT
dpc-4071	68	7	was	be	AUX
dpc-4071	68	8	graded	grade	VERB
dpc-4071	68	9	as	as	ADP
dpc-4071	68	10	mild	mild	ADJ
dpc-4071	68	11	(	(	PUNCT
dpc-4071	68	12	500	500	NUM
dpc-4071	68	13	-	-	SYM
dpc-4071	68	14	1500	1500	NUM
dpc-4071	68	15	eosinophils	eosinophil	NOUN
dpc-4071	68	16	per	per	ADP
dpc-4071	68	17	microliter	microliter	NOUN
dpc-4071	68	18	)	)	PUNCT
dpc-4071	68	19	,	,	PUNCT
dpc-4071	68	20	moderate	moderate	ADJ
dpc-4071	68	21	(	(	PUNCT
dpc-4071	68	22	1500	1500	NUM
dpc-4071	68	23	-	-	SYM
dpc-4071	68	24	5000	5000	NUM
dpc-4071	68	25	eosinophils	eosinophil	NOUN
dpc-4071	68	26	per	per	ADP
dpc-4071	68	27	microliter	microliter	NOUN
dpc-4071	68	28	)	)	PUNCT
dpc-4071	68	29	,	,	PUNCT
dpc-4071	68	30	and	and	CCONJ
dpc-4071	68	31	severe	severe	ADJ
dpc-4071	68	32	(	(	PUNCT
dpc-4071	68	33	more	more	ADJ
dpc-4071	68	34	than	than	ADP
dpc-4071	68	35	5000	5000	NUM
dpc-4071	68	36	eosinophils	eosinophil	NOUN
dpc-4071	68	37	per	per	ADP
dpc-4071	68	38	microliter	microliter	NOUN
dpc-4071	68	39	)	)	PUNCT
dpc-4071	69	1	[	[	X
dpc-4071	69	2	14	14	NUM
dpc-4071	69	3	]	]	PUNCT
dpc-4071	69	4	.	.	PUNCT
dpc-4071	70	1	statistical	statistical	ADJ
dpc-4071	70	2	analysis	analysis	NOUN
dpc-4071	70	3	the	the	DET
dpc-4071	70	4	data	datum	NOUN
dpc-4071	70	5	were	be	AUX
dpc-4071	70	6	analyzed	analyze	VERB
dpc-4071	70	7	using	use	VERB
dpc-4071	70	8	the	the	DET
dpc-4071	70	9	statistical	statistical	ADJ
dpc-4071	70	10	package	package	NOUN
dpc-4071	70	11	for	for	ADP
dpc-4071	70	12	social	social	ADJ
dpc-4071	70	13	science	science	NOUN
dpc-4071	70	14	(	(	PUNCT
dpc-4071	70	15	spss	spss	PROPN
dpc-4071	70	16	)	)	PUNCT
dpc-4071	70	17	version	version	NOUN
dpc-4071	70	18	24	24	NUM
dpc-4071	70	19	for	for	ADP
dpc-4071	70	20	windows	window	NOUN
dpc-4071	70	21	.	.	PUNCT
dpc-4071	71	1	descriptive	descriptive	ADJ
dpc-4071	71	2	statistics	statistic	NOUN
dpc-4071	71	3	(	(	PUNCT
dpc-4071	71	4	frequencies	frequency	NOUN
dpc-4071	71	5	,	,	PUNCT
dpc-4071	71	6	percentages	percentage	NOUN
dpc-4071	71	7	,	,	PUNCT
dpc-4071	71	8	means	mean	NOUN
dpc-4071	71	9	,	,	PUNCT
dpc-4071	71	10	and	and	CCONJ
dpc-4071	71	11	standard	standard	ADJ
dpc-4071	71	12	deviations	deviation	NOUN
dpc-4071	71	13	)	)	PUNCT
dpc-4071	71	14	were	be	AUX
dpc-4071	71	15	used	use	VERB
dpc-4071	71	16	for	for	ADP
dpc-4071	71	17	each	each	DET
dpc-4071	71	18	item	item	NOUN
dpc-4071	71	19	to	to	PART
dpc-4071	71	20	describe	describe	VERB
dpc-4071	71	21	the	the	DET
dpc-4071	71	22	sample	sample	NOUN
dpc-4071	71	23	characteristics	characteristic	NOUN
dpc-4071	71	24	.	.	PUNCT
dpc-4071	72	1	independent	independent	ADJ
dpc-4071	72	2	t	t	PROPN
dpc-4071	72	3	-	-	PUNCT
dpc-4071	72	4	test	test	NOUN
dpc-4071	72	5	,	,	PUNCT
dpc-4071	72	6	one	one	NUM
dpc-4071	72	7	-	-	PUNCT
dpc-4071	72	8	way	way	NOUN
dpc-4071	72	9	anova	anova	PROPN
dpc-4071	72	10	,	,	PUNCT
dpc-4071	72	11	chi	chi	NOUN
dpc-4071	72	12	-	-	PUNCT
dpc-4071	72	13	square	square	ADJ
dpc-4071	72	14	,	,	PUNCT
dpc-4071	72	15	and	and	CCONJ
dpc-4071	72	16	spearman	spearman	NOUN
dpc-4071	72	17	-	-	PUNCT
dpc-4071	72	18	pearson	pearson	NOUN
dpc-4071	72	19	correlation	correlation	NOUN
dpc-4071	72	20	test	test	NOUN
dpc-4071	72	21	were	be	AUX
dpc-4071	72	22	performed	perform	VERB
dpc-4071	72	23	.	.	PUNCT
dpc-4071	73	1	a	a	DET
dpc-4071	73	2	multivariate	multivariate	NOUN
dpc-4071	73	3	linear	linear	PROPN
dpc-4071	73	4	regression	regression	NOUN
dpc-4071	73	5	test	test	NOUN
dpc-4071	73	6	was	be	AUX
dpc-4071	73	7	also	also	ADV
dpc-4071	73	8	used	use	VERB
dpc-4071	73	9	to	to	PART
dpc-4071	73	10	investigate	investigate	VERB
dpc-4071	73	11	and	and	CCONJ
dpc-4071	73	12	eliminate	eliminate	VERB
dpc-4071	73	13	the	the	DET
dpc-4071	73	14	effect	effect	NOUN
dpc-4071	73	15	of	of	ADP
dpc-4071	73	16	confounding	confound	VERB
dpc-4071	73	17	factors	factor	NOUN
dpc-4071	73	18	affecting	affect	VERB
dpc-4071	73	19	the	the	DET
dpc-4071	73	20	severity	severity	NOUN
dpc-4071	73	21	of	of	ADP
dpc-4071	73	22	the	the	DET
dpc-4071	73	23	disease	disease	NOUN
dpc-4071	73	24	.	.	PUNCT
dpc-4071	74	1	p	p	X
dpc-4071	74	2	-	-	PUNCT
dpc-4071	74	3	value	value	NOUN
dpc-4071	74	4	<	<	X
dpc-4071	74	5	0.05	0.05	NUM
dpc-4071	74	6	was	be	AUX
dpc-4071	74	7	considered	consider	VERB
dpc-4071	74	8	as	as	ADP
dpc-4071	74	9	the	the	DET
dpc-4071	74	10	significance	significance	NOUN
dpc-4071	74	11	threshold	threshold	NOUN
dpc-4071	74	12	.	.	PUNCT
dpc-4071	75	1	results	result	VERB
dpc-4071	75	2	a	a	DET
dpc-4071	75	3	total	total	ADJ
dpc-4071	75	4	number	number	NOUN
dpc-4071	75	5	of	of	ADP
dpc-4071	75	6	108	108	NUM
dpc-4071	75	7	patients	patient	NOUN
dpc-4071	75	8	were	be	AUX
dpc-4071	75	9	included	include	VERB
dpc-4071	75	10	in	in	ADP
dpc-4071	75	11	this	this	DET
dpc-4071	75	12	study	study	NOUN
dpc-4071	75	13	.	.	PUNCT
dpc-4071	76	1	thirty	thirty	NUM
dpc-4071	76	2	-	-	PUNCT
dpc-4071	76	3	five	five	NUM
dpc-4071	76	4	were	be	AUX
dpc-4071	76	5	excluded	exclude	VERB
dpc-4071	76	6	due	due	ADP
dpc-4071	76	7	to	to	ADP
dpc-4071	76	8	our	our	PRON
dpc-4071	76	9	exclusion	exclusion	NOUN
dpc-4071	76	10	criteria	criterion	NOUN
dpc-4071	76	11	.	.	PUNCT
dpc-4071	77	1	finally	finally	ADV
dpc-4071	77	2	,	,	PUNCT
dpc-4071	77	3	data	datum	NOUN
dpc-4071	77	4	from	from	ADP
dpc-4071	77	5	73	73	NUM
dpc-4071	77	6	patients	patient	NOUN
dpc-4071	77	7	were	be	AUX
dpc-4071	77	8	analyzed	analyze	VERB
dpc-4071	77	9	.	.	PUNCT
dpc-4071	78	1	among	among	ADP
dpc-4071	78	2	them	they	PRON
dpc-4071	78	3	,	,	PUNCT
dpc-4071	78	4	45	45	NUM
dpc-4071	78	5	patients	patient	NOUN
dpc-4071	78	6	had	have	VERB
dpc-4071	78	7	complete	complete	ADJ
dpc-4071	78	8	available	available	ADJ
dpc-4071	78	9	histopathological	histopathological	ADJ
dpc-4071	78	10	data	datum	NOUN
dpc-4071	78	11	;	;	PUNCT
dpc-4071	78	12	57.5	57.5	NUM
dpc-4071	78	13	%	%	NOUN
dpc-4071	78	14	of	of	ADP
dpc-4071	78	15	the	the	DET
dpc-4071	78	16	population	population	NOUN
dpc-4071	78	17	was	be	AUX
dpc-4071	78	18	female	female	ADJ
dpc-4071	78	19	.	.	PUNCT
dpc-4071	79	1	the	the	DET
dpc-4071	79	2	mean	mean	ADJ
dpc-4071	79	3	age	age	NOUN
dpc-4071	79	4	was	be	AUX
dpc-4071	79	5	72.1	72.1	NUM
dpc-4071	79	6	 	 	SPACE
dpc-4071	79	7	years	year	NOUN
dpc-4071	79	8	.	.	PUNCT
dpc-4071	80	1	none	none	NOUN
dpc-4071	80	2	of	of	ADP
dpc-4071	80	3	the	the	DET
dpc-4071	80	4	patients	patient	NOUN
dpc-4071	80	5	were	be	AUX
dpc-4071	80	6	pregnant	pregnant	ADJ
dpc-4071	80	7	.	.	PUNCT
dpc-4071	81	1	hypertension	hypertension	NOUN
dpc-4071	81	2	was	be	AUX
dpc-4071	81	3	the	the	DET
dpc-4071	81	4	most	most	ADV
dpc-4071	81	5	frequent	frequent	ADJ
dpc-4071	81	6	medical	medical	ADJ
dpc-4071	81	7	history	history	NOUN
dpc-4071	81	8	and	and	CCONJ
dpc-4071	81	9	46.6	46.6	NUM
dpc-4071	81	10	%	%	NOUN
dpc-4071	81	11	of	of	ADP
dpc-4071	81	12	patients	patient	NOUN
dpc-4071	81	13	had	have	VERB
dpc-4071	81	14	histories	history	NOUN
dpc-4071	81	15	of	of	ADP
dpc-4071	81	16	cardiovascular	cardiovascular	ADJ
dpc-4071	81	17	drug	drug	NOUN
dpc-4071	81	18	consumption	consumption	NOUN
dpc-4071	81	19	.	.	PUNCT
dpc-4071	82	1	one	one	NUM
dpc-4071	82	2	patient	patient	NOUN
dpc-4071	82	3	had	have	VERB
dpc-4071	82	4	bp	bp	PROPN
dpc-4071	82	5	lesions	lesion	NOUN
dpc-4071	82	6	without	without	ADP
dpc-4071	82	7	blisters	blister	NOUN
dpc-4071	82	8	and	and	CCONJ
dpc-4071	82	9	one	one	NUM
dpc-4071	82	10	had	have	VERB
dpc-4071	82	11	localized	localize	VERB
dpc-4071	82	12	bp	bp	PROPN
dpc-4071	82	13	.	.	PUNCT
dpc-4071	83	1	limbs	limb	NOUN
dpc-4071	83	2	and	and	CCONJ
dpc-4071	83	3	trunk	trunk	NOUN
dpc-4071	83	4	were	be	AUX
dpc-4071	83	5	the	the	DET
dpc-4071	83	6	most	most	ADV
dpc-4071	83	7	frequent	frequent	ADJ
dpc-4071	83	8	sites	site	NOUN
dpc-4071	83	9	of	of	ADP
dpc-4071	83	10	involvement	involvement	NOUN
dpc-4071	83	11	.	.	PUNCT
dpc-4071	84	1	the	the	DET
dpc-4071	84	2	mean	mean	ADJ
dpc-4071	84	3	hospitalization	hospitalization	NOUN
dpc-4071	84	4	duration	duration	NOUN
dpc-4071	84	5	was	be	AUX
dpc-4071	84	6	11	11	NUM
dpc-4071	84	7	  	  	SPACE
dpc-4071	84	8	days	day	NOUN
dpc-4071	84	9	.	.	PUNCT
dpc-4071	85	1	topical	topical	ADJ
dpc-4071	85	2	corticosteroids	corticosteroid	NOUN
dpc-4071	85	3	,	,	PUNCT
dpc-4071	85	4	systemic	systemic	ADJ
dpc-4071	85	5	corticosteroids	corticosteroid	NOUN
dpc-4071	85	6	,	,	PUNCT
dpc-4071	85	7	and	and	CCONJ
dpc-4071	85	8	topical	topical	ADJ
dpc-4071	85	9	burrows	burrow	NOUN
dpc-4071	85	10	were	be	AUX
dpc-4071	85	11	the	the	DET
dpc-4071	85	12	most	most	ADV
dpc-4071	85	13	common	common	ADJ
dpc-4071	85	14	treatment	treatment	NOUN
dpc-4071	85	15	protocols	protocol	NOUN
dpc-4071	85	16	among	among	ADP
dpc-4071	85	17	the	the	DET
dpc-4071	85	18	patients	patient	NOUN
dpc-4071	85	19	.	.	PUNCT
dpc-4071	86	1	the	the	DET
dpc-4071	86	2	most	most	ADV
dpc-4071	86	3	common	common	ADJ
dpc-4071	86	4	histopathological	histopathological	ADJ
dpc-4071	86	5	findings	finding	NOUN
dpc-4071	86	6	were	be	AUX
dpc-4071	86	7	subepidermal	subepidermal	ADJ
dpc-4071	86	8	blisters	blister	NOUN
dpc-4071	86	9	and	and	CCONJ
dpc-4071	86	10	positive	positive	ADJ
dpc-4071	86	11	c3	c3	NOUN
dpc-4071	86	12	in	in	ADP
dpc-4071	86	13	a	a	DET
dpc-4071	86	14	linear	linear	ADJ
dpc-4071	86	15	pattern	pattern	NOUN
dpc-4071	86	16	in	in	ADP
dpc-4071	86	17	the	the	DET
dpc-4071	86	18	slide	slide	NOUN
dpc-4071	86	19	samples	sample	NOUN
dpc-4071	86	20	.	.	PUNCT
dpc-4071	87	1	the	the	DET
dpc-4071	87	2	most	most	ADV
dpc-4071	87	3	common	common	ADJ
dpc-4071	87	4	grade	grade	NOUN
dpc-4071	87	5	of	of	ADP
dpc-4071	87	6	tissue	tissue	NOUN
dpc-4071	87	7	eosinophilia	eosinophilia	PROPN
dpc-4071	87	8	was	be	AUX
dpc-4071	87	9	grade	grade	NOUN
dpc-4071	87	10	1	1	NUM
dpc-4071	87	11	.	.	PUNCT
dpc-4071	88	1	analysis	analysis	NOUN
dpc-4071	88	2	of	of	ADP
dpc-4071	88	3	patient	patient	ADJ
dpc-4071	88	4	characteristics	characteristic	NOUN
dpc-4071	88	5	between	between	ADP
dpc-4071	88	6	males	male	NOUN
dpc-4071	88	7	and	and	CCONJ
dpc-4071	88	8	females	female	NOUN
dpc-4071	88	9	is	be	AUX
dpc-4071	88	10	summarized	summarize	VERB
dpc-4071	88	11	in	in	ADP
dpc-4071	88	12	table	table	NOUN
dpc-4071	88	13	1	1	NUM
dpc-4071	88	14	.	.	PUNCT
dpc-4071	89	1	our	our	PRON
dpc-4071	89	2	results	result	NOUN
dpc-4071	89	3	showed	show	VERB
dpc-4071	89	4	that	that	SCONJ
dpc-4071	89	5	patients	patient	NOUN
dpc-4071	89	6	with	with	ADP
dpc-4071	89	7	mucosal	mucosal	ADJ
dpc-4071	89	8	involvements	involvement	NOUN
dpc-4071	89	9	had	have	VERB
dpc-4071	89	10	significantly	significantly	ADV
dpc-4071	89	11	lower	low	ADJ
dpc-4071	89	12	serum	serum	NOUN
dpc-4071	89	13	eosinophil	eosinophil	ADJ
dpc-4071	89	14	count	count	NOUN
dpc-4071	89	15	(	(	PUNCT
dpc-4071	89	16	p	p	X
dpc-4071	89	17	 	 	SPACE
dpc-4071	89	18	=	=	NOUN
dpc-4071	89	19	0.02	0.02	NUM
dpc-4071	89	20	)	)	PUNCT
dpc-4071	89	21	.	.	PUNCT
dpc-4071	90	1	our	our	PRON
dpc-4071	90	2	study	study	NOUN
dpc-4071	90	3	also	also	ADV
dpc-4071	90	4	showed	show	VERB
dpc-4071	90	5	that	that	SCONJ
dpc-4071	90	6	patients	patient	NOUN
dpc-4071	90	7	with	with	ADP
dpc-4071	90	8	higher	high	ADJ
dpc-4071	90	9	grades	grade	NOUN
dpc-4071	90	10	of	of	ADP
dpc-4071	90	11	tissue	tissue	NOUN
dpc-4071	90	12	eosinophilia	eosinophilia	PROPN
dpc-4071	90	13	had	have	VERB
dpc-4071	90	14	significantly	significantly	ADV
dpc-4071	90	15	higher	high	ADJ
dpc-4071	90	16	grades	grade	NOUN
dpc-4071	90	17	of	of	ADP
dpc-4071	90	18	serum	serum	NOUN
dpc-4071	90	19	eosinophil	eosinophil	ADJ
dpc-4071	90	20	count	count	NOUN
dpc-4071	90	21	(	(	PUNCT
dpc-4071	90	22	p	p	X
dpc-4071	90	23	<	<	X
dpc-4071	90	24	0.01	0.01	NUM
dpc-4071	90	25	)	)	PUNCT
dpc-4071	90	26	and	and	CCONJ
dpc-4071	90	27	also	also	ADV
dpc-4071	90	28	higher	high	ADJ
dpc-4071	90	29	serum	serum	NOUN
dpc-4071	90	30	eosinophil	eosinophil	ADJ
dpc-4071	90	31	percentage	percentage	NOUN
dpc-4071	90	32	(	(	PUNCT
dpc-4071	90	33	p	p	X
dpc-4071	90	34	<	<	X
dpc-4071	90	35	0.0001	0.0001	NUM
dpc-4071	90	36	)	)	PUNCT
dpc-4071	90	37	(	(	PUNCT
dpc-4071	90	38	table	table	NOUN
dpc-4071	90	39	2	2	NUM
dpc-4071	90	40	)	)	PUNCT
dpc-4071	90	41	.	.	PUNCT
dpc-4071	91	1	there	there	PRON
dpc-4071	91	2	was	be	VERB
dpc-4071	91	3	a	a	DET
dpc-4071	91	4	significant	significant	ADJ
dpc-4071	91	5	correlation	correlation	NOUN
dpc-4071	91	6	between	between	ADP
dpc-4071	91	7	bpdai	bpdai	NOUN
dpc-4071	91	8	severity	severity	NOUN
dpc-4071	91	9	score	score	NOUN
dpc-4071	91	10	and	and	CCONJ
dpc-4071	91	11	tissue	tissue	NOUN
dpc-4071	91	12	eosinophilia	eosinophilia	PROPN
dpc-4071	91	13	grade	grade	NOUN
dpc-4071	91	14	(	(	PUNCT
dpc-4071	91	15	p	p	X
dpc-4071	91	16	=	=	NOUN
dpc-4071	91	17	0.03	0.03	NUM
dpc-4071	91	18	;	;	PUNCT
dpc-4071	91	19	r	r	NOUN
dpc-4071	91	20	=	=	NOUN
dpc-4071	91	21	0.33	0.33	NUM
dpc-4071	91	22	)	)	PUNCT
dpc-4071	91	23	.	.	PUNCT
dpc-4071	92	1	although	although	SCONJ
dpc-4071	92	2	,	,	PUNCT
dpc-4071	92	3	there	there	PRON
dpc-4071	92	4	was	be	VERB
dpc-4071	92	5	no	no	DET
dpc-4071	92	6	significant	significant	ADJ
dpc-4071	92	7	correlation	correlation	NOUN
dpc-4071	92	8	between	between	ADP
dpc-4071	92	9	bpdai	bpdai	NOUN
dpc-4071	92	10	severity	severity	NOUN
dpc-4071	92	11	score	score	NOUN
dpc-4071	92	12	and	and	CCONJ
dpc-4071	92	13	peripheral	peripheral	ADJ
dpc-4071	92	14	eosinophilia	eosinophilia	NOUN
dpc-4071	92	15	grade	grade	NOUN
dpc-4071	92	16	(	(	PUNCT
dpc-4071	92	17	p	p	X
dpc-4071	92	18	=	=	NOUN
dpc-4071	92	19	0.52	0.52	NUM
dpc-4071	92	20	;	;	PUNCT
dpc-4071	92	21	r	r	NOUN
dpc-4071	92	22	=	=	NOUN
dpc-4071	92	23	0.76	0.76	NUM
dpc-4071	92	24	)	)	PUNCT
dpc-4071	92	25	.	.	PUNCT
dpc-4071	93	1	there	there	PRON
dpc-4071	93	2	was	be	VERB
dpc-4071	93	3	also	also	ADV
dpc-4071	93	4	a	a	DET
dpc-4071	93	5	significant	significant	ADJ
dpc-4071	93	6	relationship	relationship	NOUN
dpc-4071	93	7	between	between	ADP
dpc-4071	93	8	dermal	dermal	ADJ
dpc-4071	93	9	inflammation	inflammation	NOUN
dpc-4071	93	10	and	and	CCONJ
dpc-4071	93	11	serum	serum	VERB
dpc-4071	93	12	eosinophil	eosinophil	ADJ
dpc-4071	93	13	count	count	NOUN
dpc-4071	93	14	(	(	PUNCT
dpc-4071	93	15	r	r	NOUN
dpc-4071	93	16	=	=	NOUN
dpc-4071	93	17	0.95	0.95	NUM
dpc-4071	93	18	;	;	PUNCT
dpc-4071	93	19	p	p	X
dpc-4071	93	20	<	<	X
dpc-4071	93	21	0.0001	0.0001	NUM
dpc-4071	93	22	)	)	PUNCT
dpc-4071	93	23	and	and	CCONJ
dpc-4071	93	24	serum	serum	VERB
dpc-4071	93	25	eosinophil	eosinophil	ADJ
dpc-4071	93	26	percentage	percentage	NOUN
dpc-4071	93	27	(	(	PUNCT
dpc-4071	93	28	r	r	NOUN
dpc-4071	93	29	=	=	SYM
dpc-4071	93	30	0.46	0.46	NUM
dpc-4071	93	31	;	;	PUNCT
dpc-4071	93	32	p	p	X
dpc-4071	93	33	=	=	NOUN
dpc-4071	93	34	0.003	0.003	NUM
dpc-4071	93	35	)	)	PUNCT
dpc-4071	93	36	(	(	PUNCT
dpc-4071	93	37	table	table	NOUN
dpc-4071	93	38	3	3	NUM
dpc-4071	93	39	)	)	PUNCT
dpc-4071	93	40	.	.	PUNCT
dpc-4071	94	1	investigating	investigate	VERB
dpc-4071	94	2	the	the	DET
dpc-4071	94	3	relationship	relationship	NOUN
dpc-4071	94	4	between	between	ADP
dpc-4071	94	5	disease	disease	NOUN
dpc-4071	94	6	severity	severity	NOUN
dpc-4071	94	7	and	and	CCONJ
dpc-4071	94	8	other	other	ADJ
dpc-4071	94	9	clinical	clinical	ADJ
dpc-4071	94	10	and	and	CCONJ
dpc-4071	94	11	histopathological	histopathological	ADJ
dpc-4071	94	12	factors	factor	NOUN
dpc-4071	94	13	,	,	PUNCT
dpc-4071	94	14	only	only	ADV
dpc-4071	94	15	a	a	DET
dpc-4071	94	16	significant	significant	ADJ
dpc-4071	94	17	relationship	relationship	NOUN
dpc-4071	94	18	was	be	AUX
dpc-4071	94	19	observed	observe	VERB
dpc-4071	94	20	between	between	ADP
dpc-4071	94	21	the	the	DET
dpc-4071	94	22	duration	duration	NOUN
dpc-4071	94	23	of	of	ADP
dpc-4071	94	24	the	the	DET
dpc-4071	94	25	disease	disease	NOUN
dpc-4071	94	26	and	and	CCONJ
dpc-4071	94	27	the	the	DET
dpc-4071	94	28	severity	severity	NOUN
dpc-4071	94	29	of	of	ADP
dpc-4071	94	30	the	the	DET
dpc-4071	94	31	disease	disease	NOUN
dpc-4071	94	32	,	,	PUNCT
dpc-4071	94	33	but	but	CCONJ
dpc-4071	94	34	the	the	DET
dpc-4071	94	35	designed	design	VERB
dpc-4071	94	36	regression	regression	NOUN
dpc-4071	94	37	model	model	NOUN
dpc-4071	94	38	was	be	AUX
dpc-4071	94	39	not	not	PART
dpc-4071	94	40	statistically	statistically	ADV
dpc-4071	94	41	significant	significant	ADJ
dpc-4071	94	42	(	(	PUNCT
dpc-4071	94	43	coefficient	coefficient	NOUN
dpc-4071	94	44	of	of	ADP
dpc-4071	94	45	determination	determination	NOUN
dpc-4071	94	46	[	[	X
dpc-4071	94	47	r2	r2	X
dpc-4071	94	48	]	]	X
dpc-4071	94	49	=	=	SYM
dpc-4071	94	50	0.06	0.06	NUM
dpc-4071	94	51	,	,	PUNCT
dpc-4071	94	52	f	f	PROPN
dpc-4071	94	53	=	=	SYM
dpc-4071	94	54	1.53	1.53	NUM
dpc-4071	94	55	,	,	PUNCT
dpc-4071	94	56	degrees	degree	NOUN
dpc-4071	94	57	of	of	ADP
dpc-4071	94	58	freedom	freedom	NOUN
dpc-4071	94	59	[	[	X
dpc-4071	94	60	df	df	X
dpc-4071	94	61	]	]	X
dpc-4071	94	62	=	=	SYM
dpc-4071	94	63	3	3	NUM
dpc-4071	94	64	,	,	PUNCT
dpc-4071	94	65	p	p	NOUN
dpc-4071	94	66	-	-	PUNCT
dpc-4071	94	67	value	value	NOUN
dpc-4071	94	68	>	>	NOUN
dpc-4071	94	69	0.05	0.05	NUM
dpc-4071	94	70	)	)	PUNCT
dpc-4071	94	71	.	.	PUNCT
dpc-4071	95	1	in	in	ADP
dpc-4071	95	2	the	the	DET
dpc-4071	95	3	regression	regression	NOUN
dpc-4071	95	4	model	model	NOUN
dpc-4071	95	5	of	of	ADP
dpc-4071	95	6	patients	patient	NOUN
dpc-4071	95	7	medications	medication	NOUN
dpc-4071	95	8	,	,	PUNCT
dpc-4071	95	9	after	after	ADP
dpc-4071	95	10	the	the	DET
dpc-4071	95	11	entering	entering	NOUN
dpc-4071	95	12	of	of	ADP
dpc-4071	95	13	anti	anti	ADJ
dpc-4071	95	14	-	-	ADJ
dpc-4071	95	15	neoplastic	neoplastic	ADJ
dpc-4071	95	16	drugs	drug	NOUN
dpc-4071	95	17	and	and	CCONJ
dpc-4071	95	18	oral	oral	ADJ
dpc-4071	95	19	corticosteroids	corticosteroid	NOUN
dpc-4071	95	20	into	into	ADP
dpc-4071	95	21	the	the	DET
dpc-4071	95	22	model	model	NOUN
dpc-4071	95	23	,	,	PUNCT
dpc-4071	95	24	the	the	DET
dpc-4071	95	25	model	model	NOUN
dpc-4071	95	26	was	be	AUX
dpc-4071	95	27	statistically	statistically	ADV
dpc-4071	95	28	significant	significant	ADJ
dpc-4071	95	29	and	and	CCONJ
dpc-4071	95	30	only	only	ADV
dpc-4071	95	31	the	the	DET
dpc-4071	95	32	dose	dose	NOUN
dpc-4071	95	33	of	of	ADP
dpc-4071	95	34	corticosteroids	corticosteroid	NOUN
dpc-4071	95	35	was	be	AUX
dpc-4071	95	36	still	still	ADV
dpc-4071	95	37	statistically	statistically	ADV
dpc-4071	95	38	inversely	inversely	ADV
dpc-4071	95	39	related	relate	VERB
dpc-4071	95	40	to	to	ADP
dpc-4071	95	41	the	the	DET
dpc-4071	95	42	severity	severity	NOUN
dpc-4071	95	43	of	of	ADP
dpc-4071	95	44	the	the	DET
dpc-4071	95	45	underlying	underlie	VERB
dpc-4071	95	46	disease	disease	NOUN
dpc-4071	95	47	(	(	PUNCT
dpc-4071	95	48	r2	r2	PROPN
dpc-4071	95	49	=	=	PUNCT
dpc-4071	95	50	0.11	0.11	NUM
dpc-4071	95	51	,	,	PUNCT
dpc-4071	95	52	f	f	PROPN
dpc-4071	95	53	=	=	SYM
dpc-4071	95	54	4.5	4.5	NUM
dpc-4071	95	55	,	,	PUNCT
dpc-4071	95	56	df	df	NOUN
dpc-4071	95	57	=	=	SYM
dpc-4071	95	58	2	2	NUM
dpc-4071	95	59	,	,	PUNCT
dpc-4071	95	60	p	p	NOUN
dpc-4071	95	61	-	-	PUNCT
dpc-4071	95	62	value	value	NOUN
dpc-4071	95	63	=	=	NOUN
dpc-4071	95	64	0.01	0.01	NUM
dpc-4071	95	65	)	)	PUNCT
dpc-4071	95	66	.	.	PUNCT
dpc-4071	96	1	in	in	ADP
dpc-4071	96	2	the	the	DET
dpc-4071	96	3	regression	regression	NOUN
dpc-4071	96	4	model	model	NOUN
dpc-4071	96	5	of	of	ADP
dpc-4071	96	6	mucosal	mucosal	NOUN
dpc-4071	96	7	involvement	involvement	NOUN
dpc-4071	96	8	and	and	CCONJ
dpc-4071	96	9	disease	disease	NOUN
dpc-4071	96	10	severity	severity	NOUN
dpc-4071	96	11	,	,	PUNCT
dpc-4071	96	12	after	after	ADP
dpc-4071	96	13	the	the	DET
dpc-4071	96	14	inclusion	inclusion	NOUN
dpc-4071	96	15	of	of	ADP
dpc-4071	96	16	facial	facial	ADJ
dpc-4071	96	17	and	and	CCONJ
dpc-4071	96	18	trunk	trunk	NOUN
dpc-4071	96	19	bullous	bullous	ADJ
dpc-4071	96	20	involvement	involvement	NOUN
dpc-4071	96	21	factors	factor	NOUN
dpc-4071	96	22	in	in	ADP
dpc-4071	96	23	the	the	DET
dpc-4071	96	24	model	model	NOUN
dpc-4071	96	25	,	,	PUNCT
dpc-4071	96	26	the	the	DET
dpc-4071	96	27	model	model	NOUN
dpc-4071	96	28	was	be	AUX
dpc-4071	96	29	statistically	statistically	ADV
dpc-4071	96	30	significant	significant	ADJ
dpc-4071	96	31	and	and	CCONJ
dpc-4071	96	32	no	no	DET
dpc-4071	96	33	statistically	statistically	ADV
dpc-4071	96	34	significant	significant	ADJ
dpc-4071	96	35	relationship	relationship	NOUN
dpc-4071	96	36	was	be	AUX
dpc-4071	96	37	observed	observe	VERB
dpc-4071	96	38	between	between	ADP
dpc-4071	96	39	the	the	DET
dpc-4071	96	40	severity	severity	NOUN
dpc-4071	96	41	of	of	ADP
dpc-4071	96	42	the	the	DET
dpc-4071	96	43	disease	disease	NOUN
dpc-4071	96	44	and	and	CCONJ
dpc-4071	96	45	trunk	trunk	NOUN
dpc-4071	96	46	and	and	CCONJ
dpc-4071	96	47	facial	facial	ADJ
dpc-4071	96	48	bullous	bullous	ADJ
dpc-4071	96	49	involvement	involvement	NOUN
dpc-4071	96	50	(	(	PUNCT
dpc-4071	96	51	r2	r2	NOUN
dpc-4071	96	52	=	=	SYM
dpc-4071	96	53	0.1	0.1	NUM
dpc-4071	96	54	,	,	PUNCT
dpc-4071	96	55	f	f	PROPN
dpc-4071	96	56	=	=	SYM
dpc-4071	96	57	3.99	3.99	NUM
dpc-4071	96	58	,	,	PUNCT
dpc-4071	96	59	df	df	PROPN
dpc-4071	96	60	=	=	SYM
dpc-4071	96	61	2	2	NUM
dpc-4071	96	62	,	,	PUNCT
dpc-4071	96	63	p	p	NOUN
dpc-4071	96	64	-	-	PUNCT
dpc-4071	96	65	value	value	NOUN
dpc-4071	96	66	=	=	NOUN
dpc-4071	96	67	0.02	0.02	NUM
dpc-4071	96	68	)	)	PUNCT
dpc-4071	96	69	.	.	PUNCT
dpc-4071	97	1	in	in	ADP
dpc-4071	97	2	the	the	DET
dpc-4071	97	3	regression	regression	NOUN
dpc-4071	97	4	model	model	NOUN
dpc-4071	97	5	of	of	ADP
dpc-4071	97	6	peripheral	peripheral	ADJ
dpc-4071	97	7	and	and	CCONJ
dpc-4071	97	8	tissue	tissue	NOUN
dpc-4071	97	9	eosinophilia	eosinophilia	PROPN
dpc-4071	97	10	involvement	involvement	PROPN
dpc-4071	97	11	,	,	PUNCT
dpc-4071	97	12	the	the	DET
dpc-4071	97	13	tissue	tissue	NOUN
dpc-4071	97	14	eosinophilia	eosinophilia	PROPN
dpc-4071	97	15	grade	grade	NOUN
dpc-4071	97	16	(	(	PUNCT
dpc-4071	97	17	p	p	NOUN
dpc-4071	97	18	=	=	NOUN
dpc-4071	97	19	0.001	0.001	NUM
dpc-4071	97	20	)	)	PUNCT
dpc-4071	97	21	and	and	CCONJ
dpc-4071	97	22	severity	severity	NOUN
dpc-4071	97	23	of	of	ADP
dpc-4071	97	24	tissue	tissue	NOUN
dpc-4071	97	25	inflammation	inflammation	NOUN
dpc-4071	97	26	(	(	PUNCT
dpc-4071	97	27	p	p	X
dpc-4071	97	28	=	=	NOUN
dpc-4071	97	29	0.04	0.04	NUM
dpc-4071	97	30	)	)	PUNCT
dpc-4071	97	31	had	have	VERB
dpc-4071	97	32	significant	significant	ADJ
dpc-4071	97	33	relationships	relationship	NOUN
dpc-4071	97	34	with	with	ADP
dpc-4071	97	35	the	the	DET
dpc-4071	97	36	severity	severity	NOUN
dpc-4071	97	37	of	of	ADP
dpc-4071	97	38	the	the	DET
dpc-4071	97	39	disease	disease	NOUN
dpc-4071	97	40	(	(	PUNCT
dpc-4071	97	41	table	table	NOUN
dpc-4071	97	42	4	4	NUM
dpc-4071	97	43	)	)	PUNCT
dpc-4071	97	44	.	.	PUNCT
dpc-4071	98	1	conclusions	conclusion	NOUN
dpc-4071	98	2	in	in	ADP
dpc-4071	98	3	this	this	DET
dpc-4071	98	4	study	study	NOUN
dpc-4071	98	5	,	,	PUNCT
dpc-4071	98	6	analysis	analysis	NOUN
dpc-4071	98	7	of	of	ADP
dpc-4071	98	8	clinical	clinical	ADJ
dpc-4071	98	9	and	and	CCONJ
dpc-4071	98	10	histopathological	histopathological	ADJ
dpc-4071	98	11	findings	finding	NOUN
dpc-4071	98	12	revealed	reveal	VERB
dpc-4071	98	13	a	a	DET
dpc-4071	98	14	direct	direct	ADJ
dpc-4071	98	15	and	and	CCONJ
dpc-4071	98	16	significant	significant	ADJ
dpc-4071	98	17	relationship	relationship	NOUN
dpc-4071	98	18	between	between	ADP
dpc-4071	98	19	bp	bp	PROPN
dpc-4071	98	20	severity	severity	NOUN
dpc-4071	98	21	and	and	CCONJ
dpc-4071	98	22	tissue	tissue	NOUN
dpc-4071	98	23	eosinophilia	eosinophilia	PROPN
dpc-4071	98	24	,	,	PUNCT
dpc-4071	98	25	despite	despite	SCONJ
dpc-4071	98	26	peripheral	peripheral	ADJ
dpc-4071	98	27	eosinophilia	eosinophilia	PROPN
dpc-4071	98	28	.	.	PUNCT
dpc-4071	99	1	furthermore	furthermore	ADV
dpc-4071	99	2	,	,	PUNCT
dpc-4071	99	3	a	a	DET
dpc-4071	99	4	significant	significant	ADJ
dpc-4071	99	5	direct	direct	ADJ
dpc-4071	99	6	correlation	correlation	NOUN
dpc-4071	99	7	was	be	AUX
dpc-4071	99	8	found	find	VERB
dpc-4071	99	9	between	between	ADP
dpc-4071	99	10	tissue	tissue	NOUN
dpc-4071	99	11	eosinophilia	eosinophilia	NOUN
dpc-4071	99	12	and	and	CCONJ
dpc-4071	99	13	serum	serum	VERB
dpc-4071	99	14	absolute	absolute	ADJ
dpc-4071	99	15	eosinophil	eosinophil	ADJ
dpc-4071	99	16	count	count	NOUN
dpc-4071	99	17	and	and	CCONJ
dpc-4071	99	18	percentage	percentage	NOUN
dpc-4071	99	19	.	.	PUNCT
dpc-4071	100	1	eosinophils	eosinophil	NOUN
dpc-4071	100	2	may	may	AUX
dpc-4071	100	3	play	play	VERB
dpc-4071	100	4	a	a	DET
dpc-4071	100	5	significant	significant	ADJ
dpc-4071	100	6	role	role	NOUN
dpc-4071	100	7	in	in	ADP
dpc-4071	100	8	the	the	DET
dpc-4071	100	9	pathogenesis	pathogenesis	NOUN
dpc-4071	100	10	of	of	ADP
dpc-4071	100	11	bp	bp	PROPN
dpc-4071	100	12	.	.	PUNCT
dpc-4071	101	1	some	some	DET
dpc-4071	101	2	serial	serial	ADJ
dpc-4071	101	3	histological	histological	ADJ
dpc-4071	101	4	observations	observation	NOUN
dpc-4071	101	5	in	in	ADP
dpc-4071	101	6	the	the	DET
dpc-4071	101	7	studies	study	NOUN
dpc-4071	101	8	support	support	VERB
dpc-4071	101	9	this	this	DET
dpc-4071	101	10	hypothesis	hypothesis	NOUN
dpc-4071	101	11	,	,	PUNCT
dpc-4071	101	12	such	such	ADJ
dpc-4071	101	13	as	as	ADP
dpc-4071	101	14	eosinophilic	eosinophilic	ADJ
dpc-4071	101	15	dermal	dermal	NOUN
dpc-4071	101	16	infiltration	infiltration	NOUN
dpc-4071	101	17	,	,	PUNCT
dpc-4071	101	18	the	the	DET
dpc-4071	101	19	presence	presence	NOUN
dpc-4071	101	20	of	of	ADP
dpc-4071	101	21	degranulated	degranulate	VERB
dpc-4071	101	22	eosinophils	eosinophil	NOUN
dpc-4071	101	23	,	,	PUNCT
dpc-4071	101	24	extracellular	extracellular	ADJ
dpc-4071	101	25	eosinophilic	eosinophilic	ADJ
dpc-4071	101	26	granules	granule	NOUN
dpc-4071	101	27	,	,	PUNCT
dpc-4071	101	28	and	and	CCONJ
dpc-4071	101	29	free	free	ADJ
dpc-4071	101	30	granular	granular	ADJ
dpc-4071	101	31	proteins	protein	NOUN
dpc-4071	101	32	in	in	ADP
dpc-4071	101	33	the	the	DET
dpc-4071	101	34	lesions	lesion	NOUN
dpc-4071	101	35	.	.	PUNCT
dpc-4071	102	1	therefore	therefore	ADV
dpc-4071	102	2	,	,	PUNCT
dpc-4071	102	3	eosinophils	eosinophil	VERB
dpc-4071	102	4	infiltration	infiltration	NOUN
dpc-4071	102	5	may	may	AUX
dpc-4071	102	6	initiate	initiate	VERB
dpc-4071	102	7	and	and	CCONJ
dpc-4071	102	8	later	later	ADV
dpc-4071	102	9	the	the	DET
dpc-4071	102	10	degranulation	degranulation	NOUN
dpc-4071	102	11	process	process	NOUN
dpc-4071	102	12	may	may	AUX
dpc-4071	102	13	progress	progress	VERB
dpc-4071	102	14	the	the	DET
dpc-4071	102	15	formation	formation	NOUN
dpc-4071	102	16	of	of	ADP
dpc-4071	102	17	bullous	bullous	ADJ
dpc-4071	102	18	lesions	lesion	NOUN
dpc-4071	102	19	in	in	ADP
dpc-4071	102	20	bp	bp	PROPN
dpc-4071	103	1	[	[	X
dpc-4071	103	2	6	6	NUM
dpc-4071	103	3	]	]	PUNCT
dpc-4071	103	4	.	.	PUNCT
dpc-4071	104	1	there	there	PRON
dpc-4071	104	2	are	be	VERB
dpc-4071	104	3	some	some	DET
dpc-4071	104	4	studies	study	NOUN
dpc-4071	104	5	evaluating	evaluate	VERB
dpc-4071	104	6	the	the	DET
dpc-4071	104	7	association	association	NOUN
dpc-4071	104	8	between	between	ADP
dpc-4071	104	9	bp	bp	PROPN
dpc-4071	104	10	severity	severity	NOUN
dpc-4071	104	11	and	and	CCONJ
dpc-4071	104	12	related	relate	VERB
dpc-4071	104	13	clinical	clinical	ADJ
dpc-4071	104	14	and	and	CCONJ
dpc-4071	104	15	histopathological	histopathological	ADJ
dpc-4071	104	16	factors	factor	NOUN
dpc-4071	104	17	[	[	X
dpc-4071	104	18	15,16	15,16	NUM
dpc-4071	104	19	]	]	PUNCT
dpc-4071	104	20	.	.	PUNCT
dpc-4071	105	1	a	a	DET
dpc-4071	105	2	recent	recent	ADJ
dpc-4071	105	3	prospective	prospective	ADJ
dpc-4071	105	4	study	study	NOUN
dpc-4071	105	5	was	be	AUX
dpc-4071	105	6	performed	perform	VERB
dpc-4071	105	7	on	on	ADP
dpc-4071	105	8	27	27	NUM
dpc-4071	105	9	patients	patient	NOUN
dpc-4071	105	10	with	with	ADP
dpc-4071	105	11	newly	newly	ADV
dpc-4071	105	12	diagnosed	diagnose	VERB
dpc-4071	105	13	bp	bp	PROPN
dpc-4071	105	14	.	.	PUNCT
dpc-4071	106	1	this	this	DET
dpc-4071	106	2	study	study	NOUN
dpc-4071	106	3	reported	report	VERB
dpc-4071	106	4	that	that	SCONJ
dpc-4071	106	5	there	there	PRON
dpc-4071	106	6	is	be	VERB
dpc-4071	106	7	a	a	DET
dpc-4071	106	8	correlation	correlation	NOUN
dpc-4071	106	9	between	between	ADP
dpc-4071	106	10	dermal	dermal	ADJ
dpc-4071	106	11	eosinophilia	eosinophilia	NOUN
dpc-4071	106	12	and	and	CCONJ
dpc-4071	106	13	tissue	tissue	NOUN
dpc-4071	106	14	inflammation	inflammation	NOUN
dpc-4071	106	15	severity	severity	NOUN
dpc-4071	106	16	.	.	PUNCT
dpc-4071	107	1	also	also	ADV
dpc-4071	107	2	,	,	PUNCT
dpc-4071	107	3	a	a	DET
dpc-4071	107	4	significant	significant	ADJ
dpc-4071	107	5	direct	direct	ADJ
dpc-4071	107	6	4	4	NUM
dpc-4071	107	7	original	original	ADJ
dpc-4071	107	8	article	article	NOUN
dpc-4071	107	9	|	|	ADV
dpc-4071	107	10	dermatol	dermatol	ADJ
dpc-4071	107	11	pract	pract	NOUN
dpc-4071	107	12	concept	concept	NOUN
dpc-4071	107	13	.	.	PUNCT
dpc-4071	108	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	108	2	table	table	NOUN
dpc-4071	108	3	1	1	NUM
dpc-4071	108	4	.	.	PUNCT
dpc-4071	108	5	characteristics	characteristic	NOUN
dpc-4071	108	6	of	of	ADP
dpc-4071	108	7	the	the	DET
dpc-4071	108	8	study	study	NOUN
dpc-4071	108	9	population	population	NOUN
dpc-4071	108	10	.	.	PUNCT
dpc-4071	109	1	variable	variable	ADJ
dpc-4071	109	2	total	total	NOUN
dpc-4071	109	3	(	(	PUNCT
dpc-4071	109	4	n	n	NOUN
dpc-4071	109	5	=	=	SYM
dpc-4071	109	6	73	73	NUM
dpc-4071	109	7	)	)	PUNCT
dpc-4071	109	8	male	male	NOUN
dpc-4071	109	9	(	(	PUNCT
dpc-4071	109	10	n	n	NOUN
dpc-4071	109	11	=	=	SYM
dpc-4071	109	12	31	31	NUM
dpc-4071	109	13	)	)	PUNCT
dpc-4071	109	14	female	female	NOUN
dpc-4071	109	15	(	(	PUNCT
dpc-4071	109	16	n	n	NOUN
dpc-4071	109	17	=	=	SYM
dpc-4071	109	18	42	42	NUM
dpc-4071	109	19	)	)	PUNCT
dpc-4071	109	20	p	p	X
dpc-4071	109	21	-	-	PUNCT
dpc-4071	109	22	value	value	NOUN
dpc-4071	109	23	age	age	NOUN
dpc-4071	109	24	(	(	PUNCT
dpc-4071	109	25	years	year	NOUN
dpc-4071	109	26	)	)	PUNCT
dpc-4071	109	27	mean	mean	NOUN
dpc-4071	109	28	(	(	PUNCT
dpc-4071	109	29	sd	sd	NOUN
dpc-4071	109	30	)	)	PUNCT
dpc-4071	109	31	72.1	72.1	NUM
dpc-4071	109	32	(	(	PUNCT
dpc-4071	109	33	15.17	15.17	NUM
dpc-4071	109	34	)	)	PUNCT
dpc-4071	109	35	70.81	70.81	NUM
dpc-4071	109	36	(	(	PUNCT
dpc-4071	109	37	13.31	13.31	NUM
dpc-4071	109	38	)	)	PUNCT
dpc-4071	109	39	73.10	73.10	NUM
dpc-4071	109	40	(	(	PUNCT
dpc-4071	109	41	16.52	16.52	NUM
dpc-4071	109	42	)	)	PUNCT
dpc-4071	109	43	0.53	0.53	NUM
dpc-4071	109	44	median	median	NOUN
dpc-4071	109	45	(	(	PUNCT
dpc-4071	109	46	min	min	NOUN
dpc-4071	109	47	-	-	PUNCT
dpc-4071	109	48	max	max	NOUN
dpc-4071	109	49	)	)	PUNCT
dpc-4071	109	50	76	76	NUM
dpc-4071	109	51	(	(	PUNCT
dpc-4071	109	52	26	26	NUM
dpc-4071	109	53	-	-	SYM
dpc-4071	109	54	97	97	NUM
dpc-4071	109	55	)	)	PUNCT
dpc-4071	109	56	72	72	NUM
dpc-4071	109	57	(	(	PUNCT
dpc-4071	109	58	43	43	NUM
dpc-4071	109	59	-	-	SYM
dpc-4071	109	60	91	91	NUM
dpc-4071	109	61	)	)	PUNCT
dpc-4071	109	62	76	76	NUM
dpc-4071	109	63	(	(	PUNCT
dpc-4071	109	64	26	26	NUM
dpc-4071	109	65	-	-	SYM
dpc-4071	109	66	97	97	NUM
dpc-4071	109	67	)	)	PUNCT
dpc-4071	109	68	past	past	ADP
dpc-4071	109	69	medical	medical	ADJ
dpc-4071	109	70	history	history	NOUN
dpc-4071	109	71	n	n	PROPN
dpc-4071	109	72	(	(	PUNCT
dpc-4071	109	73	%	%	INTJ
dpc-4071	109	74	)	)	PUNCT
dpc-4071	109	75	hypertension	hypertension	NOUN
dpc-4071	109	76	33	33	NUM
dpc-4071	109	77	(	(	PUNCT
dpc-4071	109	78	45.2	45.2	NUM
dpc-4071	109	79	)	)	PUNCT
dpc-4071	109	80	10	10	NUM
dpc-4071	109	81	(	(	PUNCT
dpc-4071	109	82	30.3	30.3	NUM
dpc-4071	109	83	)	)	PUNCT
dpc-4071	109	84	23	23	NUM
dpc-4071	109	85	(	(	PUNCT
dpc-4071	109	86	69.7	69.7	NUM
dpc-4071	109	87	)	)	PUNCT
dpc-4071	109	88	0.05	0.05	NUM
dpc-4071	109	89	endocrine	endocrine	NOUN
dpc-4071	109	90	disease	disease	NOUN
dpc-4071	109	91	28	28	NUM
dpc-4071	109	92	(	(	PUNCT
dpc-4071	109	93	38.4	38.4	NUM
dpc-4071	109	94	)	)	PUNCT
dpc-4071	109	95	10	10	NUM
dpc-4071	109	96	(	(	PUNCT
dpc-4071	109	97	35.7	35.7	NUM
dpc-4071	109	98	)	)	SYM
dpc-4071	109	99	18	18	NUM
dpc-4071	109	100	(	(	PUNCT
dpc-4071	109	101	64.3	64.3	NUM
dpc-4071	109	102	)	)	PUNCT
dpc-4071	109	103	0.33	0.33	NUM
dpc-4071	109	104	neurologic	neurologic	ADJ
dpc-4071	109	105	disease	disease	NOUN
dpc-4071	109	106	16	16	NUM
dpc-4071	109	107	(	(	PUNCT
dpc-4071	109	108	21.9	21.9	NUM
dpc-4071	109	109	)	)	PUNCT
dpc-4071	109	110	6	6	NUM
dpc-4071	109	111	(	(	PUNCT
dpc-4071	109	112	37.5	37.5	NUM
dpc-4071	109	113	)	)	PUNCT
dpc-4071	109	114	10	10	NUM
dpc-4071	109	115	(	(	PUNCT
dpc-4071	109	116	62.5	62.5	NUM
dpc-4071	109	117	)	)	PUNCT
dpc-4071	109	118	0.57	0.57	NUM
dpc-4071	109	119	hyperlipidemia	hyperlipidemia	NOUN
dpc-4071	109	120	7	7	NUM
dpc-4071	109	121	(	(	PUNCT
dpc-4071	109	122	9.6	9.6	NUM
dpc-4071	109	123	)	)	PUNCT
dpc-4071	109	124	0	0	NUM
dpc-4071	110	1	(	(	PUNCT
dpc-4071	110	2	0.0	0.0	NUM
dpc-4071	110	3	)	)	PUNCT
dpc-4071	110	4	7	7	NUM
dpc-4071	110	5	(	(	PUNCT
dpc-4071	110	6	100	100	NUM
dpc-4071	110	7	)	)	PUNCT
dpc-4071	110	8	0.01	0.01	NUM
dpc-4071	110	9	malignancy	malignancy	NOUN
dpc-4071	110	10	3	3	NUM
dpc-4071	110	11	(	(	PUNCT
dpc-4071	110	12	4.1	4.1	NUM
dpc-4071	110	13	)	)	SYM
dpc-4071	110	14	2	2	NUM
dpc-4071	110	15	(	(	PUNCT
dpc-4071	110	16	66.7	66.7	NUM
dpc-4071	110	17	)	)	PUNCT
dpc-4071	110	18	1	1	NUM
dpc-4071	110	19	(	(	PUNCT
dpc-4071	110	20	33.3	33.3	NUM
dpc-4071	110	21	)	)	PUNCT
dpc-4071	110	22	0.77	0.77	NUM
dpc-4071	110	23	others	other	NOUN
dpc-4071	110	24	24	24	NUM
dpc-4071	110	25	(	(	PUNCT
dpc-4071	110	26	32.9	32.9	NUM
dpc-4071	110	27	)	)	PUNCT
dpc-4071	110	28	11	11	NUM
dpc-4071	110	29	(	(	PUNCT
dpc-4071	110	30	45.8	45.8	NUM
dpc-4071	110	31	)	)	PUNCT
dpc-4071	110	32	13	13	NUM
dpc-4071	110	33	(	(	PUNCT
dpc-4071	110	34	54.2	54.2	NUM
dpc-4071	110	35	)	)	PUNCT
dpc-4071	110	36	1	1	NUM
dpc-4071	110	37	past	past	NOUN
dpc-4071	110	38	drug	drug	NOUN
dpc-4071	110	39	history	history	NOUN
dpc-4071	110	40	n	n	PROPN
dpc-4071	110	41	(	(	PUNCT
dpc-4071	110	42	%	%	INTJ
dpc-4071	110	43	)	)	PUNCT
dpc-4071	110	44	cardiovascular	cardiovascular	ADJ
dpc-4071	110	45	34	34	NUM
dpc-4071	110	46	(	(	PUNCT
dpc-4071	110	47	46.6	46.6	NUM
dpc-4071	110	48	)	)	PUNCT
dpc-4071	110	49	14	14	NUM
dpc-4071	110	50	(	(	PUNCT
dpc-4071	110	51	41.2	41.2	NUM
dpc-4071	110	52	)	)	SYM
dpc-4071	110	53	20	20	NUM
dpc-4071	110	54	(	(	PUNCT
dpc-4071	110	55	58.8	58.8	NUM
dpc-4071	110	56	)	)	PUNCT
dpc-4071	110	57	0.81	0.81	NUM
dpc-4071	110	58	diabetes	diabetes	NOUN
dpc-4071	110	59	12	12	NUM
dpc-4071	110	60	(	(	PUNCT
dpc-4071	110	61	16.4	16.4	NUM
dpc-4071	110	62	)	)	PUNCT
dpc-4071	110	63	4	4	NUM
dpc-4071	110	64	(	(	PUNCT
dpc-4071	110	65	33.3	33.3	NUM
dpc-4071	110	66	)	)	PUNCT
dpc-4071	110	67	8	8	NUM
dpc-4071	110	68	(	(	PUNCT
dpc-4071	110	69	66.7	66.7	NUM
dpc-4071	110	70	)	)	PUNCT
dpc-4071	110	71	0.53	0.53	NUM
dpc-4071	110	72	neurologic	neurologic	ADJ
dpc-4071	110	73	11	11	NUM
dpc-4071	110	74	(	(	PUNCT
dpc-4071	110	75	15.1	15.1	NUM
dpc-4071	110	76	)	)	PUNCT
dpc-4071	110	77	6	6	NUM
dpc-4071	110	78	(	(	PUNCT
dpc-4071	110	79	54.5	54.5	NUM
dpc-4071	110	80	)	)	PUNCT
dpc-4071	110	81	5	5	NUM
dpc-4071	110	82	(	(	PUNCT
dpc-4071	110	83	45.5	45.5	NUM
dpc-4071	110	84	)	)	PUNCT
dpc-4071	110	85	0.51	0.51	NUM
dpc-4071	110	86	others	other	NOUN
dpc-4071	110	87	10	10	NUM
dpc-4071	110	88	(	(	PUNCT
dpc-4071	110	89	13.7	13.7	NUM
dpc-4071	110	90	)	)	PUNCT
dpc-4071	110	91	1	1	NUM
dpc-4071	110	92	(	(	PUNCT
dpc-4071	110	93	10.0	10.0	NUM
dpc-4071	110	94	)	)	PUNCT
dpc-4071	110	95	9	9	NUM
dpc-4071	110	96	(	(	PUNCT
dpc-4071	110	97	90.0	90.0	NUM
dpc-4071	110	98	)	)	PUNCT
dpc-4071	110	99	0.03	0.03	NUM
dpc-4071	110	100	site	site	NOUN
dpc-4071	110	101	of	of	ADP
dpc-4071	110	102	involvement	involvement	NOUN
dpc-4071	110	103	n	n	PROPN
dpc-4071	110	104	(	(	PUNCT
dpc-4071	110	105	%	%	INTJ
dpc-4071	110	106	)	)	PUNCT
dpc-4071	110	107	limbs	limb	NOUN
dpc-4071	110	108	72	72	NUM
dpc-4071	110	109	(	(	PUNCT
dpc-4071	110	110	98.6	98.6	NUM
dpc-4071	110	111	)	)	PUNCT
dpc-4071	110	112	32	32	NUM
dpc-4071	110	113	(	(	PUNCT
dpc-4071	110	114	44.4	44.4	NUM
dpc-4071	110	115	)	)	PUNCT
dpc-4071	110	116	40	40	NUM
dpc-4071	110	117	(	(	PUNCT
dpc-4071	110	118	55.6	55.6	NUM
dpc-4071	110	119	)	)	SYM
dpc-4071	110	120	1	1	NUM
dpc-4071	110	121	trunk	trunk	NOUN
dpc-4071	110	122	66	66	NUM
dpc-4071	110	123	(	(	PUNCT
dpc-4071	110	124	91.7	91.7	NUM
dpc-4071	110	125	)	)	PUNCT
dpc-4071	110	126	29	29	NUM
dpc-4071	110	127	(	(	PUNCT
dpc-4071	110	128	43.9	43.9	NUM
dpc-4071	110	129	)	)	PUNCT
dpc-4071	110	130	37	37	NUM
dpc-4071	110	131	(	(	PUNCT
dpc-4071	110	132	56.1	56.1	NUM
dpc-4071	110	133	)	)	PUNCT
dpc-4071	110	134	0.69	0.69	NUM
dpc-4071	110	135	mucus	mucus	NOUN
dpc-4071	110	136	membrane	membrane	NOUN
dpc-4071	110	137	36	36	NUM
dpc-4071	110	138	(	(	PUNCT
dpc-4071	110	139	49.3	49.3	NUM
dpc-4071	110	140	)	)	PUNCT
dpc-4071	110	141	16	16	NUM
dpc-4071	110	142	(	(	PUNCT
dpc-4071	110	143	44.4	44.4	NUM
dpc-4071	110	144	)	)	PUNCT
dpc-4071	110	145	20	20	NUM
dpc-4071	110	146	(	(	PUNCT
dpc-4071	110	147	55.6	55.6	NUM
dpc-4071	110	148	)	)	PUNCT
dpc-4071	110	149	0.91	0.91	NUM
dpc-4071	110	150	acral	acral	ADJ
dpc-4071	110	151	23	23	NUM
dpc-4071	110	152	(	(	PUNCT
dpc-4071	110	153	31.5	31.5	NUM
dpc-4071	110	154	)	)	PUNCT
dpc-4071	110	155	11	11	NUM
dpc-4071	110	156	(	(	PUNCT
dpc-4071	110	157	47.8	47.8	NUM
dpc-4071	110	158	)	)	PUNCT
dpc-4071	110	159	12	12	NUM
dpc-4071	110	160	(	(	PUNCT
dpc-4071	110	161	52.2	52.2	NUM
dpc-4071	110	162	)	)	PUNCT
dpc-4071	110	163	0.8	0.8	NUM
dpc-4071	110	164	head	head	NOUN
dpc-4071	110	165	and	and	CCONJ
dpc-4071	110	166	neck	neck	NOUN
dpc-4071	110	167	19	19	NUM
dpc-4071	110	168	(	(	PUNCT
dpc-4071	110	169	26	26	NUM
dpc-4071	110	170	)	)	PUNCT
dpc-4071	110	171	7	7	NUM
dpc-4071	110	172	(	(	PUNCT
dpc-4071	110	173	36.8	36.8	NUM
dpc-4071	110	174	)	)	PUNCT
dpc-4071	110	175	12	12	NUM
dpc-4071	110	176	(	(	PUNCT
dpc-4071	110	177	63.2	63.2	NUM
dpc-4071	110	178	)	)	PUNCT
dpc-4071	110	179	0.59	0.59	NUM
dpc-4071	110	180	hospitalization	hospitalization	NOUN
dpc-4071	110	181	duration	duration	NOUN
dpc-4071	110	182	(	(	PUNCT
dpc-4071	110	183	days	day	NOUN
dpc-4071	110	184	)	)	PUNCT
dpc-4071	110	185	mean	mean	NOUN
dpc-4071	110	186	(	(	PUNCT
dpc-4071	110	187	sd	sd	NOUN
dpc-4071	110	188	)	)	PUNCT
dpc-4071	110	189	11	11	NUM
dpc-4071	110	190	(	(	PUNCT
dpc-4071	110	191	7.48	7.48	NUM
dpc-4071	110	192	)	)	PUNCT
dpc-4071	110	193	10.16	10.16	NUM
dpc-4071	110	194	(	(	PUNCT
dpc-4071	110	195	6.50	6.50	NUM
dpc-4071	110	196	)	)	PUNCT
dpc-4071	110	197	11.69	11.69	NUM
dpc-4071	110	198	(	(	PUNCT
dpc-4071	110	199	8.20	8.20	NUM
dpc-4071	110	200	)	)	PUNCT
dpc-4071	110	201	0.39	0.39	NUM
dpc-4071	110	202	median	median	NOUN
dpc-4071	110	203	(	(	PUNCT
dpc-4071	110	204	min	min	NOUN
dpc-4071	110	205	-	-	PUNCT
dpc-4071	110	206	max	max	NOUN
dpc-4071	110	207	)	)	PUNCT
dpc-4071	110	208	9	9	NUM
dpc-4071	110	209	(	(	PUNCT
dpc-4071	110	210	1	1	NUM
dpc-4071	110	211	-	-	SYM
dpc-4071	110	212	44	44	NUM
dpc-4071	110	213	)	)	PUNCT
dpc-4071	110	214	9	9	NUM
dpc-4071	110	215	(	(	PUNCT
dpc-4071	110	216	1	1	NUM
dpc-4071	110	217	-	-	SYM
dpc-4071	110	218	30	30	NUM
dpc-4071	110	219	)	)	PUNCT
dpc-4071	110	220	10	10	NUM
dpc-4071	110	221	(	(	PUNCT
dpc-4071	110	222	4	4	NUM
dpc-4071	110	223	-	-	SYM
dpc-4071	110	224	44	44	NUM
dpc-4071	110	225	)	)	PUNCT
dpc-4071	110	226	treatment	treatment	NOUN
dpc-4071	110	227	protocol	protocol	NOUN
dpc-4071	110	228	n	n	CCONJ
dpc-4071	110	229	(	(	PUNCT
dpc-4071	110	230	%	%	INTJ
dpc-4071	110	231	)	)	PUNCT
dpc-4071	110	232	topical	topical	ADJ
dpc-4071	110	233	cs	c	NOUN
dpc-4071	110	234	69	69	NUM
dpc-4071	110	235	(	(	PUNCT
dpc-4071	110	236	94.5	94.5	NUM
dpc-4071	110	237	)	)	PUNCT
dpc-4071	110	238	30	30	NUM
dpc-4071	110	239	(	(	PUNCT
dpc-4071	110	240	43.5	43.5	NUM
dpc-4071	110	241	)	)	PUNCT
dpc-4071	110	242	39	39	NUM
dpc-4071	110	243	(	(	PUNCT
dpc-4071	110	244	56.5	56.5	NUM
dpc-4071	110	245	)	)	PUNCT
dpc-4071	110	246	1	1	NUM
dpc-4071	110	247	systemic	systemic	ADJ
dpc-4071	110	248	cs	cs	PROPN
dpc-4071	110	249	67	67	NUM
dpc-4071	110	250	(	(	PUNCT
dpc-4071	110	251	93.1	93.1	NUM
dpc-4071	110	252	)	)	SYM
dpc-4071	110	253	29	29	NUM
dpc-4071	110	254	(	(	PUNCT
dpc-4071	110	255	43.3	43.3	NUM
dpc-4071	110	256	)	)	PUNCT
dpc-4071	110	257	38	38	NUM
dpc-4071	110	258	(	(	PUNCT
dpc-4071	110	259	56.7	56.7	NUM
dpc-4071	110	260	)	)	PUNCT
dpc-4071	110	261	1	1	NUM
dpc-4071	110	262	topical	topical	ADJ
dpc-4071	110	263	burrow	burrow	NOUN
dpc-4071	110	264	66	66	NUM
dpc-4071	110	265	(	(	PUNCT
dpc-4071	110	266	90.4	90.4	NUM
dpc-4071	110	267	)	)	PUNCT
dpc-4071	110	268	29	29	NUM
dpc-4071	110	269	(	(	PUNCT
dpc-4071	110	270	43.9	43.9	NUM
dpc-4071	110	271	)	)	PUNCT
dpc-4071	110	272	37	37	NUM
dpc-4071	110	273	(	(	PUNCT
dpc-4071	110	274	59.1	59.1	NUM
dpc-4071	110	275	)	)	PUNCT
dpc-4071	110	276	1	1	NUM
dpc-4071	110	277	topical	topical	ADJ
dpc-4071	110	278	antibiotic	antibiotic	ADJ
dpc-4071	110	279	61	61	NUM
dpc-4071	110	280	(	(	PUNCT
dpc-4071	110	281	83.6	83.6	NUM
dpc-4071	110	282	)	)	PUNCT
dpc-4071	110	283	29	29	NUM
dpc-4071	110	284	(	(	PUNCT
dpc-4071	110	285	47.5	47.5	NUM
dpc-4071	110	286	)	)	PUNCT
dpc-4071	110	287	32	32	NUM
dpc-4071	110	288	(	(	PUNCT
dpc-4071	110	289	52.5	52.5	NUM
dpc-4071	110	290	)	)	PUNCT
dpc-4071	110	291	0.2	0.2	NUM
dpc-4071	110	292	antihistamine	antihistamine	NOUN
dpc-4071	110	293	58	58	NUM
dpc-4071	110	294	(	(	PUNCT
dpc-4071	110	295	79.5	79.5	NUM
dpc-4071	110	296	)	)	PUNCT
dpc-4071	110	297	27	27	NUM
dpc-4071	110	298	(	(	PUNCT
dpc-4071	110	299	46.6	46.6	NUM
dpc-4071	110	300	)	)	PUNCT
dpc-4071	110	301	31	31	NUM
dpc-4071	110	302	(	(	PUNCT
dpc-4071	110	303	53.4	53.4	NUM
dpc-4071	110	304	)	)	PUNCT
dpc-4071	110	305	0.39	0.39	NUM
dpc-4071	110	306	systemic	systemic	ADJ
dpc-4071	110	307	antibiotics	antibiotic	NOUN
dpc-4071	110	308	43	43	NUM
dpc-4071	110	309	(	(	PUNCT
dpc-4071	110	310	58.9	58.9	NUM
dpc-4071	110	311	)	)	PUNCT
dpc-4071	110	312	19	19	NUM
dpc-4071	110	313	(	(	PUNCT
dpc-4071	110	314	44.2	44.2	NUM
dpc-4071	110	315	)	)	PUNCT
dpc-4071	110	316	24	24	NUM
dpc-4071	110	317	(	(	PUNCT
dpc-4071	110	318	55.8	55.8	NUM
dpc-4071	110	319	)	)	PUNCT
dpc-4071	110	320	0.94	0.94	NUM
dpc-4071	110	321	antineoplastic	antineoplastic	ADJ
dpc-4071	110	322	35	35	NUM
dpc-4071	110	323	(	(	PUNCT
dpc-4071	110	324	47.9	47.9	NUM
dpc-4071	110	325	)	)	PUNCT
dpc-4071	110	326	16	16	NUM
dpc-4071	110	327	(	(	PUNCT
dpc-4071	110	328	45.7	45.7	NUM
dpc-4071	110	329	)	)	PUNCT
dpc-4071	110	330	19	19	NUM
dpc-4071	110	331	(	(	PUNCT
dpc-4071	110	332	54.3	54.3	NUM
dpc-4071	110	333	)	)	PUNCT
dpc-4071	110	334	0.81	0.81	NUM
dpc-4071	110	335	histopathologic	histopathologic	NOUN
dpc-4071	110	336	finding	finding	NOUN
dpc-4071	110	337	n	n	PROPN
dpc-4071	110	338	(	(	PUNCT
dpc-4071	110	339	%	%	INTJ
dpc-4071	110	340	)	)	PUNCT
dpc-4071	110	341	subepidermal	subepidermal	NOUN
dpc-4071	110	342	blisters	blister	NOUN
dpc-4071	110	343	35	35	NUM
dpc-4071	110	344	(	(	PUNCT
dpc-4071	110	345	79.5	79.5	NUM
dpc-4071	110	346	)	)	PUNCT
dpc-4071	110	347	16	16	NUM
dpc-4071	110	348	(	(	PUNCT
dpc-4071	110	349	45.7	45.7	NUM
dpc-4071	110	350	)	)	PUNCT
dpc-4071	110	351	19	19	NUM
dpc-4071	110	352	(	(	PUNCT
dpc-4071	110	353	54.3	54.3	NUM
dpc-4071	110	354	)	)	PUNCT
dpc-4071	110	355	0.71	0.71	NUM
dpc-4071	110	356	c3	c3	NOUN
dpc-4071	110	357	27	27	NUM
dpc-4071	110	358	(	(	PUNCT
dpc-4071	110	359	79.5	79.5	NUM
dpc-4071	110	360	)	)	PUNCT
dpc-4071	110	361	10	10	NUM
dpc-4071	110	362	(	(	PUNCT
dpc-4071	110	363	37.0	37.0	NUM
dpc-4071	110	364	)	)	PUNCT
dpc-4071	110	365	17	17	NUM
dpc-4071	110	366	(	(	PUNCT
dpc-4071	110	367	63.0	63.0	NUM
dpc-4071	110	368	)	)	PUNCT
dpc-4071	110	369	0.70	0.70	NUM
dpc-4071	110	370	igg	igg	PROPN
dpc-4071	110	371	33	33	NUM
dpc-4071	110	372	(	(	PUNCT
dpc-4071	110	373	75.0	75.0	NUM
dpc-4071	110	374	)	)	PUNCT
dpc-4071	110	375	12	12	NUM
dpc-4071	110	376	(	(	PUNCT
dpc-4071	110	377	36.4	36.4	NUM
dpc-4071	110	378	)	)	SYM
dpc-4071	110	379	21	21	NUM
dpc-4071	110	380	(	(	PUNCT
dpc-4071	110	381	63.6	63.6	NUM
dpc-4071	110	382	)	)	PUNCT
dpc-4071	110	383	0.56	0.56	NUM
dpc-4071	110	384	c3+igg	c3+igg	NOUN
dpc-4071	110	385	24	24	NUM
dpc-4071	110	386	(	(	PUNCT
dpc-4071	110	387	55.8	55.8	NUM
dpc-4071	110	388	)	)	PUNCT
dpc-4071	110	389	9	9	NUM
dpc-4071	110	390	(	(	PUNCT
dpc-4071	110	391	37.5	37.5	NUM
dpc-4071	110	392	)	)	SYM
dpc-4071	110	393	15	15	NUM
dpc-4071	110	394	(	(	PUNCT
dpc-4071	110	395	62.5	62.5	NUM
dpc-4071	110	396	)	)	PUNCT
dpc-4071	110	397	0.55	0.55	NUM
dpc-4071	110	398	tissue	tissue	NOUN
dpc-4071	110	399	eosinophilia	eosinophilia	NOUN
dpc-4071	110	400	n	n	PROPN
dpc-4071	110	401	(	(	PUNCT
dpc-4071	110	402	%	%	INTJ
dpc-4071	110	403	)	)	PUNCT
dpc-4071	110	404	grade	grade	NOUN
dpc-4071	110	405	1	1	NUM
dpc-4071	110	406	23	23	NUM
dpc-4071	110	407	(	(	PUNCT
dpc-4071	110	408	45.8	45.8	NUM
dpc-4071	110	409	)	)	PUNCT
dpc-4071	110	410	8	8	NUM
dpc-4071	110	411	(	(	PUNCT
dpc-4071	110	412	34.8	34.8	NUM
dpc-4071	110	413	)	)	SYM
dpc-4071	110	414	15	15	NUM
dpc-4071	110	415	(	(	PUNCT
dpc-4071	110	416	65.2	65.2	NUM
dpc-4071	110	417	)	)	PUNCT
dpc-4071	110	418	0.45	0.45	NUM
dpc-4071	110	419	grade	grade	NOUN
dpc-4071	110	420	2	2	NUM
dpc-4071	110	421	13	13	NUM
dpc-4071	110	422	(	(	PUNCT
dpc-4071	110	423	31.0	31.0	NUM
dpc-4071	110	424	)	)	SYM
dpc-4071	110	425	5	5	NUM
dpc-4071	110	426	(	(	PUNCT
dpc-4071	110	427	38.5	38.5	NUM
dpc-4071	110	428	)	)	PUNCT
dpc-4071	110	429	8	8	NUM
dpc-4071	110	430	(	(	PUNCT
dpc-4071	110	431	61.5	61.5	NUM
dpc-4071	110	432	)	)	PUNCT
dpc-4071	110	433	grade	grade	NOUN
dpc-4071	110	434	3	3	NUM
dpc-4071	110	435	5	5	NUM
dpc-4071	110	436	(	(	PUNCT
dpc-4071	110	437	11.9	11.9	NUM
dpc-4071	110	438	)	)	PUNCT
dpc-4071	110	439	3	3	NUM
dpc-4071	110	440	(	(	PUNCT
dpc-4071	110	441	60.0	60.0	NUM
dpc-4071	110	442	)	)	SYM
dpc-4071	110	443	2	2	NUM
dpc-4071	110	444	(	(	PUNCT
dpc-4071	110	445	40.0	40.0	NUM
dpc-4071	110	446	)	)	PUNCT
dpc-4071	110	447	grade	grade	NOUN
dpc-4071	110	448	4	4	NUM
dpc-4071	110	449	1	1	NUM
dpc-4071	110	450	(	(	PUNCT
dpc-4071	110	451	2.4	2.4	NUM
dpc-4071	110	452	)	)	SYM
dpc-4071	110	453	1	1	NUM
dpc-4071	110	454	(	(	PUNCT
dpc-4071	110	455	100	100	NUM
dpc-4071	110	456	)	)	PUNCT
dpc-4071	110	457	0	0	NUM
dpc-4071	111	1	(	(	PUNCT
dpc-4071	111	2	0.0	0.0	NUM
dpc-4071	111	3	)	)	PUNCT
dpc-4071	111	4	cs	cs	NOUN
dpc-4071	111	5	=	=	PUNCT
dpc-4071	111	6	corticosteroid	corticosteroid	X
dpc-4071	111	7	;	;	PUNCT
dpc-4071	111	8	sd	sd	NOUN
dpc-4071	111	9	=	=	SYM
dpc-4071	111	10	standard	standard	ADJ
dpc-4071	111	11	deviation	deviation	NOUN
dpc-4071	111	12	.	.	PUNCT
dpc-4071	112	1	relationship	relationship	NOUN
dpc-4071	112	2	between	between	ADP
dpc-4071	112	3	the	the	DET
dpc-4071	112	4	disease	disease	NOUN
dpc-4071	112	5	severity	severity	NOUN
dpc-4071	112	6	and	and	CCONJ
dpc-4071	112	7	serum	serum	NOUN
dpc-4071	112	8	eosinophil	eosinophil	ADJ
dpc-4071	112	9	is	be	AUX
dpc-4071	112	10	reported	report	VERB
dpc-4071	112	11	[	[	X
dpc-4071	112	12	10	10	NUM
dpc-4071	112	13	]	]	PUNCT
dpc-4071	112	14	.	.	PUNCT
dpc-4071	113	1	another	another	DET
dpc-4071	113	2	case	case	NOUN
dpc-4071	113	3	-	-	PUNCT
dpc-4071	113	4	control	control	NOUN
dpc-4071	113	5	study	study	NOUN
dpc-4071	113	6	on	on	ADP
dpc-4071	113	7	225	225	NUM
dpc-4071	113	8	patients	patient	NOUN
dpc-4071	113	9	with	with	ADP
dpc-4071	113	10	bp	bp	PROPN
dpc-4071	113	11	investigated	investigate	VERB
dpc-4071	113	12	the	the	DET
dpc-4071	113	13	association	association	NOUN
dpc-4071	113	14	between	between	ADP
dpc-4071	113	15	peripheral	peripheral	ADJ
dpc-4071	113	16	eosinophilia	eosinophilia	PROPN
dpc-4071	113	17	and	and	CCONJ
dpc-4071	113	18	bp	bp	PROPN
dpc-4071	113	19	clinical	clinical	ADJ
dpc-4071	113	20	manifestations	manifestation	NOUN
dpc-4071	113	21	.	.	PUNCT
dpc-4071	114	1	it	it	PRON
dpc-4071	114	2	reported	report	VERB
dpc-4071	114	3	that	that	SCONJ
dpc-4071	114	4	patients	patient	NOUN
dpc-4071	114	5	with	with	ADP
dpc-4071	114	6	bp	bp	PROPN
dpc-4071	114	7	with	with	ADP
dpc-4071	114	8	serum	serum	PROPN
dpc-4071	114	9	eosinophilia	eosinophilia	PROPN
dpc-4071	114	10	were	be	AUX
dpc-4071	114	11	significantly	significantly	ADV
dpc-4071	114	12	older	old	ADJ
dpc-4071	114	13	and	and	CCONJ
dpc-4071	114	14	had	have	VERB
dpc-4071	114	15	higher	high	ADJ
dpc-4071	114	16	palmoplantar	palmoplantar	NOUN
dpc-4071	114	17	involvement	involvement	NOUN
dpc-4071	114	18	.	.	PUNCT
dpc-4071	115	1	patients	patient	NOUN
dpc-4071	115	2	with	with	ADP
dpc-4071	115	3	bp	bp	PROPN
dpc-4071	115	4	with	with	ADP
dpc-4071	115	5	a	a	DET
dpc-4071	115	6	normal	normal	ADJ
dpc-4071	115	7	eosinophil	eosinophil	ADJ
dpc-4071	115	8	count	count	NOUN
dpc-4071	115	9	were	be	AUX
dpc-4071	115	10	younger	young	ADJ
dpc-4071	115	11	and	and	CCONJ
dpc-4071	115	12	presented	present	VERB
dpc-4071	115	13	more	more	ADJ
dpc-4071	115	14	original	original	ADJ
dpc-4071	115	15	article	article	NOUN
dpc-4071	115	16	|	|	ADV
dpc-4071	115	17	dermatol	dermatol	ADJ
dpc-4071	115	18	pract	pract	NOUN
dpc-4071	115	19	concept	concept	NOUN
dpc-4071	115	20	.	.	PUNCT
dpc-4071	116	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	116	2	5	5	NUM
dpc-4071	116	3	an	an	DET
dpc-4071	116	4	animal	animal	NOUN
dpc-4071	116	5	model	model	NOUN
dpc-4071	116	6	has	have	AUX
dpc-4071	116	7	suggested	suggest	VERB
dpc-4071	116	8	that	that	SCONJ
dpc-4071	116	9	eosinophils	eosinophil	NOUN
dpc-4071	116	10	can	can	AUX
dpc-4071	116	11	mediate	mediate	VERB
dpc-4071	116	12	tissue	tissue	NOUN
dpc-4071	116	13	injury	injury	NOUN
dpc-4071	116	14	in	in	ADP
dpc-4071	116	15	patients	patient	NOUN
dpc-4071	116	16	with	with	ADP
dpc-4071	116	17	bp	bp	PROPN
dpc-4071	116	18	by	by	ADP
dpc-4071	116	19	providing	provide	VERB
dpc-4071	116	20	a	a	DET
dpc-4071	116	21	relation	relation	NOUN
dpc-4071	116	22	between	between	ADP
dpc-4071	116	23	immunoglobulin	immunoglobulin	NOUN
dpc-4071	116	24	-	-	PUNCT
dpc-4071	116	25	e	e	NOUN
dpc-4071	116	26	auto	auto	NOUN
dpc-4071	116	27	-	-	PUNCT
dpc-4071	116	28	antibodies	antibody	NOUN
dpc-4071	116	29	and	and	CCONJ
dpc-4071	116	30	skin	skin	NOUN
dpc-4071	116	31	blistering	blister	VERB
dpc-4071	116	32	.	.	PUNCT
dpc-4071	117	1	as	as	ADP
dpc-4071	117	2	a	a	DET
dpc-4071	117	3	result	result	NOUN
dpc-4071	117	4	,	,	PUNCT
dpc-4071	117	5	higher	high	ADJ
dpc-4071	117	6	tissue	tissue	NOUN
dpc-4071	117	7	inflammations	inflammation	NOUN
dpc-4071	117	8	could	could	AUX
dpc-4071	117	9	be	be	AUX
dpc-4071	117	10	associated	associate	VERB
dpc-4071	117	11	with	with	ADP
dpc-4071	117	12	higher	high	ADJ
dpc-4071	117	13	bp	bp	PROPN
dpc-4071	117	14	severity	severity	NOUN
dpc-4071	117	15	[	[	X
dpc-4071	117	16	18	18	NUM
dpc-4071	117	17	]	]	PUNCT
dpc-4071	117	18	.	.	PUNCT
dpc-4071	118	1	an	an	DET
dpc-4071	118	2	experimental	experimental	ADJ
dpc-4071	118	3	study	study	NOUN
dpc-4071	118	4	also	also	ADV
dpc-4071	118	5	demonstrated	demonstrate	VERB
dpc-4071	118	6	the	the	DET
dpc-4071	118	7	overexpression	overexpression	NOUN
dpc-4071	118	8	of	of	ADP
dpc-4071	118	9	thelper-2	thelper-2	NUM
dpc-4071	118	10	cytokines	cytokine	NOUN
dpc-4071	118	11	like	like	ADP
dpc-4071	118	12	interleukin-31	interleukin-31	PROPN
dpc-4071	118	13	on	on	ADP
dpc-4071	118	14	the	the	DET
dpc-4071	118	15	injured	injure	VERB
dpc-4071	118	16	skin	skin	NOUN
dpc-4071	118	17	of	of	ADP
dpc-4071	118	18	bp	bp	PROPN
dpc-4071	118	19	patients	patient	NOUN
dpc-4071	118	20	[	[	X
dpc-4071	118	21	19	19	NUM
dpc-4071	118	22	]	]	PUNCT
dpc-4071	118	23	.	.	PUNCT
dpc-4071	119	1	frequently	frequently	ADV
dpc-4071	119	2	with	with	ADP
dpc-4071	119	3	atypical	atypical	ADJ
dpc-4071	119	4	clinical	clinical	ADJ
dpc-4071	119	5	manifestations	manifestation	NOUN
dpc-4071	119	6	[	[	X
dpc-4071	119	7	6	6	NUM
dpc-4071	119	8	]	]	PUNCT
dpc-4071	119	9	.	.	PUNCT
dpc-4071	120	1	although	although	SCONJ
dpc-4071	120	2	,	,	PUNCT
dpc-4071	120	3	we	we	PRON
dpc-4071	120	4	observed	observe	VERB
dpc-4071	120	5	no	no	DET
dpc-4071	120	6	significant	significant	ADJ
dpc-4071	120	7	relationship	relationship	NOUN
dpc-4071	120	8	between	between	ADP
dpc-4071	120	9	age	age	NOUN
dpc-4071	120	10	and	and	CCONJ
dpc-4071	120	11	eosinophilia	eosinophilia	PROPN
dpc-4071	120	12	.	.	PUNCT
dpc-4071	121	1	in	in	ADP
dpc-4071	121	2	1983	1983	NUM
dpc-4071	121	3	,	,	PUNCT
dpc-4071	121	4	bushkell	bushkell	VERB
dpc-4071	121	5	et	et	PROPN
dpc-4071	121	6	al	al	PROPN
dpc-4071	121	7	,	,	PUNCT
dpc-4071	121	8	reported	report	VERB
dpc-4071	121	9	a	a	DET
dpc-4071	121	10	peripheral	peripheral	ADJ
dpc-4071	121	11	serum	serum	NOUN
dpc-4071	121	12	eosinophilia	eosinophilia	PROPN
dpc-4071	121	13	in	in	ADP
dpc-4071	121	14	patients	patient	NOUN
dpc-4071	121	15	with	with	ADP
dpc-4071	121	16	bp	bp	PROPN
dpc-4071	121	17	.	.	PUNCT
dpc-4071	122	1	they	they	PRON
dpc-4071	122	2	declared	declare	VERB
dpc-4071	122	3	that	that	SCONJ
dpc-4071	122	4	peripheral	peripheral	ADJ
dpc-4071	122	5	blood	blood	NOUN
dpc-4071	122	6	eosinophilia	eosinophilia	NOUN
dpc-4071	122	7	was	be	AUX
dpc-4071	122	8	a	a	DET
dpc-4071	122	9	common	common	ADJ
dpc-4071	122	10	finding	finding	NOUN
dpc-4071	122	11	in	in	ADP
dpc-4071	122	12	their	their	PRON
dpc-4071	122	13	patients	patient	NOUN
dpc-4071	122	14	and	and	CCONJ
dpc-4071	122	15	bp	bp	PROPN
dpc-4071	122	16	should	should	AUX
dpc-4071	122	17	be	be	AUX
dpc-4071	122	18	included	include	VERB
dpc-4071	122	19	in	in	ADP
dpc-4071	122	20	the	the	DET
dpc-4071	122	21	differential	differential	ADJ
dpc-4071	122	22	diagnosis	diagnosis	NOUN
dpc-4071	122	23	of	of	ADP
dpc-4071	122	24	cutaneous	cutaneous	ADJ
dpc-4071	122	25	bullous	bullous	ADJ
dpc-4071	122	26	lesions	lesion	NOUN
dpc-4071	122	27	with	with	ADP
dpc-4071	122	28	eosinophilia	eosinophilia	PROPN
dpc-4071	123	1	[	[	X
dpc-4071	123	2	17	17	NUM
dpc-4071	123	3	]	]	PUNCT
dpc-4071	123	4	.	.	PUNCT
dpc-4071	124	1	table	table	NOUN
dpc-4071	124	2	2	2	NUM
dpc-4071	124	3	.	.	X
dpc-4071	124	4	serum	serum	VERB
dpc-4071	124	5	eosinophil	eosinophil	ADJ
dpc-4071	124	6	count	count	NOUN
dpc-4071	124	7	,	,	PUNCT
dpc-4071	124	8	percentage	percentage	NOUN
dpc-4071	124	9	,	,	PUNCT
dpc-4071	124	10	and	and	CCONJ
dpc-4071	124	11	bpdai	bpdai	NOUN
dpc-4071	124	12	severity	severity	NOUN
dpc-4071	124	13	score	score	NOUN
dpc-4071	124	14	based	base	VERB
dpc-4071	124	15	on	on	ADP
dpc-4071	124	16	different	different	ADJ
dpc-4071	124	17	variables	variable	NOUN
dpc-4071	124	18	.	.	PUNCT
dpc-4071	125	1	variable	variable	ADJ
dpc-4071	125	2	serum	serum	NOUN
dpc-4071	125	3	eosinophil	eosinophil	ADJ
dpc-4071	125	4	count	count	VERB
dpc-4071	125	5	p	p	ADJ
dpc-4071	125	6	-	-	PUNCT
dpc-4071	125	7	value	value	NOUN
dpc-4071	125	8	serum	serum	NOUN
dpc-4071	125	9	eosinophil	eosinophil	ADJ
dpc-4071	125	10	percentage	percentage	NOUN
dpc-4071	125	11	p	p	NOUN
dpc-4071	125	12	-	-	PUNCT
dpc-4071	125	13	value	value	NOUN
dpc-4071	125	14	bpdai	bpdai	NOUN
dpc-4071	125	15	severity	severity	NOUN
dpc-4071	125	16	score	score	NOUN
dpc-4071	125	17	p	p	NOUN
dpc-4071	125	18	-	-	PUNCT
dpc-4071	125	19	value	value	NOUN
dpc-4071	125	20	sex	sex	NOUN
dpc-4071	125	21	male	male	NOUN
dpc-4071	125	22	1113.5±974.86	1113.5±974.86	NOUN
dpc-4071	125	23	0.44	0.44	NUM
dpc-4071	126	1	30.6±25.1	30.6±25.1	NUM
dpc-4071	126	2	0.15	0.15	NUM
dpc-4071	126	3	42.3±29.68	42.3±29.68	NOUN
dpc-4071	126	4	0.62	0.62	NUM
dpc-4071	126	5	female	female	ADJ
dpc-4071	126	6	1412.1±2426.15	1412.1±2426.15	NUM
dpc-4071	126	7	21.3±17.15	21.3±17.15	NUM
dpc-4071	126	8	40.6±30.44	40.6±30.44	NOUN
dpc-4071	126	9	site	site	NOUN
dpc-4071	126	10	of	of	ADP
dpc-4071	126	11	involvement	involvement	NOUN
dpc-4071	126	12	mucous	mucous	ADJ
dpc-4071	127	1	yes	yes	INTJ
dpc-4071	127	2	947.8±1011.97	947.8±1011.97	NUM
dpc-4071	127	3	0.02	0.02	NUM
dpc-4071	127	4	27.7±20.66	27.7±20.66	NUM
dpc-4071	127	5	0.52	0.52	NUM
dpc-4071	127	6	39.3±30.29	39.3±30.29	NOUN
dpc-4071	127	7	0.42	0.42	NUM
dpc-4071	128	1	no	no	DET
dpc-4071	128	2	1560.7±2278.69	1560.7±2278.69	NUM
dpc-4071	128	3	23.5±21.86	23.5±21.86	NUM
dpc-4071	128	4	43.4±29.83	43.4±29.83	ADJ
dpc-4071	128	5	past	past	ADP
dpc-4071	128	6	medical	medical	ADJ
dpc-4071	128	7	history	history	NOUN
dpc-4071	128	8	autoimmune	autoimmune	ADJ
dpc-4071	128	9	disease	disease	NOUN
dpc-4071	129	1	yes	yes	INTJ
dpc-4071	129	2	899.7±499.36	899.7±499.36	NUM
dpc-4071	129	3	0.6	0.6	NUM
dpc-4071	129	4	19.7±16.58	19.7±16.58	NOUN
dpc-4071	129	5	0.16	0.16	NUM
dpc-4071	129	6	45.8±27.9	45.8±27.9	NOUN
dpc-4071	129	7	0.51	0.51	NUM
dpc-4071	130	1	no	no	DET
dpc-4071	130	2	1487.1±2235.73	1487.1±2235.73	NUM
dpc-4071	130	3	28.8±23.27	28.8±23.27	NUM
dpc-4071	130	4	38.5±31.11	38.5±31.11	NUM
dpc-4071	130	5	hypertension	hypertension	NOUN
dpc-4071	130	6	yes	yes	INTJ
dpc-4071	130	7	1113.5±974.86	1113.5±974.86	NUM
dpc-4071	130	8	0.31	0.31	NUM
dpc-4071	130	9	20.3±17.4	20.3±17.4	NUM
dpc-4071	130	10	0.17	0.17	NUM
dpc-4071	130	11	44.2±27.78	44.2±27.78	NOUN
dpc-4071	130	12	0.31	0.31	NUM
dpc-4071	130	13	no	no	DET
dpc-4071	130	14	1412.1±2426.15	1412.1±2426.15	NUM
dpc-4071	130	15	29.1±23.32	29.1±23.32	NUM
dpc-4071	130	16	38.9±31.76	38.9±31.76	NOUN
dpc-4071	130	17	hyperlipidemia	hyperlipidemia	NOUN
dpc-4071	130	18	yes	yes	INTJ
dpc-4071	130	19	1459.1±540.23	1459.1±540.23	NUM
dpc-4071	130	20	0.42	0.42	NUM
dpc-4071	130	21	25.4±21.96	25.4±21.96	NUM
dpc-4071	130	22	0.99	0.99	NUM
dpc-4071	130	23	43.8±31.95	43.8±31.95	NOUN
dpc-4071	130	24	0.81	0.81	NUM
dpc-4071	130	25	no	no	DET
dpc-4071	130	26	1220.7±1849.54	1220.7±1849.54	NUM
dpc-4071	130	27	25.3±21.4	25.3±21.4	NUM
dpc-4071	130	28	41.1±29.94	41.1±29.94	NOUN
dpc-4071	130	29	malignancy	malignancy	NOUN
dpc-4071	131	1	yes	yes	INTJ
dpc-4071	131	2	1303.3±1268.13	1303.3±1268.13	NUM
dpc-4071	132	1	0.76	0.76	NUM
dpc-4071	132	2	22.5±22.9	22.5±22.9	NUM
dpc-4071	132	3	0.63	0.63	NUM
dpc-4071	132	4	40.7±32.38	40.7±32.38	NOUN
dpc-4071	132	5	0.58	0.58	NUM
dpc-4071	133	1	no	no	DET
dpc-4071	133	2	1228.8±1885.05	1228.8±1885.05	NUM
dpc-4071	133	3	26.1±20.97	26.1±20.97	NOUN
dpc-4071	133	4	41.5±29.48	41.5±29.48	ADJ
dpc-4071	133	5	neurologic	neurologic	ADJ
dpc-4071	133	6	disease	disease	NOUN
dpc-4071	133	7	yes	yes	INTJ
dpc-4071	133	8	1303.3±1268.13	1303.3±1268.13	NUM
dpc-4071	133	9	0.61	0.61	NUM
dpc-4071	133	10	17.4±20.21	17.4±20.21	NUM
dpc-4071	133	11	0.50	0.50	NUM
dpc-4071	133	12	58.3±16.07	58.3±16.07	NOUN
dpc-4071	133	13	0.31	0.31	NUM
dpc-4071	133	14	no	no	DET
dpc-4071	133	15	1228.8±1885.05	1228.8±1885.05	NUM
dpc-4071	133	16	25.9±21.4	25.9±21.4	NUM
dpc-4071	133	17	40.6±30.23	40.6±30.23	PROPN
dpc-4071	133	18	histopathologic	histopathologic	PROPN
dpc-4071	133	19	findings	finding	NOUN
dpc-4071	133	20	subepidermal	subepidermal	NOUN
dpc-4071	133	21	blister	blister	NOUN
dpc-4071	133	22	yes	yes	ADV
dpc-4071	133	23	1364	1364	NUM
dpc-4071	133	24	±2177.73	±2177.73	NUM
dpc-4071	133	25	0.75	0.75	NUM
dpc-4071	133	26	*	*	PUNCT
dpc-4071	133	27	*	*	PUNCT
dpc-4071	133	28	*	*	PUNCT
dpc-4071	133	29	25.2±19.26	25.2±19.26	NUM
dpc-4071	133	30	0.92	0.92	NUM
dpc-4071	133	31	*	*	PUNCT
dpc-4071	133	32	49.6±30.36	49.6±30.36	NOUN
dpc-4071	133	33	0.24	0.24	NUM
dpc-4071	134	1	no	no	DET
dpc-4071	134	2	770±309.39	770±309.39	NOUN
dpc-4071	134	3	25.9±29.00	25.9±29.00	NUM
dpc-4071	134	4	36.7±30.86	36.7±30.86	NOUN
dpc-4071	134	5	c3	c3	NOUN
dpc-4071	134	6	yes	yes	INTJ
dpc-4071	134	7	1428.3±2604.77	1428.3±2604.77	NUM
dpc-4071	134	8	0.19	0.19	NUM
dpc-4071	134	9	*	*	PUNCT
dpc-4071	134	10	*	*	PUNCT
dpc-4071	134	11	*	*	PUNCT
dpc-4071	135	1	24.5±19.6	24.5±19.6	NUM
dpc-4071	135	2	0.19	0.19	NUM
dpc-4071	135	3	*	*	PUNCT
dpc-4071	135	4	46.0±33.23	46.0±33.23	X
dpc-4071	135	5	0.56	0.56	NUM
dpc-4071	135	6	*	*	PUNCT
dpc-4071	135	7	*	*	PUNCT
dpc-4071	135	8	*	*	PUNCT
dpc-4071	136	1	no	no	DET
dpc-4071	136	2	1006.6±515.21	1006.6±515.21	NOUN
dpc-4071	136	3	35.5±28.51	35.5±28.51	ADJ
dpc-4071	136	4	58.7±26.44	58.7±26.44	NUM
dpc-4071	136	5	igg	igg	PROPN
dpc-4071	136	6	yes	yes	INTJ
dpc-4071	136	7	1331.9±2326.14	1331.9±2326.14	NUM
dpc-4071	136	8	0.66	0.66	NUM
dpc-4071	136	9	*	*	PUNCT
dpc-4071	136	10	*	*	PUNCT
dpc-4071	136	11	*	*	PUNCT
dpc-4071	136	12	25.2±21.88	25.2±21.88	NUM
dpc-4071	136	13	0.31	0.31	NUM
dpc-4071	136	14	*	*	PUNCT
dpc-4071	136	15	47.6±32.25	47.6±32.25	NOUN
dpc-4071	136	16	0.96	0.96	NUM
dpc-4071	136	17	*	*	PUNCT
dpc-4071	136	18	*	*	PUNCT
dpc-4071	136	19	*	*	PUNCT
dpc-4071	136	20	no	no	DET
dpc-4071	136	21	1014.8±474.4	1014.8±474.4	NUM
dpc-4071	136	22	33.8±23.28	33.8±23.28	NUM
dpc-4071	136	23	49.8±30.25	49.8±30.25	NOUN
dpc-4071	137	1	c3+igg	c3+igg	VERB
dpc-4071	138	1	yes	yes	INTJ
dpc-4071	138	2	1448.4±2795.72	1448.4±2795.72	NUM
dpc-4071	139	1	0.32	0.32	NUM
dpc-4071	139	2	*	*	PUNCT
dpc-4071	139	3	*	*	PUNCT
dpc-4071	139	4	*	*	X
dpc-4071	139	5	23.1±20.20	23.1±20.20	NOUN
dpc-4071	139	6	0.47	0.47	NUM
dpc-4071	139	7	*	*	PUNCT
dpc-4071	139	8	41.9±33.09	41.9±33.09	NUM
dpc-4071	140	1	0.19	0.19	NUM
dpc-4071	140	2	*	*	PUNCT
dpc-4071	140	3	*	*	PUNCT
dpc-4071	140	4	*	*	PUNCT
dpc-4071	140	5	no	no	DET
dpc-4071	140	6	980.3±494.69	980.3±494.69	NOUN
dpc-4071	140	7	31.0±24.12	31.0±24.12	NUM
dpc-4071	140	8	59.4±25.10	59.4±25.10	NOUN
dpc-4071	140	9	peripheral	peripheral	ADJ
dpc-4071	140	10	eosinophilia	eosinophilia	NOUN
dpc-4071	141	1	yes	yes	INTJ
dpc-4071	142	1	1445.7±1880.36	1445.7±1880.36	NUM
dpc-4071	142	2	<	<	X
dpc-4071	142	3	0.0001	0.0001	NUM
dpc-4071	142	4	*	*	PUNCT
dpc-4071	142	5	*	*	PUNCT
dpc-4071	142	6	*	*	PUNCT
dpc-4071	142	7	25.0±21.12	25.0±21.12	NUM
dpc-4071	142	8	0.8	0.8	NUM
dpc-4071	142	9	*	*	NUM
dpc-4071	142	10	42.9±30.53	42.9±30.53	NOUN
dpc-4071	142	11	0.48	0.48	NUM
dpc-4071	142	12	*	*	PUNCT
dpc-4071	142	13	*	*	PUNCT
dpc-4071	142	14	*	*	PUNCT
dpc-4071	142	15	no	no	DET
dpc-4071	142	16	309.7±111.02	309.7±111.02	NUM
dpc-4071	142	17	27.4±23.72	27.4±23.72	NOUN
dpc-4071	142	18	33.5±26.37	33.5±26.37	NUM
dpc-4071	142	19	tissue	tissue	NOUN
dpc-4071	142	20	eosinophilia	eosinophilia	PROPN
dpc-4071	142	21	grade	grade	NOUN
dpc-4071	142	22	1	1	NUM
dpc-4071	142	23	714.3	714.3	NUM
dpc-4071	142	24	±364.30	±364.30	NOUN
dpc-4071	142	25	<	<	X
dpc-4071	142	26	0.01	0.01	NUM
dpc-4071	142	27	*	*	PUNCT
dpc-4071	142	28	*	*	PUNCT
dpc-4071	142	29	*	*	PUNCT
dpc-4071	142	30	*	*	PUNCT
dpc-4071	142	31	10.5±6.01	10.5±6.01	NUM
dpc-4071	142	32	<	<	X
dpc-4071	142	33	0.0001	0.0001	NUM
dpc-4071	142	34	*	*	PUNCT
dpc-4071	142	35	*	*	PUNCT
dpc-4071	142	36	37.0±26.98	37.0±26.98	NUM
dpc-4071	143	1	0.08	0.08	NUM
dpc-4071	143	2	*	*	PUNCT
dpc-4071	143	3	*	*	PUNCT
dpc-4071	143	4	*	*	PUNCT
dpc-4071	143	5	*	*	SYM
dpc-4071	143	6	2	2	NUM
dpc-4071	143	7	1176.5±415.24	1176.5±415.24	NUM
dpc-4071	143	8	34.6±7.61	34.6±7.61	NUM
dpc-4071	143	9	61.4±30.4	61.4±30.4	NUM
dpc-4071	143	10	3	3	NUM
dpc-4071	143	11	1092.6±533.4	1092.6±533.4	NUM
dpc-4071	143	12	63.7±3.79	63.7±3.79	NUM
dpc-4071	143	13	62.8±34.19	62.8±34.19	ADP
dpc-4071	143	14	4	4	NUM
dpc-4071	143	15	13200	13200	NUM
dpc-4071	143	16	83.7	83.7	NUM
dpc-4071	143	17	dermal	dermal	ADJ
dpc-4071	143	18	inflammation	inflammation	NOUN
dpc-4071	143	19	mild	mild	ADJ
dpc-4071	143	20	911.9	911.9	NUM
dpc-4071	143	21	±551.13	±551.13	NOUN
dpc-4071	143	22	0.95	0.95	NUM
dpc-4071	143	23	*	*	PUNCT
dpc-4071	143	24	*	*	PUNCT
dpc-4071	143	25	*	*	PUNCT
dpc-4071	143	26	*	*	PUNCT
dpc-4071	143	27	13.0±17.02	13.0±17.02	NUM
dpc-4071	143	28	0.14	0.14	NUM
dpc-4071	143	29	*	*	PUNCT
dpc-4071	143	30	*	*	PUNCT
dpc-4071	143	31	50.5±31.42	50.5±31.42	NUM
dpc-4071	143	32	0.86	0.86	NUM
dpc-4071	143	33	*	*	PUNCT
dpc-4071	143	34	*	*	PUNCT
dpc-4071	143	35	*	*	PUNCT
dpc-4071	143	36	*	*	PUNCT
dpc-4071	143	37	moderate	moderate	ADJ
dpc-4071	143	38	964.5±469.64	964.5±469.64	PROPN
dpc-4071	143	39	25.0±20.38	25.0±20.38	NUM
dpc-4071	143	40	43.1±23.38	43.1±23.38	NOUN
dpc-4071	144	1	severe	severe	ADJ
dpc-4071	144	2	1849.1±3295.53	1849.1±3295.53	NUM
dpc-4071	144	3	31.8±22.41	31.8±22.41	NUM
dpc-4071	144	4	47.8±29.36	47.8±29.36	NOUN
dpc-4071	144	5	bpdai	bpdai	NOUN
dpc-4071	144	6	=	=	PUNCT
dpc-4071	144	7	bullous	bullous	ADJ
dpc-4071	144	8	pemphigoid	pemphigoid	PROPN
dpc-4071	144	9	disease	disease	PROPN
dpc-4071	144	10	area	area	PROPN
dpc-4071	144	11	index	index	PROPN
dpc-4071	144	12	.	.	PUNCT
dpc-4071	145	1	6	6	NUM
dpc-4071	145	2	original	original	ADJ
dpc-4071	145	3	article	article	NOUN
dpc-4071	145	4	|	|	ADV
dpc-4071	145	5	dermatol	dermatol	ADJ
dpc-4071	145	6	pract	pract	NOUN
dpc-4071	145	7	concept	concept	NOUN
dpc-4071	145	8	.	.	PUNCT
dpc-4071	146	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	146	2	and	and	CCONJ
dpc-4071	146	3	clinical	clinical	ADJ
dpc-4071	146	4	findings	finding	NOUN
dpc-4071	146	5	severity	severity	NOUN
dpc-4071	146	6	in	in	ADP
dpc-4071	146	7	patients	patient	NOUN
dpc-4071	146	8	with	with	ADP
dpc-4071	146	9	bp	bp	PROPN
dpc-4071	146	10	.	.	PUNCT
dpc-4071	147	1	the	the	DET
dpc-4071	147	2	limitations	limitation	NOUN
dpc-4071	147	3	of	of	ADP
dpc-4071	147	4	this	this	DET
dpc-4071	147	5	study	study	NOUN
dpc-4071	147	6	are	be	AUX
dpc-4071	147	7	a	a	DET
dpc-4071	147	8	restricted	restricted	ADJ
dpc-4071	147	9	study	study	NOUN
dpc-4071	147	10	population	population	NOUN
dpc-4071	147	11	,	,	PUNCT
dpc-4071	147	12	unknown	unknown	ADJ
dpc-4071	147	13	potential	potential	ADJ
dpc-4071	147	14	confounders	confounder	NOUN
dpc-4071	147	15	,	,	PUNCT
dpc-4071	147	16	and	and	CCONJ
dpc-4071	147	17	also	also	ADV
dpc-4071	147	18	,	,	PUNCT
dpc-4071	147	19	we	we	PRON
dpc-4071	147	20	had	have	VERB
dpc-4071	147	21	inferior	inferior	ADJ
dpc-4071	147	22	  	  	SPACE
dpc-4071	147	23	level	level	NOUN
dpc-4071	147	24	of	of	ADP
dpc-4071	147	25	evidence	evidence	NOUN
dpc-4071	147	26	compared	compare	VERB
dpc-4071	147	27	to	to	ADP
dpc-4071	147	28	prospective	prospective	ADJ
dpc-4071	147	29	studies	study	NOUN
dpc-4071	147	30	.	.	PUNCT
dpc-4071	148	1	therefore	therefore	ADV
dpc-4071	148	2	,	,	PUNCT
dpc-4071	148	3	more	more	ADJ
dpc-4071	148	4	studies	study	NOUN
dpc-4071	148	5	with	with	ADP
dpc-4071	148	6	larger	large	ADJ
dpc-4071	148	7	populations	population	NOUN
dpc-4071	148	8	are	be	AUX
dpc-4071	148	9	suggested	suggest	VERB
dpc-4071	148	10	.	.	PUNCT
dpc-4071	149	1	in	in	ADP
dpc-4071	149	2	conclusion	conclusion	NOUN
dpc-4071	149	3	,	,	PUNCT
dpc-4071	149	4	our	our	PRON
dpc-4071	149	5	study	study	NOUN
dpc-4071	149	6	showed	show	VERB
dpc-4071	149	7	a	a	DET
dpc-4071	149	8	significant	significant	ADJ
dpc-4071	149	9	correlation	correlation	NOUN
dpc-4071	149	10	between	between	ADP
dpc-4071	149	11	histopathological	histopathological	ADJ
dpc-4071	149	12	findings	finding	NOUN
dpc-4071	149	13	in	in	ADP
dpc-4071	149	14	bp	bp	PROPN
dpc-4071	149	15	(	(	PUNCT
dpc-4071	149	16	such	such	ADJ
dpc-4071	149	17	as	as	ADP
dpc-4071	149	18	tissue	tissue	NOUN
dpc-4071	149	19	eosinophilia	eosinophilia	PROPN
dpc-4071	149	20	)	)	PUNCT
dpc-4071	149	21	and	and	CCONJ
dpc-4071	149	22	the	the	DET
dpc-4071	149	23	disease	disease	NOUN
dpc-4071	149	24	severity	severity	NOUN
dpc-4071	149	25	.	.	PUNCT
dpc-4071	150	1	in	in	ADP
dpc-4071	150	2	conclusion	conclusion	NOUN
dpc-4071	150	3	,	,	PUNCT
dpc-4071	150	4	the	the	DET
dpc-4071	150	5	possible	possible	ADJ
dpc-4071	150	6	role	role	NOUN
dpc-4071	150	7	of	of	ADP
dpc-4071	150	8	eosinophils	eosinophil	NOUN
dpc-4071	150	9	in	in	ADP
dpc-4071	150	10	bp	bp	PROPN
dpc-4071	150	11	clinical	clinical	ADJ
dpc-4071	150	12	features	feature	NOUN
dpc-4071	150	13	should	should	AUX
dpc-4071	150	14	be	be	AUX
dpc-4071	150	15	considered	consider	VERB
dpc-4071	150	16	as	as	ADP
dpc-4071	150	17	a	a	DET
dpc-4071	150	18	promising	promising	ADJ
dpc-4071	150	19	help	help	NOUN
dpc-4071	150	20	for	for	ADP
dpc-4071	150	21	better	well	ADJ
dpc-4071	150	22	diagnosis	diagnosis	NOUN
dpc-4071	150	23	and	and	CCONJ
dpc-4071	150	24	treatment	treatment	NOUN
dpc-4071	150	25	.	.	PUNCT
dpc-4071	151	1	although	although	SCONJ
dpc-4071	151	2	,	,	PUNCT
dpc-4071	151	3	wakugawa	wakugawa	PROPN
dpc-4071	151	4	et	et	PROPN
dpc-4071	151	5	al	al	PROPN
dpc-4071	151	6	,	,	PUNCT
dpc-4071	151	7	suggested	suggest	VERB
dpc-4071	151	8	that	that	SCONJ
dpc-4071	151	9	eotaxin	eotaxin	PROPN
dpc-4071	151	10	and	and	CCONJ
dpc-4071	151	11	interleukin‐5	interleukin‐5	ADV
dpc-4071	151	12	contribute	contribute	VERB
dpc-4071	151	13	to	to	ADP
dpc-4071	151	14	the	the	DET
dpc-4071	151	15	blister	blister	NOUN
dpc-4071	151	16	formation	formation	NOUN
dpc-4071	151	17	but	but	CCONJ
dpc-4071	151	18	no	no	DET
dpc-4071	151	19	correlations	correlation	NOUN
dpc-4071	151	20	were	be	AUX
dpc-4071	151	21	reported	report	VERB
dpc-4071	151	22	between	between	ADP
dpc-4071	151	23	tissue	tissue	NOUN
dpc-4071	151	24	eosinophilia	eosinophilia	NOUN
dpc-4071	151	25	and	and	CCONJ
dpc-4071	151	26	bp	bp	PROPN
dpc-4071	151	27	severity	severity	NOUN
dpc-4071	152	1	[	[	X
dpc-4071	152	2	20	20	NUM
dpc-4071	152	3	]	]	PUNCT
dpc-4071	152	4	.	.	PUNCT
dpc-4071	153	1	there	there	PRON
dpc-4071	153	2	are	be	VERB
dpc-4071	153	3	also	also	ADV
dpc-4071	153	4	a	a	DET
dpc-4071	153	5	number	number	NOUN
dpc-4071	153	6	of	of	ADP
dpc-4071	153	7	reports	report	NOUN
dpc-4071	153	8	about	about	ADP
dpc-4071	153	9	bp	bp	PROPN
dpc-4071	153	10	and	and	CCONJ
dpc-4071	153	11	hyper	hyper	NOUN
dpc-4071	153	12	-	-	NOUN
dpc-4071	153	13	eosinophilia	eosinophilia	NOUN
dpc-4071	153	14	.	.	PUNCT
dpc-4071	154	1	a	a	DET
dpc-4071	154	2	recent	recent	ADJ
dpc-4071	154	3	report	report	NOUN
dpc-4071	154	4	in	in	ADP
dpc-4071	154	5	2023	2023	NUM
dpc-4071	154	6	,	,	PUNCT
dpc-4071	154	7	was	be	AUX
dpc-4071	154	8	a	a	DET
dpc-4071	154	9	16	16	NUM
dpc-4071	154	10	-	-	PUNCT
dpc-4071	154	11	year	year	NOUN
dpc-4071	154	12	-	-	PUNCT
dpc-4071	154	13	old	old	ADJ
dpc-4071	154	14	girl	girl	NOUN
dpc-4071	154	15	with	with	ADP
dpc-4071	154	16	generalized	generalized	ADJ
dpc-4071	154	17	aggressive	aggressive	ADJ
dpc-4071	154	18	bullous	bullous	ADJ
dpc-4071	154	19	lesions	lesion	NOUN
dpc-4071	154	20	diagnosed	diagnose	VERB
dpc-4071	154	21	as	as	ADP
dpc-4071	154	22	bp	bp	PROPN
dpc-4071	154	23	which	which	PRON
dpc-4071	154	24	was	be	AUX
dpc-4071	154	25	unresponsive	unresponsive	ADJ
dpc-4071	154	26	to	to	ADP
dpc-4071	154	27	low	low	ADJ
dpc-4071	154	28	dose	dose	NOUN
dpc-4071	154	29	prednisolone	prednisolone	PROPN
dpc-4071	154	30	.	.	PUNCT
dpc-4071	155	1	more	more	ADJ
dpc-4071	155	2	investigations	investigation	NOUN
dpc-4071	155	3	revealed	reveal	VERB
dpc-4071	155	4	bp	bp	PROPN
dpc-4071	155	5	associated	associate	VERB
dpc-4071	155	6	with	with	ADP
dpc-4071	155	7	hyper	hyper	ADJ
dpc-4071	155	8	-	-	ADJ
dpc-4071	155	9	eosinophilic	eosinophilic	ADJ
dpc-4071	155	10	syndrome	syndrome	NOUN
dpc-4071	155	11	.	.	PUNCT
dpc-4071	156	1	finally	finally	ADV
dpc-4071	156	2	,	,	PUNCT
dpc-4071	156	3	the	the	DET
dpc-4071	156	4	patient	patient	NOUN
dpc-4071	156	5	was	be	AUX
dpc-4071	156	6	treated	treat	VERB
dpc-4071	156	7	with	with	ADP
dpc-4071	156	8	high	high	ADJ
dpc-4071	156	9	dose	dose	NOUN
dpc-4071	156	10	corticosteroid	corticosteroid	NOUN
dpc-4071	156	11	[	[	X
dpc-4071	156	12	21	21	NUM
dpc-4071	156	13	]	]	PUNCT
dpc-4071	156	14	.	.	PUNCT
dpc-4071	157	1	our	our	PRON
dpc-4071	157	2	study	study	NOUN
dpc-4071	157	3	supports	support	VERB
dpc-4071	157	4	the	the	DET
dpc-4071	157	5	possible	possible	ADJ
dpc-4071	157	6	association	association	NOUN
dpc-4071	157	7	between	between	ADP
dpc-4071	157	8	histopathological	histopathological	ADJ
dpc-4071	157	9	markers	marker	NOUN
dpc-4071	157	10	like	like	ADP
dpc-4071	157	11	tissue	tissue	NOUN
dpc-4071	157	12	hyper	hyper	ADJ
dpc-4071	157	13	-	-	PROPN
dpc-4071	157	14	eosinophilia	eosinophilia	ADJ
dpc-4071	157	15	table	table	NOUN
dpc-4071	157	16	3	3	NUM
dpc-4071	157	17	.	.	PUNCT
dpc-4071	157	18	relationships	relationship	NOUN
dpc-4071	157	19	between	between	ADP
dpc-4071	157	20	quantitative	quantitative	ADJ
dpc-4071	157	21	variables	variable	NOUN
dpc-4071	157	22	related	relate	VERB
dpc-4071	157	23	to	to	ADP
dpc-4071	157	24	bpdai	bpdai	NOUN
dpc-4071	157	25	severity	severity	NOUN
dpc-4071	157	26	.	.	PUNCT
dpc-4071	158	1	variable	variable	ADJ
dpc-4071	158	2	hospitalization	hospitalization	NOUN
dpc-4071	158	3	duration	duration	NOUN
dpc-4071	158	4	serum	serum	NOUN
dpc-4071	158	5	eosinophil	eosinophil	ADJ
dpc-4071	158	6	count	count	VERB
dpc-4071	158	7	serum	serum	NOUN
dpc-4071	158	8	eosinophil	eosinophil	ADJ
dpc-4071	158	9	percentage	percentage	NOUN
dpc-4071	158	10	bpdai	bpdai	NOUN
dpc-4071	158	11	severity	severity	NOUN
dpc-4071	158	12	score	score	NOUN
dpc-4071	158	13	age	age	NOUN
dpc-4071	158	14	r	r	NOUN
dpc-4071	158	15	−0.11	−0.11	NOUN
dpc-4071	158	16	−0.09	−0.09	VERB
dpc-4071	159	1	−0.289	−0.289	ADV
dpc-4071	159	2	0.008	0.008	NUM
dpc-4071	160	1	p	p	NOUN
dpc-4071	160	2	0.34	0.34	NUM
dpc-4071	160	3	0.45	0.45	NUM
dpc-4071	160	4	0.06	0.06	NUM
dpc-4071	160	5	0.945	0.945	NUM
dpc-4071	160	6	hospitalization	hospitalization	NOUN
dpc-4071	160	7	duration	duration	NOUN
dpc-4071	160	8	r	r	NOUN
dpc-4071	160	9	1	1	NUM
dpc-4071	160	10	−0.03	−0.03	NOUN
dpc-4071	160	11	0.003	0.003	NUM
dpc-4071	160	12	−0.21	−0.21	NOUN
dpc-4071	160	13	p	p	NOUN
dpc-4071	160	14	0.77	0.77	NUM
dpc-4071	160	15	0.984	0.984	NUM
dpc-4071	160	16	0.08	0.08	NUM
dpc-4071	160	17	peripheral	peripheral	ADJ
dpc-4071	160	18	eosinophilia	eosinophilia	NOUN
dpc-4071	160	19	grade	grade	NOUN
dpc-4071	160	20	r	r	NOUN
dpc-4071	160	21	−0.09	−0.09	PROPN
dpc-4071	160	22	0.15	0.15	NUM
dpc-4071	160	23	0.15	0.15	NUM
dpc-4071	160	24	0.76	0.76	NUM
dpc-4071	160	25	p	p	NOUN
dpc-4071	160	26	0.42	0.42	NUM
dpc-4071	160	27	0.30	0.30	NUM
dpc-4071	160	28	0.30	0.30	NUM
dpc-4071	160	29	0.52	0.52	NUM
dpc-4071	160	30	tissue	tissue	NOUN
dpc-4071	160	31	eosinophilia	eosinophilia	NOUN
dpc-4071	160	32	grade	grade	NOUN
dpc-4071	160	33	r	r	NOUN
dpc-4071	160	34	−0.04	−0.04	NOUN
dpc-4071	160	35	0.49	0.49	NUM
dpc-4071	160	36	0.89	0.89	NUM
dpc-4071	160	37	0.33	0.33	NUM
dpc-4071	160	38	p	p	NOUN
dpc-4071	160	39	0.80	0.80	NUM
dpc-4071	160	40	0.002	0.002	NUM
dpc-4071	160	41	<	<	NOUN
dpc-4071	160	42	0.000	0.000	NUM
dpc-4071	160	43	0.03	0.03	NUM
dpc-4071	160	44	dermal	dermal	NOUN
dpc-4071	160	45	inflammation	inflammation	NOUN
dpc-4071	160	46	r	r	NOUN
dpc-4071	160	47	−0.01	−0.01	ADV
dpc-4071	160	48	0.95	0.95	NUM
dpc-4071	160	49	0.46	0.46	NUM
dpc-4071	160	50	0.22	0.22	NUM
dpc-4071	160	51	p	p	NOUN
dpc-4071	160	52	0.95	0.95	NUM
dpc-4071	160	53	<	<	NOUN
dpc-4071	160	54	0.0001	0.0001	NUM
dpc-4071	160	55	0.003	0.003	NUM
dpc-4071	160	56	0.06	0.06	NUM
dpc-4071	160	57	bpdai	bpdai	NOUN
dpc-4071	160	58	=	=	PUNCT
dpc-4071	160	59	bullous	bullous	ADJ
dpc-4071	160	60	pemphigoid	pemphigoid	PROPN
dpc-4071	160	61	disease	disease	PROPN
dpc-4071	160	62	area	area	PROPN
dpc-4071	160	63	index	index	PROPN
dpc-4071	160	64	.	.	PUNCT
dpc-4071	161	1	table	table	NOUN
dpc-4071	161	2	4	4	NUM
dpc-4071	161	3	.	.	PUNCT
dpc-4071	162	1	regression	regression	NOUN
dpc-4071	162	2	model	model	NOUN
dpc-4071	162	3	analyses	analysis	NOUN
dpc-4071	162	4	.	.	PUNCT
dpc-4071	163	1	model	model	NOUN
dpc-4071	163	2	standardized	standardize	VERB
dpc-4071	163	3	beta	beta	ADJ
dpc-4071	163	4	coefficients	coefficient	NOUN
dpc-4071	163	5	t	t	PROPN
dpc-4071	163	6	p	p	NOUN
dpc-4071	163	7	-	-	PUNCT
dpc-4071	163	8	value	value	NOUN
dpc-4071	163	9	95	95	NUM
dpc-4071	163	10	%	%	NOUN
dpc-4071	163	11	confidence	confidence	NOUN
dpc-4071	163	12	interval	interval	NOUN
dpc-4071	163	13	for	for	ADP
dpc-4071	163	14	beta	beta	NOUN
dpc-4071	163	15	lower	lower	ADV
dpc-4071	163	16	bound	bind	VERB
dpc-4071	163	17	upper	upper	ADJ
dpc-4071	163	18	bound	bound	ADJ
dpc-4071	163	19	1	1	NUM
dpc-4071	163	20	constant	constant	ADJ
dpc-4071	163	21	3.04	3.04	NUM
dpc-4071	163	22	0.003	0.003	NUM
dpc-4071	163	23	19.87	19.87	NUM
dpc-4071	163	24	95.88	95.88	NUM
dpc-4071	163	25	age	age	NOUN
dpc-4071	163	26	-0.02	-0.02	NUM
dpc-4071	163	27	-0.22	-0.22	NOUN
dpc-4071	163	28	>	>	NOUN
dpc-4071	163	29	0.05	0.05	NUM
dpc-4071	163	30	-0.52	-0.52	NUM
dpc-4071	163	31	0.42	0.42	NUM
dpc-4071	163	32	sex	sex	NOUN
dpc-4071	163	33	(	(	PUNCT
dpc-4071	163	34	female	female	NOUN
dpc-4071	163	35	/	/	SYM
dpc-4071	163	36	male	male	NOUN
dpc-4071	163	37	)	)	PUNCT
dpc-4071	163	38	-0.02	-0.02	NUM
dpc-4071	163	39	-0.16	-0.16	X
dpc-4071	163	40	>	>	SYM
dpc-4071	163	41	0.05	0.05	NUM
dpc-4071	163	42	-15.73	-15.73	SYM
dpc-4071	163	43	13.28	13.28	NUM
dpc-4071	163	44	hospitalization	hospitalization	NOUN
dpc-4071	163	45	duration	duration	NOUN
dpc-4071	163	46	-0.25	-0.25	NUM
dpc-4071	163	47	-2.11	-2.11	NUM
dpc-4071	163	48	0.03	0.03	NUM
dpc-4071	163	49	-2.00	-2.00	NUM
dpc-4071	163	50	-0.05	-0.05	NUM
dpc-4071	163	51	2	2	NUM
dpc-4071	163	52	constant	constant	ADJ
dpc-4071	163	53	6.86	6.86	NUM
dpc-4071	163	54	0.0001	0.0001	NUM
dpc-4071	163	55	45.51	45.51	NUM
dpc-4071	163	56	82.83	82.83	NUM
dpc-4071	163	57	oral	oral	ADJ
dpc-4071	163	58	prednisolone	prednisolone	PROPN
dpc-4071	163	59	-0.26	-0.26	PROPN
dpc-4071	163	60	-2.33	-2.33	NUM
dpc-4071	163	61	0.02	0.02	NUM
dpc-4071	163	62	-29.38	-29.38	PROPN
dpc-4071	163	63	-2.33	-2.33	NUM
dpc-4071	163	64	3	3	NUM
dpc-4071	163	65	constant	constant	ADJ
dpc-4071	163	66	5.45	5.45	NUM
dpc-4071	163	67	0.0001	0.0001	NUM
dpc-4071	163	68	40.71	40.71	NUM
dpc-4071	163	69	87.62	87.62	NUM
dpc-4071	163	70	facial	facial	ADJ
dpc-4071	163	71	bullous	bullous	ADJ
dpc-4071	163	72	lesion	lesion	NOUN
dpc-4071	163	73	(	(	PUNCT
dpc-4071	163	74	yes	yes	INTJ
dpc-4071	163	75	/	/	SYM
dpc-4071	163	76	no	no	NOUN
dpc-4071	163	77	)	)	PUNCT
dpc-4071	163	78	-0.22	-0.22	NUM
dpc-4071	163	79	-1.93	-1.93	NUM
dpc-4071	163	80	0.05	0.05	NUM
dpc-4071	163	81	-31.39	-31.39	PROPN
dpc-4071	163	82	0.457	0.457	NUM
dpc-4071	163	83	trunk	trunk	NOUN
dpc-4071	163	84	bullous	bullous	ADJ
dpc-4071	163	85	lesion	lesion	NOUN
dpc-4071	163	86	(	(	PUNCT
dpc-4071	163	87	yes	yes	INTJ
dpc-4071	163	88	/	/	SYM
dpc-4071	163	89	no	no	NOUN
dpc-4071	163	90	)	)	PUNCT
dpc-4071	163	91	-0.19	-0.19	NOUN
dpc-4071	163	92	-1.68	-1.68	NOUN
dpc-4071	163	93	>	>	PUNCT
dpc-4071	163	94	0.05	0.05	NUM
dpc-4071	163	95	-45.88	-45.88	NUM
dpc-4071	163	96	3.934	3.934	NUM
dpc-4071	163	97	4	4	NUM
dpc-4071	163	98	constant	constant	ADJ
dpc-4071	163	99	1.45	1.45	NUM
dpc-4071	163	100	>	>	SYM
dpc-4071	163	101	0.05	0.05	NUM
dpc-4071	163	102	-9.72	-9.72	NUM
dpc-4071	163	103	57.37	57.37	NUM
dpc-4071	163	104	tissue	tissue	NOUN
dpc-4071	163	105	eosinophilia	eosinophilia	NOUN
dpc-4071	163	106	grade	grade	NOUN
dpc-4071	163	107	0.61	0.61	NUM
dpc-4071	163	108	3.65	3.65	NUM
dpc-4071	163	109	0.001	0.001	NUM
dpc-4071	163	110	16.25	16.25	NUM
dpc-4071	163	111	57.40	57.40	NUM
dpc-4071	163	112	peripheral	peripheral	ADJ
dpc-4071	163	113	eosinophilia	eosinophilia	PROPN
dpc-4071	163	114	grade	grade	NOUN
dpc-4071	163	115	0.21	0.21	NUM
dpc-4071	163	116	1.45	1.45	NUM
dpc-4071	163	117	>	>	SYM
dpc-4071	163	118	0.05	0.05	NUM
dpc-4071	163	119	-4.67	-4.67	NUM
dpc-4071	163	120	28.06	28.06	NUM
dpc-4071	163	121	tissue	tissue	NOUN
dpc-4071	163	122	inflammation	inflammation	NOUN
dpc-4071	163	123	grade	grade	NOUN
dpc-4071	163	124	-0.35	-0.35	NOUN
dpc-4071	163	125	-2.08	-2.08	NUM
dpc-4071	163	126	0.04	0.04	NUM
dpc-4071	163	127	-22.52	-22.52	NUM
dpc-4071	163	128	-0.24	-0.24	ADJ
dpc-4071	163	129	presence	presence	NOUN
dpc-4071	163	130	of	of	ADP
dpc-4071	163	131	subepidermal	subepidermal	ADJ
dpc-4071	163	132	blister	blister	NOUN
dpc-4071	163	133	(	(	PUNCT
dpc-4071	163	134	yes	yes	INTJ
dpc-4071	163	135	/	/	SYM
dpc-4071	163	136	no	no	NOUN
dpc-4071	163	137	)	)	PUNCT
dpc-4071	163	138	0.12	0.12	NUM
dpc-4071	163	139	0.88	0.88	NUM
dpc-4071	163	140	>	>	PUNCT
dpc-4071	163	141	0.05	0.05	NUM
dpc-4071	163	142	-11.56	-11.56	SYM
dpc-4071	163	143	29.11	29.11	NUM
dpc-4071	163	144	c3	c3	NOUN
dpc-4071	163	145	(	(	PUNCT
dpc-4071	163	146	positive	positive	ADJ
dpc-4071	163	147	/	/	SYM
dpc-4071	163	148	negative	negative	ADJ
dpc-4071	163	149	)	)	PUNCT
dpc-4071	163	150	0.05	0.05	NUM
dpc-4071	163	151	0.35	0.35	NUM
dpc-4071	163	152	>	>	PUNCT
dpc-4071	163	153	0.05	0.05	NUM
dpc-4071	163	154	-13.07	-13.07	SYM
dpc-4071	163	155	18.54	18.54	NUM
dpc-4071	163	156	igg	igg	PROPN
dpc-4071	163	157	(	(	PUNCT
dpc-4071	163	158	positive	positive	ADJ
dpc-4071	163	159	/	/	SYM
dpc-4071	163	160	negative	negative	ADJ
dpc-4071	163	161	)	)	PUNCT
dpc-4071	163	162	0.31	0.31	NUM
dpc-4071	163	163	1.86	1.86	NUM
dpc-4071	163	164	>	>	PUNCT
dpc-4071	163	165	0.05	0.05	NUM
dpc-4071	163	166	-1.73	-1.73	NUM
dpc-4071	163	167	38.04	38.04	NUM
dpc-4071	163	168	original	original	ADJ
dpc-4071	163	169	article	article	NOUN
dpc-4071	163	170	|	|	ADV
dpc-4071	163	171	dermatol	dermatol	ADJ
dpc-4071	163	172	pract	pract	NOUN
dpc-4071	163	173	concept	concept	NOUN
dpc-4071	163	174	.	.	PUNCT
dpc-4071	164	1	2024;14(3):e2024169	2024;14(3):e2024169	NUM
dpc-4071	164	2	7	7	NUM
dpc-4071	164	3	11	11	NUM
dpc-4071	164	4	.	.	PUNCT
dpc-4071	165	1	masmoudi	masmoudi	PROPN
dpc-4071	165	2	w	w	PROPN
dpc-4071	165	3	,	,	PUNCT
dpc-4071	165	4	vaillant	vaillant	PROPN
dpc-4071	165	5	m	m	PROPN
dpc-4071	165	6	,	,	PUNCT
dpc-4071	165	7	vassileva	vassileva	PROPN
dpc-4071	165	8	s	s	PROPN
dpc-4071	165	9	,	,	PUNCT
dpc-4071	165	10	et	et	PROPN
dpc-4071	165	11	al	al	PROPN
dpc-4071	165	12	.	.	PUNCT
dpc-4071	165	13	international	international	ADJ
dpc-4071	165	14	validation	validation	NOUN
dpc-4071	165	15	of	of	ADP
dpc-4071	165	16	the	the	DET
dpc-4071	165	17	bullous	bullous	ADJ
dpc-4071	165	18	pemphigoid	pemphigoid	PROPN
dpc-4071	165	19	disease	disease	PROPN
dpc-4071	165	20	area	area	NOUN
dpc-4071	165	21	index	index	NOUN
dpc-4071	165	22	severity	severity	NOUN
dpc-4071	165	23	score	score	NOUN
dpc-4071	165	24	and	and	CCONJ
dpc-4071	165	25	calculation	calculation	NOUN
dpc-4071	165	26	of	of	ADP
dpc-4071	165	27	cut‐off	cut‐off	NOUN
dpc-4071	165	28	values	value	NOUN
dpc-4071	165	29	for	for	ADP
dpc-4071	165	30	defining	define	VERB
dpc-4071	165	31	mild	mild	ADJ
dpc-4071	165	32	,	,	PUNCT
dpc-4071	165	33	moderate	moderate	ADJ
dpc-4071	165	34	and	and	CCONJ
dpc-4071	165	35	severe	severe	ADJ
dpc-4071	165	36	types	type	NOUN
dpc-4071	165	37	of	of	ADP
dpc-4071	165	38	bullous	bullous	ADJ
dpc-4071	165	39	pemphigoid	pemphigoid	NOUN
dpc-4071	165	40	.	.	PUNCT
dpc-4071	166	1	british	british	ADJ
dpc-4071	166	2	journal	journal	PROPN
dpc-4071	166	3	of	of	ADP
dpc-4071	166	4	dermatology	dermatology	NOUN
dpc-4071	166	5	.	.	PUNCT
dpc-4071	167	1	2021;184(6):1106	2021;184(6):1106	NUM
dpc-4071	167	2	-	-	SYM
dpc-4071	167	3	12	12	NUM
dpc-4071	167	4	.	.	PUNCT
dpc-4071	168	1	doi	doi	NOUN
dpc-4071	168	2	:	:	PUNCT
dpc-4071	168	3	10.1111	10.1111	NUM
dpc-4071	168	4	/	/	SYM
dpc-4071	168	5	bjd.19611	bjd.19611	NUM
dpc-4071	168	6	.	.	PUNCT
dpc-4071	169	1	pmid	pmid	NOUN
dpc-4071	169	2	:	:	PUNCT
dpc-4071	169	3	33067805	33067805	NUM
dpc-4071	169	4	.	.	PUNCT
dpc-4071	170	1	12	12	NUM
dpc-4071	170	2	.	.	PUNCT
dpc-4071	171	1	billings	billing	NOUN
dpc-4071	171	2	sd	sd	NOUN
dpc-4071	171	3	,	,	PUNCT
dpc-4071	171	4	cotton	cotton	NOUN
dpc-4071	171	5	j.	j.	PROPN
dpc-4071	171	6	inflammatory	inflammatory	ADJ
dpc-4071	171	7	dermatopathology	dermatopathology	NOUN
dpc-4071	171	8	:	:	PUNCT
dpc-4071	171	9	springer	springer	NOUN
dpc-4071	171	10	;	;	PUNCT
dpc-4071	171	11	2011	2011	NUM
dpc-4071	171	12	.	.	PUNCT
dpc-4071	172	1	doi	doi	NOUN
dpc-4071	172	2	:	:	PUNCT
dpc-4071	172	3	10.1007/978	10.1007/978	NUM
dpc-4071	172	4	-	-	SYM
dpc-4071	172	5	3	3	NUM
dpc-4071	172	6	-	-	NUM
dpc-4071	172	7	319	319	NUM
dpc-4071	172	8	-	-	PUNCT
dpc-4071	172	9	41897	41897	NUM
dpc-4071	172	10	-	-	SYM
dpc-4071	172	11	1	1	NUM
dpc-4071	172	12	.	.	NOUN
dpc-4071	172	13	13	13	NUM
dpc-4071	172	14	.	.	PUNCT
dpc-4071	172	15	pasman	pasman	PROPN
dpc-4071	172	16	ea	ea	PROPN
dpc-4071	172	17	,	,	PUNCT
dpc-4071	172	18	heifert	heifert	ADJ
dpc-4071	172	19	ta	ta	ADP
dpc-4071	172	20	,	,	PUNCT
dpc-4071	172	21	nylund	nylund	ADJ
dpc-4071	172	22	cm	cm	NOUN
dpc-4071	172	23	.	.	PUNCT
dpc-4071	173	1	esophageal	esophageal	ADJ
dpc-4071	173	2	squamous	squamous	ADJ
dpc-4071	173	3	papillomas	papilloma	NOUN
dpc-4071	173	4	with	with	ADP
dpc-4071	173	5	focal	focal	ADJ
dpc-4071	173	6	dermal	dermal	NOUN
dpc-4071	173	7	hypoplasia	hypoplasia	NOUN
dpc-4071	173	8	and	and	CCONJ
dpc-4071	173	9	eosinophilic	eosinophilic	ADJ
dpc-4071	173	10	esophagitis	esophagitis	NOUN
dpc-4071	173	11	.	.	PUNCT
dpc-4071	174	1	world	world	PROPN
dpc-4071	174	2	j	j	PROPN
dpc-4071	174	3	gastroenterol	gastroenterol	PROPN
dpc-4071	174	4	.	.	PUNCT
dpc-4071	175	1	2017;23(12):2246	2017;23(12):2246	X
dpc-4071	175	2	.	.	PUNCT
dpc-4071	176	1	doi	doi	NOUN
dpc-4071	176	2	:	:	PUNCT
dpc-4071	176	3	10.3748/	10.3748/	NUM
dpc-4071	176	4	wjg.v23.i12.2246	wjg.v23.i12.2246	NOUN
dpc-4071	176	5	.	.	PUNCT
dpc-4071	177	1	pmid	pmid	NOUN
dpc-4071	177	2	:	:	PUNCT
dpc-4071	177	3	28405153	28405153	NUM
dpc-4071	177	4	.	.	PUNCT
dpc-4071	178	1	pmcid	pmcid	NOUN
dpc-4071	178	2	:	:	PUNCT
dpc-4071	178	3	pmc5374137	pmc5374137	NOUN
dpc-4071	178	4	.	.	PUNCT
dpc-4071	179	1	14	14	NUM
dpc-4071	179	2	.	.	PUNCT
dpc-4071	180	1	rosenwasser	rosenwasser	PROPN
dpc-4071	180	2	lj	lj	PROPN
dpc-4071	180	3	.	.	PROPN
dpc-4071	180	4	approach	approach	NOUN
dpc-4071	180	5	to	to	ADP
dpc-4071	180	6	patients	patient	NOUN
dpc-4071	180	7	with	with	ADP
dpc-4071	180	8	eosinophilia	eosinophilia	PROPN
dpc-4071	180	9	.	.	PUNCT
dpc-4071	181	1	mo	mo	PROPN
dpc-4071	181	2	med	med	PROPN
dpc-4071	181	3	.	.	PUNCT
dpc-4071	182	1	2011;108(5):358	2011;108(5):358	NUM
dpc-4071	182	2	-	-	SYM
dpc-4071	182	3	60	60	NUM
dpc-4071	182	4	.	.	PUNCT
dpc-4071	183	1	pmid	pmid	NOUN
dpc-4071	183	2	:	:	PUNCT
dpc-4071	183	3	22073495	22073495	NUM
dpc-4071	183	4	.	.	PUNCT
dpc-4071	184	1	pmcid	pmcid	NOUN
dpc-4071	184	2	:	:	PUNCT
dpc-4071	184	3	pmc6188379	pmc6188379	NOUN
dpc-4071	184	4	.	.	PUNCT
dpc-4071	185	1	15	15	X
dpc-4071	185	2	.	.	PUNCT
dpc-4071	186	1	nishioka	nishioka	PROPN
dpc-4071	186	2	k	k	PROPN
dpc-4071	186	3	,	,	PUNCT
dpc-4071	186	4	hashimoto	hashimoto	NOUN
dpc-4071	186	5	k	k	NOUN
dpc-4071	186	6	,	,	PUNCT
dpc-4071	186	7	katayama	katayama	PROPN
dpc-4071	186	8	i	i	PRON
dpc-4071	186	9	,	,	PUNCT
dpc-4071	186	10	sarashi	sarashi	PROPN
dpc-4071	186	11	c	c	PROPN
dpc-4071	186	12	,	,	PUNCT
dpc-4071	186	13	kubo	kubo	PROPN
dpc-4071	186	14	t	t	PROPN
dpc-4071	186	15	,	,	PUNCT
dpc-4071	186	16	sano	sano	PROPN
dpc-4071	186	17	s.	s.	PROPN
dpc-4071	186	18	eosinophilic	eosinophilic	PROPN
dpc-4071	186	19	spongiosis	spongiosis	NOUN
dpc-4071	186	20	in	in	ADP
dpc-4071	186	21	bullous	bullous	ADJ
dpc-4071	186	22	pemphigoid	pemphigoid	NOUN
dpc-4071	186	23	.	.	PUNCT
dpc-4071	187	1	arch	arch	ADJ
dpc-4071	187	2	dermatol	dermatol	NOUN
dpc-4071	187	3	.	.	PUNCT
dpc-4071	188	1	1984;120(9):1166	1984;120(9):1166	NUM
dpc-4071	188	2	-	-	SYM
dpc-4071	188	3	8	8	NUM
dpc-4071	188	4	.	.	PUNCT
dpc-4071	189	1	pmid	pmid	NOUN
dpc-4071	189	2	:	:	PUNCT
dpc-4071	189	3	6383222	6383222	NUM
dpc-4071	189	4	.	.	PUNCT
dpc-4071	190	1	16	16	NUM
dpc-4071	190	2	.	.	PUNCT
dpc-4071	191	1	dvorak	dvorak	PROPN
dpc-4071	191	2	am	am	PROPN
dpc-4071	191	3	,	,	PUNCT
dpc-4071	191	4	mihm	mihm	PROPN
dpc-4071	191	5	jr	jr	PROPN
dpc-4071	191	6	mc	mc	PROPN
dpc-4071	191	7	,	,	PUNCT
dpc-4071	191	8	osage	osage	PROPN
dpc-4071	191	9	je	je	PROPN
dpc-4071	191	10	,	,	PUNCT
dpc-4071	191	11	kwan	kwan	PROPN
dpc-4071	191	12	th	th	PROPN
dpc-4071	191	13	,	,	PUNCT
dpc-4071	191	14	austen	austen	PROPN
dpc-4071	191	15	kf	kf	PROPN
dpc-4071	191	16	,	,	PUNCT
dpc-4071	191	17	wintroub	wintroub	PROPN
dpc-4071	191	18	bu	bu	PROPN
dpc-4071	191	19	.	.	PUNCT
dpc-4071	191	20	bullous	bullous	ADJ
dpc-4071	191	21	pemphigoid	pemphigoid	NOUN
dpc-4071	191	22	,	,	PUNCT
dpc-4071	191	23	and	and	CCONJ
dpc-4071	191	24	ultrastructural	ultrastructural	ADJ
dpc-4071	191	25	study	study	NOUN
dpc-4071	191	26	of	of	ADP
dpc-4071	191	27	the	the	DET
dpc-4071	191	28	inflammatory	inflammatory	ADJ
dpc-4071	191	29	response	response	NOUN
dpc-4071	191	30	:	:	PUNCT
dpc-4071	191	31	eosinophil	eosinophil	ADJ
dpc-4071	191	32	,	,	PUNCT
dpc-4071	191	33	basophil	basophil	NOUN
dpc-4071	191	34	and	and	CCONJ
dpc-4071	191	35	mast	mast	NOUN
dpc-4071	191	36	cell	cell	NOUN
dpc-4071	191	37	granule	granule	NOUN
dpc-4071	191	38	changes	change	NOUN
dpc-4071	191	39	in	in	ADP
dpc-4071	191	40	multiple	multiple	ADJ
dpc-4071	191	41	biopsies	biopsy	NOUN
dpc-4071	191	42	from	from	ADP
dpc-4071	191	43	one	one	NUM
dpc-4071	191	44	patient	patient	NOUN
dpc-4071	191	45	.	.	PUNCT
dpc-4071	192	1	j	j	PROPN
dpc-4071	192	2	invest	invest	VERB
dpc-4071	192	3	dermatol	dermatol	NOUN
dpc-4071	192	4	.	.	PUNCT
dpc-4071	193	1	1982;78(2):91	1982;78(2):91	NUM
dpc-4071	193	2	-	-	SYM
dpc-4071	193	3	101	101	NUM
dpc-4071	193	4	.	.	PUNCT
dpc-4071	194	1	doi	doi	NOUN
dpc-4071	194	2	:	:	PUNCT
dpc-4071	194	3	10.1111/1523	10.1111/1523	NUM
dpc-4071	194	4	-	-	SYM
dpc-4071	194	5	1747	1747	NUM
dpc-4071	194	6	.	.	PUNCT
dpc-4071	195	1	pmid	pmid	NOUN
dpc-4071	195	2	:	:	PUNCT
dpc-4071	195	3	7035575	7035575	NUM
dpc-4071	195	4	.	.	PUNCT
dpc-4071	196	1	17	17	NUM
dpc-4071	196	2	.	.	X
dpc-4071	196	3	bushkell	bushkell	PROPN
dpc-4071	196	4	ll	ll	NOUN
dpc-4071	196	5	,	,	PUNCT
dpc-4071	196	6	jordon	jordon	PROPN
dpc-4071	196	7	re	re	NOUN
dpc-4071	196	8	.	.	PUNCT
dpc-4071	197	1	bullous	bullous	ADJ
dpc-4071	197	2	pemphigoid	pemphigoid	ADV
dpc-4071	197	3	:	:	PUNCT
dpc-4071	197	4	a	a	DET
dpc-4071	197	5	cause	cause	NOUN
dpc-4071	197	6	of	of	ADP
dpc-4071	197	7	peripheral	peripheral	ADJ
dpc-4071	197	8	blood	blood	NOUN
dpc-4071	197	9	eosinophilia	eosinophilia	NOUN
dpc-4071	197	10	.	.	PUNCT
dpc-4071	198	1	j	j	PROPN
dpc-4071	198	2	am	be	AUX
dpc-4071	198	3	acad	acad	ADJ
dpc-4071	198	4	dermatol	dermatol	NOUN
dpc-4071	198	5	.	.	PUNCT
dpc-4071	199	1	1983;8(5):648	1983;8(5):648	X
dpc-4071	199	2	-	-	SYM
dpc-4071	199	3	51	51	NUM
dpc-4071	199	4	.	.	PUNCT
dpc-4071	199	5	doi	doi	NOUN
dpc-4071	199	6	:	:	PUNCT
dpc-4071	199	7	10.1016	10.1016	NUM
dpc-4071	199	8	/	/	SYM
dpc-4071	199	9	s0190	s0190	VERB
dpc-4071	199	10	-	-	PUNCT
dpc-4071	199	11	9622(83)70073	9622(83)70073	NUM
dpc-4071	199	12	-	-	SYM
dpc-4071	199	13	3	3	NUM
dpc-4071	199	14	.	.	PUNCT
dpc-4071	200	1	pmid	pmid	NOUN
dpc-4071	200	2	:	:	PUNCT
dpc-4071	200	3	6345605	6345605	NUM
dpc-4071	200	4	.	.	PUNCT
dpc-4071	201	1	18	18	NUM
dpc-4071	201	2	.	.	PUNCT
dpc-4071	202	1	lin	lin	PROPN
dpc-4071	202	2	l	l	PROPN
dpc-4071	202	3	,	,	PUNCT
dpc-4071	202	4	hwang	hwang	PROPN
dpc-4071	202	5	b	b	PROPN
dpc-4071	202	6	-	-	PUNCT
dpc-4071	202	7	j	j	PROPN
dpc-4071	202	8	,	,	PUNCT
dpc-4071	202	9	culton	culton	PROPN
dpc-4071	202	10	da	da	PROPN
dpc-4071	202	11	,	,	PUNCT
dpc-4071	202	12	et	et	PROPN
dpc-4071	202	13	al	al	PROPN
dpc-4071	202	14	.	.	PROPN
dpc-4071	202	15	eosinophils	eosinophil	NOUN
dpc-4071	202	16	mediate	mediate	VERB
dpc-4071	202	17	tissue	tissue	NOUN
dpc-4071	202	18	injury	injury	NOUN
dpc-4071	202	19	in	in	ADP
dpc-4071	202	20	the	the	DET
dpc-4071	202	21	autoimmune	autoimmune	ADJ
dpc-4071	202	22	skin	skin	NOUN
dpc-4071	202	23	disease	disease	NOUN
dpc-4071	202	24	bullous	bullous	ADJ
dpc-4071	202	25	pemphigoid	pemphigoid	ADV
dpc-4071	202	26	.	.	PUNCT
dpc-4071	203	1	j	j	PROPN
dpc-4071	203	2	invest	invest	VERB
dpc-4071	203	3	dermatol	dermatol	NOUN
dpc-4071	203	4	.	.	PUNCT
dpc-4071	204	1	2018;138(5):1032	2018;138(5):1032	NUM
dpc-4071	204	2	-	-	SYM
dpc-4071	204	3	43	43	NUM
dpc-4071	204	4	.	.	PUNCT
dpc-4071	205	1	doi	doi	NOUN
dpc-4071	205	2	:	:	PUNCT
dpc-4071	205	3	10.1016	10.1016	NUM
dpc-4071	205	4	/	/	SYM
dpc-4071	205	5	j.jid	j.jid	PROPN
dpc-4071	205	6	.2017.11.031	.2017.11.031	PROPN
dpc-4071	205	7	.	.	PUNCT
dpc-4071	206	1	pmid	pmid	NOUN
dpc-4071	206	2	:	:	PUNCT
dpc-4071	206	3	29246800	29246800	NUM
dpc-4071	206	4	.	.	PUNCT
dpc-4071	207	1	pmcid	pmcid	NOUN
dpc-4071	207	2	:	:	PUNCT
dpc-4071	207	3	pmc7531612	pmc7531612	NOUN
dpc-4071	207	4	.	.	PUNCT
dpc-4071	208	1	19	19	NUM
dpc-4071	208	2	.	.	PUNCT
dpc-4071	208	3	ergun	ergun	PROPN
dpc-4071	208	4	ez	ez	PROPN
dpc-4071	208	5	,	,	PUNCT
dpc-4071	208	6	aoki	aoki	PROPN
dpc-4071	208	7	r	r	PROPN
dpc-4071	208	8	,	,	PUNCT
dpc-4071	208	9	horváth	horváth	ADV
dpc-4071	208	10	on	on	ADV
dpc-4071	208	11	,	,	PUNCT
dpc-4071	208	12	et	et	PROPN
dpc-4071	208	13	al	al	PROPN
dpc-4071	208	14	.	.	PROPN
dpc-4071	208	15	divergent	divergent	ADJ
dpc-4071	208	16	in	in	ADP
dpc-4071	208	17	situ	situ	ADJ
dpc-4071	208	18	expression	expression	NOUN
dpc-4071	208	19	of	of	ADP
dpc-4071	208	20	il-31	il-31	NUM
dpc-4071	208	21	and	and	CCONJ
dpc-4071	208	22	il-31ra	il-31ra	NOUN
dpc-4071	208	23	between	between	ADP
dpc-4071	208	24	bullous	bullous	ADJ
dpc-4071	208	25	pemphigoid	pemphigoid	NOUN
dpc-4071	208	26	and	and	CCONJ
dpc-4071	208	27	pemphigus	pemphigus	NOUN
dpc-4071	208	28	vulgaris	vulgaris	NOUN
dpc-4071	208	29	.	.	PUNCT
dpc-4071	209	1	experimental	experimental	ADJ
dpc-4071	209	2	dermatology	dermatology	NOUN
dpc-4071	209	3	.	.	PUNCT
dpc-4071	210	1	2023;32(9):1412	2023;32(9):1412	NUM
dpc-4071	210	2	-	-	SYM
dpc-4071	210	3	9	9	NUM
dpc-4071	210	4	.	.	PUNCT
dpc-4071	210	5	doi	doi	NOUN
dpc-4071	210	6	:	:	PUNCT
dpc-4071	210	7	10.1111	10.1111	NUM
dpc-4071	210	8	/	/	SYM
dpc-4071	210	9	exd.14842	exd.14842	NOUN
dpc-4071	210	10	.	.	PUNCT
dpc-4071	211	1	pmid	pmid	NOUN
dpc-4071	211	2	:	:	PUNCT
dpc-4071	211	3	37260420	37260420	NUM
dpc-4071	211	4	.	.	PUNCT
dpc-4071	212	1	20	20	NUM
dpc-4071	212	2	.	.	PUNCT
dpc-4071	213	1	wakugawa	wakugawa	PROPN
dpc-4071	213	2	m	m	PROPN
dpc-4071	213	3	,	,	PUNCT
dpc-4071	213	4	nakamura	nakamura	PROPN
dpc-4071	213	5	k	k	PROPN
dpc-4071	213	6	,	,	PUNCT
dpc-4071	213	7	hino	hino	PROPN
dpc-4071	213	8	h	h	NOUN
dpc-4071	213	9	,	,	PUNCT
dpc-4071	213	10	et	et	PROPN
dpc-4071	213	11	al	al	PROPN
dpc-4071	213	12	.	.	PROPN
dpc-4071	213	13	elevated	elevated	ADJ
dpc-4071	213	14	levels	level	NOUN
dpc-4071	213	15	of	of	ADP
dpc-4071	213	16	eotaxin	eotaxin	PROPN
dpc-4071	213	17	and	and	CCONJ
dpc-4071	213	18	interleukin‐5	interleukin‐5	ADV
dpc-4071	213	19	in	in	ADP
dpc-4071	213	20	blister	blister	NOUN
dpc-4071	213	21	fluid	fluid	NOUN
dpc-4071	213	22	of	of	ADP
dpc-4071	213	23	bullous	bullous	ADJ
dpc-4071	213	24	pemphigoid	pemphigoid	NOUN
dpc-4071	213	25	:	:	PUNCT
dpc-4071	213	26	correlation	correlation	NOUN
dpc-4071	213	27	with	with	ADP
dpc-4071	213	28	tissue	tissue	NOUN
dpc-4071	213	29	eosinophilia	eosinophilia	PROPN
dpc-4071	213	30	.	.	PUNCT
dpc-4071	214	1	br	br	PROPN
dpc-4071	214	2	j	j	PROPN
dpc-4071	214	3	dermatol	dermatol	NOUN
dpc-4071	214	4	.	.	PUNCT
dpc-4071	215	1	2000;143(1):112	2000;143(1):112	NUM
dpc-4071	215	2	-	-	SYM
dpc-4071	215	3	6	6	NUM
dpc-4071	215	4	.	.	PUNCT
dpc-4071	216	1	doi	doi	NOUN
dpc-4071	216	2	:	:	PUNCT
dpc-4071	216	3	10.1046	10.1046	NUM
dpc-4071	216	4	/	/	SYM
dpc-4071	216	5	j.1365	j.1365	NOUN
dpc-4071	216	6	-	-	PUNCT
dpc-4071	216	7	2133.2000.03599.x	2133.2000.03599.x	NUM
dpc-4071	216	8	.	.	PUNCT
dpc-4071	217	1	pmid	pmid	NOUN
dpc-4071	217	2	:	:	PUNCT
dpc-4071	217	3	10886144	10886144	NUM
dpc-4071	217	4	.	.	PUNCT
dpc-4071	218	1	21	21	NUM
dpc-4071	218	2	.	.	PUNCT
dpc-4071	218	3	ganji	ganji	PROPN
dpc-4071	218	4	r	r	NOUN
dpc-4071	218	5	,	,	PUNCT
dpc-4071	218	6	diab	diab	PROPN
dpc-4071	218	7	r	r	PROPN
dpc-4071	218	8	,	,	PUNCT
dpc-4071	218	9	mousavi	mousavi	PROPN
dpc-4071	218	10	f	f	PROPN
dpc-4071	218	11	,	,	PUNCT
dpc-4071	218	12	abdollahimajd	abdollahimajd	PROPN
dpc-4071	218	13	f.	f.	PROPN
dpc-4071	218	14	recalcitrant	recalcitrant	ADJ
dpc-4071	218	15	course	course	NOUN
dpc-4071	218	16	of	of	ADP
dpc-4071	218	17	bullous	bullous	ADJ
dpc-4071	218	18	pemphigoid	pemphigoid	NOUN
dpc-4071	218	19	indicating	indicate	VERB
dpc-4071	218	20	coexisting	coexist	VERB
dpc-4071	218	21	hypereosinophilic	hypereosinophilic	ADJ
dpc-4071	218	22	syndrome	syndrome	NOUN
dpc-4071	218	23	:	:	PUNCT
dpc-4071	218	24	a	a	DET
dpc-4071	218	25	case	case	NOUN
dpc-4071	218	26	report	report	NOUN
dpc-4071	218	27	and	and	CCONJ
dpc-4071	218	28	literature	literature	PROPN
dpc-4071	218	29	review	review	PROPN
dpc-4071	218	30	.	.	PUNCT
dpc-4071	219	1	clin	clin	PROPN
dpc-4071	219	2	case	case	PROPN
dpc-4071	219	3	rep	rep	PROPN
dpc-4071	219	4	.	.	PROPN
dpc-4071	219	5	2023;11(6):e7384	2023;11(6):e7384	PROPN
dpc-4071	219	6	.	.	PUNCT
dpc-4071	219	7	doi	doi	NOUN
dpc-4071	219	8	:	:	PUNCT
dpc-4071	219	9	10.1002	10.1002	NUM
dpc-4071	219	10	/	/	SYM
dpc-4071	219	11	ccr3.7384	ccr3.7384	X
dpc-4071	219	12	.	.	PUNCT
dpc-4071	220	1	pmid	pmid	PROPN
dpc-4071	220	2	:	:	PUNCT
dpc-4071	220	3	37323291	37323291	NUM
dpc-4071	220	4	.	.	PUNCT
dpc-4071	221	1	pmcid	pmcid	NOUN
dpc-4071	221	2	:	:	PUNCT
dpc-4071	221	3	pmc10264926	pmc10264926	PROPN
dpc-4071	221	4	.	.	PUNCT
dpc-4071	222	1	references	reference	NOUN
dpc-4071	222	2	1	1	NUM
dpc-4071	222	3	.	.	PUNCT
dpc-4071	222	4	colbert	colbert	PROPN
dpc-4071	222	5	rl	rl	PROPN
dpc-4071	222	6	,	,	PUNCT
dpc-4071	222	7	allen	allen	PROPN
dpc-4071	222	8	dm	dm	PROPN
dpc-4071	222	9	,	,	PUNCT
dpc-4071	222	10	eastwood	eastwood	PROPN
dpc-4071	222	11	d	d	PROPN
dpc-4071	222	12	,	,	PUNCT
dpc-4071	222	13	fairley	fairley	PROPN
dpc-4071	222	14	ja	ja	PROPN
dpc-4071	222	15	.	.	PUNCT
dpc-4071	222	16	mortality	mortality	NOUN
dpc-4071	222	17	rate	rate	NOUN
dpc-4071	222	18	of	of	ADP
dpc-4071	222	19	bullous	bullous	ADJ
dpc-4071	222	20	pemphigoid	pemphigoid	NOUN
dpc-4071	222	21	in	in	ADP
dpc-4071	222	22	a	a	DET
dpc-4071	222	23	us	us	PROPN
dpc-4071	222	24	medical	medical	ADJ
dpc-4071	222	25	center	center	NOUN
dpc-4071	222	26	.	.	PUNCT
dpc-4071	223	1	j	j	NOUN
dpc-4071	223	2	  	  	SPACE
dpc-4071	223	3	invest	invest	VERB
dpc-4071	223	4	dermatol	dermatol	NOUN
dpc-4071	223	5	.	.	PUNCT
dpc-4071	224	1	2004;122(5):1091	2004;122(5):1091	NUM
dpc-4071	224	2	-	-	SYM
dpc-4071	224	3	1095	1095	NUM
dpc-4071	224	4	.	.	PUNCT
dpc-4071	225	1	doi	doi	NOUN
dpc-4071	225	2	:	:	PUNCT
dpc-4071	225	3	10.1111	10.1111	NUM
dpc-4071	225	4	/	/	SYM
dpc-4071	225	5	j.0022	j.0022	NOUN
dpc-4071	225	6	-	-	PUNCT
dpc-4071	225	7	202x	202x	NOUN
dpc-4071	225	8	.2004.22504.x	.2004.22504.x	PRON
dpc-4071	225	9	.	.	PUNCT
dpc-4071	226	1	pmid	pmid	NOUN
dpc-4071	226	2	:	:	PUNCT
dpc-4071	226	3	15140208	15140208	NUM
dpc-4071	226	4	.	.	PUNCT
dpc-4071	227	1	2	2	X
dpc-4071	227	2	.	.	X
dpc-4071	227	3	miyamoto	miyamoto	PROPN
dpc-4071	227	4	d	d	PROPN
dpc-4071	227	5	,	,	PUNCT
dpc-4071	227	6	santi	santi	PROPN
dpc-4071	227	7	cg	cg	PROPN
dpc-4071	227	8	,	,	PUNCT
dpc-4071	227	9	aoki	aoki	PROPN
dpc-4071	227	10	v	v	PROPN
dpc-4071	227	11	,	,	PUNCT
dpc-4071	227	12	maruta	maruta	PROPN
dpc-4071	227	13	cw	cw	PROPN
dpc-4071	227	14	.	.	PUNCT
dpc-4071	227	15	bullous	bullous	ADJ
dpc-4071	227	16	pemphigoid	pemphigoid	NOUN
dpc-4071	227	17	.	.	PUNCT
dpc-4071	228	1	an	an	DET
dpc-4071	228	2	bras	bras	NOUN
dpc-4071	228	3	dermatol	dermatol	NOUN
dpc-4071	228	4	.	.	PUNCT
dpc-4071	229	1	2019;94(2):133	2019;94(2):133	PROPN
dpc-4071	229	2	-	-	SYM
dpc-4071	229	3	46	46	NUM
dpc-4071	229	4	.	.	PUNCT
dpc-4071	230	1	doi	doi	NOUN
dpc-4071	230	2	:	:	PUNCT
dpc-4071	230	3	10.1590	10.1590	NUM
dpc-4071	230	4	/	/	SYM
dpc-4071	230	5	abd18064841.20199007	abd18064841.20199007	ADJ
dpc-4071	230	6	.	.	PUNCT
dpc-4071	231	1	pmid	pmid	NOUN
dpc-4071	231	2	:	:	PUNCT
dpc-4071	231	3	31090818	31090818	NUM
dpc-4071	231	4	.	.	PUNCT
dpc-4071	232	1	pmcid	pmcid	NOUN
dpc-4071	232	2	:	:	PUNCT
dpc-4071	232	3	pmc6486083	pmc6486083	NOUN
dpc-4071	232	4	.	.	PUNCT
dpc-4071	233	1	3	3	X
dpc-4071	233	2	.	.	X
dpc-4071	233	3	murrell	murrell	PROPN
dpc-4071	233	4	df	df	PROPN
dpc-4071	233	5	,	,	PUNCT
dpc-4071	233	6	daniel	daniel	PROPN
dpc-4071	233	7	bs	bs	PROPN
dpc-4071	233	8	,	,	PUNCT
dpc-4071	233	9	joly	joly	PROPN
dpc-4071	233	10	p	p	PROPN
dpc-4071	233	11	,	,	PUNCT
dpc-4071	233	12	et	et	PROPN
dpc-4071	233	13	al	al	PROPN
dpc-4071	233	14	.	.	PUNCT
dpc-4071	234	1	definitions	definition	NOUN
dpc-4071	234	2	and	and	CCONJ
dpc-4071	234	3	outcome	outcome	VERB
dpc-4071	234	4	measures	measure	NOUN
dpc-4071	234	5	for	for	ADP
dpc-4071	234	6	bullous	bullous	ADJ
dpc-4071	234	7	pemphigoid	pemphigoid	NOUN
dpc-4071	234	8	:	:	PUNCT
dpc-4071	234	9	recommendations	recommendation	NOUN
dpc-4071	234	10	by	by	ADP
dpc-4071	234	11	an	an	DET
dpc-4071	234	12	international	international	ADJ
dpc-4071	234	13	panel	panel	NOUN
dpc-4071	234	14	of	of	ADP
dpc-4071	234	15	experts	expert	NOUN
dpc-4071	234	16	.	.	PUNCT
dpc-4071	235	1	journal	journal	NOUN
dpc-4071	235	2	of	of	ADP
dpc-4071	235	3	the	the	DET
dpc-4071	235	4	american	american	PROPN
dpc-4071	235	5	academy	academy	PROPN
dpc-4071	235	6	of	of	ADP
dpc-4071	235	7	dermatology	dermatology	NOUN
dpc-4071	235	8	.	.	PUNCT
dpc-4071	236	1	2012;66(3):479	2012;66(3):479	NUM
dpc-4071	236	2	-	-	PUNCT
dpc-4071	236	3	85	85	NUM
dpc-4071	236	4	.	.	PUNCT
dpc-4071	237	1	doi	doi	NOUN
dpc-4071	237	2	:	:	PUNCT
dpc-4071	237	3	10.1016	10.1016	NUM
dpc-4071	237	4	/	/	SYM
dpc-4071	237	5	j.jaad.2011.06.032	j.jaad.2011.06.032	PROPN
dpc-4071	237	6	.	.	PROPN
dpc-4071	238	1	4	4	X
dpc-4071	238	2	.	.	X
dpc-4071	238	3	bernard	bernard	PROPN
dpc-4071	238	4	p	p	PROPN
dpc-4071	238	5	,	,	PUNCT
dpc-4071	238	6	antonicelli	antonicelli	PROPN
dpc-4071	238	7	f.	f.	PROPN
dpc-4071	238	8	bullous	bullous	ADJ
dpc-4071	238	9	pemphigoid	pemphigoid	ADV
dpc-4071	238	10	:	:	PUNCT
dpc-4071	238	11	a	a	DET
dpc-4071	238	12	review	review	NOUN
dpc-4071	238	13	of	of	ADP
dpc-4071	238	14	its	its	PRON
dpc-4071	238	15	diagnosis	diagnosis	NOUN
dpc-4071	238	16	,	,	PUNCT
dpc-4071	238	17	associations	association	NOUN
dpc-4071	238	18	and	and	CCONJ
dpc-4071	238	19	treatment	treatment	NOUN
dpc-4071	238	20	.	.	PUNCT
dpc-4071	239	1	am	be	AUX
dpc-4071	239	2	j	j	PROPN
dpc-4071	239	3	clin	clin	PROPN
dpc-4071	239	4	dermatol	dermatol	NOUN
dpc-4071	239	5	.	.	PUNCT
dpc-4071	240	1	2017;18(4):513	2017;18(4):513	NUM
dpc-4071	240	2	-	-	PUNCT
dpc-4071	240	3	28	28	NUM
dpc-4071	240	4	.	.	PUNCT
dpc-4071	241	1	doi	doi	NOUN
dpc-4071	241	2	:	:	PUNCT
dpc-4071	241	3	10.1007	10.1007	NUM
dpc-4071	241	4	/	/	SYM
dpc-4071	241	5	s40257	s40257	NOUN
dpc-4071	241	6	-	-	PUNCT
dpc-4071	241	7	017	017	NUM
dpc-4071	241	8	-	-	PUNCT
dpc-4071	241	9	0264	0264	NUM
dpc-4071	241	10	-	-	PUNCT
dpc-4071	241	11	2	2	NUM
dpc-4071	241	12	.	.	PUNCT
dpc-4071	242	1	pmid	pmid	NOUN
dpc-4071	242	2	:	:	PUNCT
dpc-4071	242	3	28247089	28247089	NUM
dpc-4071	242	4	.	.	PUNCT
dpc-4071	243	1	5	5	X
dpc-4071	243	2	.	.	PUNCT
dpc-4071	243	3	amber	amber	PROPN
dpc-4071	243	4	kt	kt	PROPN
dpc-4071	243	5	,	,	PUNCT
dpc-4071	243	6	valdebran	valdebran	PROPN
dpc-4071	243	7	m	m	PROPN
dpc-4071	243	8	,	,	PUNCT
dpc-4071	243	9	kridin	kridin	VERB
dpc-4071	243	10	k	k	NOUN
dpc-4071	243	11	,	,	PUNCT
dpc-4071	243	12	grando	grando	PROPN
dpc-4071	243	13	sa	sa	PROPN
dpc-4071	243	14	.	.	PUNCT
dpc-4071	244	1	the	the	DET
dpc-4071	244	2	role	role	NOUN
dpc-4071	244	3	of	of	ADP
dpc-4071	244	4	eosinophils	eosinophil	NOUN
dpc-4071	244	5	in	in	ADP
dpc-4071	244	6	bullous	bullous	ADJ
dpc-4071	244	7	pemphigoid	pemphigoid	NOUN
dpc-4071	244	8	:	:	PUNCT
dpc-4071	244	9	a	a	DET
dpc-4071	244	10	developing	develop	VERB
dpc-4071	244	11	model	model	NOUN
dpc-4071	244	12	of	of	ADP
dpc-4071	244	13	eosinophil	eosinophil	ADJ
dpc-4071	244	14	pathogenicity	pathogenicity	NOUN
dpc-4071	244	15	in	in	ADP
dpc-4071	244	16	mucocutaneous	mucocutaneous	ADJ
dpc-4071	244	17	disease	disease	NOUN
dpc-4071	244	18	.	.	PUNCT
dpc-4071	245	1	frontiers	frontier	NOUN
dpc-4071	245	2	in	in	ADP
dpc-4071	245	3	medicine	medicine	NOUN
dpc-4071	245	4	.	.	PUNCT
dpc-4071	246	1	2018;5:201	2018;5:201	NUM
dpc-4071	246	2	.	.	PUNCT
dpc-4071	247	1	doi	doi	NOUN
dpc-4071	247	2	:	:	PUNCT
dpc-4071	247	3	10.3389	10.3389	NUM
dpc-4071	247	4	/	/	SYM
dpc-4071	247	5	fmed.2018.00201	fmed.2018.00201	PROPN
dpc-4071	247	6	.	.	PUNCT
dpc-4071	248	1	pmid	pmid	NOUN
dpc-4071	248	2	:	:	PUNCT
dpc-4071	248	3	30042946	30042946	NUM
dpc-4071	248	4	.	.	PUNCT
dpc-4071	249	1	pmcid	pmcid	NOUN
dpc-4071	249	2	:	:	PUNCT
dpc-4071	249	3	pmc6048777	pmc6048777	PROPN
dpc-4071	249	4	.	.	PUNCT
dpc-4071	250	1	6	6	X
dpc-4071	250	2	.	.	X
dpc-4071	250	3	kridin	kridin	VERB
dpc-4071	250	4	k.	k.	PROPN
dpc-4071	250	5	peripheral	peripheral	ADJ
dpc-4071	250	6	eosinophilia	eosinophilia	PROPN
dpc-4071	250	7	in	in	ADP
dpc-4071	250	8	bullous	bullous	ADJ
dpc-4071	250	9	pemphigoid	pemphigoid	NOUN
dpc-4071	250	10	:	:	PUNCT
dpc-4071	250	11	prevalence	prevalence	NOUN
dpc-4071	250	12	and	and	CCONJ
dpc-4071	250	13	influence	influence	NOUN
dpc-4071	250	14	on	on	ADP
dpc-4071	250	15	the	the	DET
dpc-4071	250	16	clinical	clinical	ADJ
dpc-4071	250	17	manifestation	manifestation	NOUN
dpc-4071	250	18	.	.	PUNCT
dpc-4071	251	1	br	br	PROPN
dpc-4071	251	2	j	j	PROPN
dpc-4071	251	3	dermatol	dermatol	NOUN
dpc-4071	251	4	.	.	PUNCT
dpc-4071	252	1	2018;179(5):1141	2018;179(5):1141	NUM
dpc-4071	252	2	-	-	SYM
dpc-4071	252	3	7	7	NUM
dpc-4071	252	4	.	.	PUNCT
dpc-4071	252	5	doi	doi	NOUN
dpc-4071	252	6	:	:	PUNCT
dpc-4071	252	7	10.1111	10.1111	NUM
dpc-4071	252	8	/	/	SYM
dpc-4071	252	9	bjd.16679	bjd.16679	NOUN
dpc-4071	252	10	.	.	PUNCT
dpc-4071	253	1	pmid	pmid	NOUN
dpc-4071	253	2	:	:	PUNCT
dpc-4071	253	3	29663327	29663327	NUM
dpc-4071	253	4	.	.	PUNCT
dpc-4071	254	1	7	7	X
dpc-4071	254	2	.	.	X
dpc-4071	254	3	engineer	engineer	NOUN
dpc-4071	254	4	l	l	PROPN
dpc-4071	254	5	,	,	PUNCT
dpc-4071	254	6	bhol	bhol	PROPN
dpc-4071	254	7	k	k	PROPN
dpc-4071	254	8	,	,	PUNCT
dpc-4071	254	9	kumari	kumari	PROPN
dpc-4071	254	10	s	s	PART
dpc-4071	254	11	,	,	PUNCT
dpc-4071	254	12	razzaque	razzaque	NOUN
dpc-4071	254	13	ahmed	ahmed	PROPN
dpc-4071	254	14	a.	a.	NOUN
dpc-4071	254	15	bullous	bullous	ADJ
dpc-4071	254	16	pemphigoid	pemphigoid	ADV
dpc-4071	254	17	:	:	PUNCT
dpc-4071	254	18	interaction	interaction	NOUN
dpc-4071	254	19	of	of	ADP
dpc-4071	254	20	interleukin	interleukin	NOUN
dpc-4071	254	21	5	5	NUM
dpc-4071	254	22	,	,	PUNCT
dpc-4071	254	23	anti	anti	ADJ
dpc-4071	254	24	-	-	ADJ
dpc-4071	254	25	basement	basement	ADJ
dpc-4071	254	26	membrane	membrane	NOUN
dpc-4071	254	27	zone	zone	NOUN
dpc-4071	254	28	antibodies	antibodie	VERB
dpc-4071	254	29	and	and	CCONJ
dpc-4071	254	30	eosinophils	eosinophil	VERB
dpc-4071	254	31	.	.	PUNCT
dpc-4071	255	1	a	a	DET
dpc-4071	255	2	preliminary	preliminary	ADJ
dpc-4071	255	3	observation	observation	NOUN
dpc-4071	255	4	.	.	PUNCT
dpc-4071	256	1	cytokine	cytokine	NOUN
dpc-4071	256	2	.	.	PUNCT
dpc-4071	257	1	2001	2001	NUM
dpc-4071	257	2	jan	jan	PROPN
dpc-4071	257	3	7;13(1):32	7;13(1):32	PROPN
dpc-4071	257	4	-	-	SYM
dpc-4071	257	5	38	38	NUM
dpc-4071	257	6	.	.	PUNCT
dpc-4071	258	1	doi	doi	NOUN
dpc-4071	258	2	:	:	PUNCT
dpc-4071	258	3	10.1006	10.1006	NUM
dpc-4071	258	4	/	/	SYM
dpc-4071	258	5	cyto.2000.0791	cyto.2000.0791	ADJ
dpc-4071	258	6	.	.	PUNCT
dpc-4071	259	1	pmid	pmid	NOUN
dpc-4071	259	2	:	:	PUNCT
dpc-4071	259	3	11145840	11145840	NUM
dpc-4071	259	4	.	.	PUNCT
dpc-4071	260	1	8	8	X
dpc-4071	260	2	.	.	X
dpc-4071	260	3	marzano	marzano	PROPN
dpc-4071	260	4	a	a	PRON
dpc-4071	260	5	,	,	PUNCT
dpc-4071	260	6	tedeschi	tedeschi	PROPN
dpc-4071	260	7	a	a	PRON
dpc-4071	260	8	,	,	PUNCT
dpc-4071	260	9	fanoni	fanoni	NOUN
dpc-4071	260	10	d	d	PROPN
dpc-4071	260	11	,	,	PUNCT
dpc-4071	260	12	et	et	PROPN
dpc-4071	260	13	al	al	PROPN
dpc-4071	260	14	.	.	PUNCT
dpc-4071	261	1	activation	activation	NOUN
dpc-4071	261	2	of	of	ADP
dpc-4071	261	3	blood	blood	NOUN
dpc-4071	261	4	coagulation	coagulation	NOUN
dpc-4071	261	5	in	in	ADP
dpc-4071	261	6	bullous	bullous	ADJ
dpc-4071	261	7	pemphigoid	pemphigoid	NOUN
dpc-4071	261	8	:	:	PUNCT
dpc-4071	261	9	role	role	NOUN
dpc-4071	261	10	of	of	ADP
dpc-4071	261	11	eosinophils	eosinophil	NOUN
dpc-4071	261	12	,	,	PUNCT
dpc-4071	261	13	and	and	CCONJ
dpc-4071	261	14	local	local	ADJ
dpc-4071	261	15	and	and	CCONJ
dpc-4071	261	16	systemic	systemic	ADJ
dpc-4071	261	17	implications	implication	NOUN
dpc-4071	261	18	.	.	PUNCT
dpc-4071	262	1	br	br	PROPN
dpc-4071	262	2	j	j	PROPN
dpc-4071	262	3	dermatol	dermatol	NOUN
dpc-4071	262	4	.	.	PUNCT
dpc-4071	263	1	2009;160(2):266	2009;160(2):266	NUM
dpc-4071	263	2	-	-	SYM
dpc-4071	263	3	72	72	NUM
dpc-4071	263	4	.	.	PUNCT
dpc-4071	264	1	doi	doi	NOUN
dpc-4071	264	2	:	:	PUNCT
dpc-4071	264	3	10.1111	10.1111	NUM
dpc-4071	264	4	/	/	SYM
dpc-4071	264	5	j.1365	j.1365	NOUN
dpc-4071	264	6	-	-	PUNCT
dpc-4071	264	7	2133.2008.08880.x	2133.2008.08880.x	NOUN
dpc-4071	264	8	.	.	PUNCT
dpc-4071	265	1	pmid	pmid	NOUN
dpc-4071	265	2	:	:	PUNCT
dpc-4071	265	3	18945300	18945300	NUM
dpc-4071	265	4	.	.	PUNCT
dpc-4071	266	1	9	9	X
dpc-4071	266	2	.	.	X
dpc-4071	266	3	fudge	fudge	PROPN
dpc-4071	266	4	jg	jg	PROPN
dpc-4071	266	5	,	,	PUNCT
dpc-4071	266	6	crawford	crawford	PROPN
dpc-4071	266	7	ri	ri	PROPN
dpc-4071	266	8	.	.	PUNCT
dpc-4071	267	1	bullous	bullous	ADJ
dpc-4071	267	2	pemphigoid	pemphigoid	ADV
dpc-4071	267	3	:	:	PUNCT
dpc-4071	267	4	a	a	DET
dpc-4071	267	5	10	10	NUM
dpc-4071	267	6	-	-	PUNCT
dpc-4071	267	7	year	year	NOUN
dpc-4071	267	8	study	study	NOUN
dpc-4071	267	9	of	of	ADP
dpc-4071	267	10	discordant	discordant	ADJ
dpc-4071	267	11	results	result	NOUN
dpc-4071	267	12	on	on	ADP
dpc-4071	267	13	direct	direct	ADJ
dpc-4071	267	14	immunofluorescence	immunofluorescence	NOUN
dpc-4071	267	15	.	.	PUNCT
dpc-4071	268	1	j	j	PROPN
dpc-4071	268	2	cutan	cutan	PROPN
dpc-4071	268	3	med	med	ADJ
dpc-4071	268	4	surg	surg	NOUN
dpc-4071	268	5	.	.	PUNCT
dpc-4071	269	1	2018;22(5):472	2018;22(5):472	NUM
dpc-4071	269	2	-	-	SYM
dpc-4071	269	3	5	5	NUM
dpc-4071	269	4	.	.	PUNCT
dpc-4071	269	5	doi	doi	NOUN
dpc-4071	269	6	:	:	PUNCT
dpc-4071	269	7	10.1177/1203475418773359	10.1177/1203475418773359	NUM
dpc-4071	269	8	.	.	PUNCT
dpc-4071	270	1	pmid	pmid	NOUN
dpc-4071	270	2	:	:	PUNCT
dpc-4071	270	3	29681159	29681159	NUM
dpc-4071	270	4	.	.	PUNCT
dpc-4071	271	1	10	10	NUM
dpc-4071	271	2	.	.	PUNCT
dpc-4071	271	3	farnaghi	farnaghi	PROPN
dpc-4071	272	1	f	f	X
dpc-4071	272	2	,	,	PUNCT
dpc-4071	272	3	ehsani	ehsani	ADJ
dpc-4071	272	4	ah	ah	INTJ
dpc-4071	272	5	,	,	PUNCT
dpc-4071	272	6	kamyab	kamyab	ADJ
dpc-4071	272	7	-	-	PUNCT
dpc-4071	272	8	hesary	hesary	PROPN
dpc-4071	272	9	k	k	NOUN
dpc-4071	272	10	,	,	PUNCT
dpc-4071	272	11	abbasian	abbasian	PROPN
dpc-4071	272	12	s	s	PROPN
dpc-4071	272	13	,	,	PUNCT
dpc-4071	272	14	seirafi	seirafi	PROPN
dpc-4071	272	15	h	h	PROPN
dpc-4071	272	16	,	,	PUNCT
dpc-4071	272	17	nasimi	nasimi	PROPN
dpc-4071	272	18	m.	m.	NOUN
dpc-4071	272	19	correlation	correlation	NOUN
dpc-4071	272	20	of	of	ADP
dpc-4071	272	21	dermal	dermal	NOUN
dpc-4071	272	22	and	and	CCONJ
dpc-4071	272	23	blood	blood	NOUN
dpc-4071	272	24	eosinophilia	eosinophilia	NOUN
dpc-4071	272	25	with	with	ADP
dpc-4071	272	26	bullous	bullous	ADJ
dpc-4071	272	27	pemphigoid	pemphigoid	ADJ
dpc-4071	272	28	disease	disease	NOUN
dpc-4071	272	29	severity	severity	NOUN
dpc-4071	272	30	.	.	PUNCT
dpc-4071	273	1	int	int	PROPN
dpc-4071	273	2	j	j	PROPN
dpc-4071	273	3	womens	womens	PROPN
dpc-4071	273	4	dermatol	dermatol	NOUN
dpc-4071	273	5	.	.	PUNCT
dpc-4071	274	1	2020;6(3):171	2020;6(3):171	NUM
dpc-4071	274	2	-	-	SYM
dpc-4071	274	3	5	5	NUM
dpc-4071	274	4	.	.	PUNCT
dpc-4071	274	5	doi	doi	NOUN
dpc-4071	274	6	:	:	PUNCT
dpc-4071	274	7	10.1016	10.1016	NUM
dpc-4071	274	8	/	/	SYM
dpc-4071	274	9	j.ijwd.2020.01.005	j.ijwd.2020.01.005	PROPN
dpc-4071	274	10	.	.	PUNCT
dpc-4071	275	1	pmid	pmid	NOUN
dpc-4071	275	2	:	:	PUNCT
dpc-4071	275	3	32637539	32637539	NUM
dpc-4071	275	4	.	.	PUNCT
dpc-4071	276	1	pmcid	pmcid	ADJ
dpc-4071	276	2	:	:	PUNCT
dpc-4071	276	3	pmc7330446	pmc7330446	NOUN
dpc-4071	276	4	.	.	PUNCT